<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
<head>

<meta charset="utf-8">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />
<meta name="author" content="Tim Woelfle" />

<meta name="date" content="2023-08-15" />


<title>PRECIS-2 Scores in PragMeta: Human Consensus vs LMM (GPT 3.5) - 2nd run</title>

<meta property="og:title" content="PRECIS-2 Scores in PragMeta: Human Consensus vs LMM (GPT 3.5) - 2nd run" />

<meta name='viewport' content='width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no' />

<link rel="icon" href="data:image/x-icon;" type="image/x-icon">


<script type="text/javascript">
window.FlexDashboardComponents = [];
</script>

<script id="flexdashboard-navbar" type="application/json">
[{"title":"Source Code","icon":"fa-code","href":"","align":"right"}]
</script>
<script src="lib/header-attrs-2.21/header-attrs.js"></script>
<script src="lib/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="lib/bootstrap-3.3.5/css/cosmo.min.css" rel="stylesheet" />
<script src="lib/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="lib/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="lib/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="lib/stickytableheaders-0.1.19/jquery.stickytableheaders.min.js"></script>
<link href="lib/font-awesome-6.4.0/css/all.min.css" rel="stylesheet" />
<link href="lib/font-awesome-6.4.0/css/v4-shims.min.css" rel="stylesheet" />
<link href="lib/value-box-accent-static-0.6.1/theme-cosmo-value-box.css" rel="stylesheet" />
<link href="lib/flexdashboard-css-0.6.1/flexdashboard.min.css" rel="stylesheet" />
<link href="lib/flexdashboard-css-0.6.1/theme-cosmo.css" rel="stylesheet" />
<script src="lib/htmlwidgets-1.6.2/htmlwidgets.js"></script>
<link href="lib/datatables-css-0.0.0/datatables-crosstalk.css" rel="stylesheet" />
<script src="lib/datatables-binding-0.28/datatables.js"></script>
<link href="lib/dt-core-1.13.4/css/jquery.dataTables.min.css" rel="stylesheet" />
<link href="lib/dt-core-1.13.4/css/jquery.dataTables.extra.css" rel="stylesheet" />
<script src="lib/dt-core-1.13.4/js/jquery.dataTables.min.js"></script>
<link href="lib/crosstalk-1.2.0/css/crosstalk.min.css" rel="stylesheet" />
<script src="lib/crosstalk-1.2.0/js/crosstalk.min.js"></script>
<style type="text/css">
/*
  CSS for flexdashboard.js' use of Sly(). The sizing/position of this CSS needs to be
  applied _before_ flexdashboard.js initializes, which is why this CSS has been pulled
  out from flexdashboard.scss and inlined in the document's head.
*/

.storyboard-nav button {
  background: transparent;
  border: 0;
  opacity: .3;
  outline: none;
  padding: 0;
}

.storyboard-nav button:hover,
.storyboard-nav button:hover {
  opacity: .5;
}

.storyboard-nav button:disabled,
.storyboard-nav button:disabled {
  opacity: .1;
}

.storyboard-nav .sbnext,
.storyboard-nav .sbprev {
  float: left;
  width: 2%;
  height: 120px;
}

.storyboard-nav .sbprev {
  text-align: left;
  width: 2%;
}

.storyboard-nav .sbnext {
  float: right;
  text-align: right;
  margin-right: 8px;
}

.storyboard-nav .sbframelist {
  margin: 0 auto;
  width: 94%;
  height: 120px;
  overflow: hidden;
  text-shadow: none;
  margin-bottom: 8px;
}

.storyboard-nav .sbframelist ul {
  list-style: none;
  margin: 0;
  padding: 0;
  height: 100%;
}

.storyboard-nav .sbframelist ul li {
  float: left;
  width: 270px;
  height: 100%;
  padding: 10px 10px 10px 10px;
  margin-right: 8px;
  text-align: left;
  cursor: pointer;
}

.storyboard-nav .sbframelist ul li:last-child {
  margin-right: 0px;
}

.sbframe-commentary {
  width: 300px;
}

.sbframe-commentary ul {
  padding-left: 22px;
}

.sbframe.active {
  display: flex;
}

.sbframe:not(.active) {
  display: none;
}
@media only screen and (min-width: 768px) {
html, body {
  height: 100%;
}

#dashboard-container {
  height: 100%;
}
}
</style>



</head>

<body>

<div class="navbar navbar-inverse navbar-fixed-top" role="navigation">
<div class="container-fluid">
<div class="navbar-header">

<span class="navbar-logo pull-left">
  
</span>
<span class="navbar-brand">
  PRECIS-2 Scores in PragMeta: Human Consensus vs LMM (GPT 3.5) - 2nd run
  <span class="navbar-author">
    Tim Woelfle &mdash; 2023-08-15
    </span>
</span>

<button id="navbar-button" type="button" class="navbar-toggle collapsed pull-right" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
<span class="icon-bar"></span>
<span class="icon-bar"></span>
<span class="icon-bar"></span>
</button>

</div>
<div id="navbar" class="navbar-collapse collapse">
<ul class="nav navbar-nav navbar-left">
</ul>
<ul class="nav navbar-nav navbar-right">
</ul>
</div><!--/.nav-collapse-->
</div><!--/.container-->
</div><!--/.navbar-->

<script type="text/javascript">


var FlexDashboard = (function () {

  // initialize options
  var _options = {};

  var FlexDashboard = function() {

    // default options
    _options = $.extend(_options, {
      theme: "cosmo",
      fillPage: false,
      orientation: 'columns',
      storyboard: false,
      defaultFigWidth: 576,
      defaultFigHeight: 461,
      defaultFigWidthMobile: 360,
      defaultFigHeightMobile: 461,
      isMobile: false,
      isPortrait: false,
      resize_reload: true
    });
  };

  function init(options) {

    // extend default options
    $.extend(true, _options, options);

    // add ids to sections that don't have them (pandoc won't assign ids
    // to e.g. sections with titles consisting of only chinese characters)
    var nextId = 1;
    $('.level1:not([id]),.level2:not([id]),.level3:not([id])').each(function() {
      $(this).attr('id', 'dashboard-' + nextId++);
    });

    // find navbar items
    var navbarItems = $('#flexdashboard-navbar');
    if (navbarItems.length)
      navbarItems = JSON.parse(navbarItems.html());
    addNavbarItems(navbarItems);

    // find the main dashboard container
    var dashboardContainer = $('#dashboard-container');

    // resolve mobile classes
    resolveMobileClasses(dashboardContainer);

    // one time global initialization for components
    componentsInit(dashboardContainer);

    // look for a global sidebar
    var globalSidebar = dashboardContainer.find(".section.level1.sidebar");
    if (globalSidebar.length > 0) {

      // global layout for fullscreen displays
      if (!isMobilePhone()) {

         // hoist it up to the top level
         globalSidebar.insertBefore(dashboardContainer);

         // lay it out (set width/positions)
         layoutSidebar(globalSidebar, dashboardContainer);

      // tuck sidebar into first page for mobile phones
      } else {

        // convert it into a level3 section
        globalSidebar.removeClass('sidebar');
        globalSidebar.removeClass('level1');
        globalSidebar.addClass('level3');
        var h1 = globalSidebar.children('h1');
        var h3 = $('<h3></h3>');
        h3.append(h1.contents());
        h3.insertBefore(h1);
        h1.detach();

        // move it into the first page
        var page = dashboardContainer.find('.section.level1').first();
        if (page.length > 0)
          page.prepend(globalSidebar);
      }
    }

    // look for pages to layout
    var pages = $('div.section.level1');
    if (pages.length > 0) {

        // find the navbar and collapse on clicked
        var navbar = $('#navbar');
        navbar.on("click", "a[data-toggle!=dropdown]", null, function () {
           navbar.collapse('hide');
        });

        // envelop the dashboard container in a tab content div
        dashboardContainer.wrapInner('<div class="tab-content"></div>');

        pages.each(function(index) {

          // lay it out
          layoutDashboardPage($(this));

          // add it to the navbar
          addToNavbar($(this), index === 0);

        });

    } else {

      // remove the navbar and navbar button if we don't
      // have any navbuttons
      if (navbarItems.length === 0) {
        $('#navbar').remove();
        $('#navbar-button').remove();
      }

      // add the storyboard class if requested
      if (_options.storyboard)
        dashboardContainer.addClass('storyboard');

      // layout the entire page
      layoutDashboardPage(dashboardContainer);
    }

    // if we are in shiny we need to trigger a window resize event to
    // force correct layout of shiny-bound-output elements
    if (isShinyDoc())
      $(window).trigger('resize');

    // make main components visible
    $('.section.sidebar').css('visibility', 'visible');
    dashboardContainer.css('visibility', 'visible');

    // handle location hash
    handleLocationHash();

    // intialize prism highlighting
    initPrismHighlighting();

    // record mobile and orientation state then register a handler
    // to refresh if resize_reload is set to true and it changes
    _options.isMobile = isMobilePhone();
    _options.isPortrait = isPortrait();
    if (_options.resize_reload) {
      $(window).on('resize', function() {
        if (_options.isMobile !== isMobilePhone() ||
            _options.isPortrait !== isPortrait()) {
          window.location.reload();
        }
      });
    } else {
      // if in desktop mode and resizing to mobile, make sure the heights are 100%
      // This enforces what `fillpage.css` does for "wider" pages.
      // Since we are not reloading once the page becomes small, we need to force the height to 100%
      // This is a new situation introduced when `_options.resize_reload` is `false`
      if (! _options.isMobile) {
        // only add if `fillpage.css` was added in the first place
        if (_options.fillPage) {
          // fillpage.css
          $("html,body,#dashboard").css("height", "100%");
        }
      }
    }
    // trigger layoutcomplete event
    dashboardContainer.trigger('flexdashboard:layoutcomplete');
  }

  function resolveMobileClasses(dashboardContainer) {
     // add top level layout class
    dashboardContainer.addClass(isMobilePhone() ? 'mobile-layout' :
                                                  'desktop-layout');

    // look for .mobile sections and add .no-mobile to their peers
    var mobileSections = $('.section.mobile');
    mobileSections.each(function() {
       var id = $(this).attr('id');
       var nomobileId = id.replace(/-\d+$/, '');
       $('#' + nomobileId).addClass('no-mobile');
    });
  }

  function addNavbarItems(navbarItems) {

    var navbarLeft = $('ul.navbar-left');
    var navbarRight = $('ul.navbar-right');

    for (var i = 0; i<navbarItems.length; i++) {

      // get the item
      var item = navbarItems[i];

      // determine the container
      var container = null;
      if (item.align === "left")
        container = navbarLeft;
      else
        container = navbarRight;

      // navbar menu if we have multiple items
      if (item.items) {
        var menu = navbarMenu(null, item.icon, item.title, container);
        for (var j = 0; j<item.items.length; j++) {
          var subItem = item.items[j];
          var li = $('<li></li>');
          var a = navbarLink(subItem.icon, subItem.title, subItem.href, subItem.target);
          a.removeClass("nav-link").addClass("dropdown-item");
          li.append(a);
          menu.append(li);
        }
      } else {
        var li = $('<li class="nav-item"></li>');
        li.append(navbarLink(item.icon, item.title, item.href, item.target));
        container.append(li);
      }
    }
  }

  // create or get a reference to an existing dropdown menu
  function navbarMenu(id, icon, title, container) {
    var existingMenu = [];
    if (id)
      existingMenu = container.children('#' + id);
    if (existingMenu.length > 0) {
      return existingMenu.children('ul');
    } else {
      var li = $('<li class="nav-item"></li>');
      if (id)
        li.attr('id', id);
      li.addClass('dropdown');
      // auto add "Share" title on mobile if necessary
      if (!title && icon && (icon === "fa-share-alt") && isMobilePhone())
        title = "Share";
      if (title) {
        title = title + ' <span class="caret"></span>';
      }
      var a = navbarLink(icon, title, "#");
      a.addClass('dropdown-toggle');
      a.attr('data-toggle', 'dropdown');
      a.attr('data-bs-toggle', 'dropdown');
      a.attr('role', 'button');
      a.attr('aria-expanded', 'false');
      li.append(a);
      var ul = $('<ul class="dropdown-menu"></ul>');
      ul.attr('role', 'menu');
      li.append(ul);
      container.append(li);
      return ul;
    }
  }

  function addToNavbar(page, active) {

    // capture the id and data-icon attribute (if any)
    var id = page.attr('id');
    var icon = page.attr('data-icon');
    var navmenu = page.attr('data-navmenu');

    // get hidden state (transfer this to navbar)
    var hidden = page.hasClass('hidden');
    page.removeClass('hidden');

    // sanitize the id for use with bootstrap tabs
    id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
    page.attr('id', id);

    // get the wrapper
    var wrapper = page.closest('.dashboard-page-wrapper');

    // move the id to the wrapper
    page.removeAttr('id');
    wrapper.attr('id', id);

    // add the tab-pane class to the wrapper
    wrapper.addClass('tab-pane');
    if (active)
      wrapper.addClass('active');

    // get a reference to the h1, discover its inner contens, then detach it
    var h1 = wrapper.find('h1').first();
    var title = h1.contents();
    h1.detach();

    // create a navbar item
    var li = $('<li></li>');
    var a = navbarLink(icon, title, '#' + id);
    a.attr('data-toggle', 'tab');
    li.append(a);

    // add it to the navbar (or navbar menu if specified)
    var container = $('ul.navbar-left');
    if (navmenu) {
      var menuId = navmenu.replace(/\s+/g, '');
      var menu = navbarMenu(menuId, null, navmenu, container);
      li.find("> a").removeClass("nav-link").addClass("dropdown-item");
      menu.append(li);
    } else {
      li.addClass("nav-item")
      container.append(li);
    }

    // hide it if requested
    if (hidden)
      li.addClass('hidden');
  }

  function navbarLink(icon, title, href, target) {

    var a = $('<a class="nav-link"></a>');
    if (icon) {

      // get the name of the icon set and icon
      var dashPos = icon.indexOf("-");
      var iconSet = null;
      var iconSplit = icon.split(" ");
      if (iconSplit.length > 1) {
        iconSet = iconSplit[0];
        icon = iconSplit.slice(1).join(" ");
      } else {
        iconSet = icon.substring(0, dashPos);
      }
      var iconName = icon.substring(dashPos + 1);

      // create the icon
      var iconElement = $('<span class="' + iconSet + ' ' + icon + '"></span>');
      if (title)
        iconElement.css('margin-right', '7px');
      a.append(iconElement);
      // if href is null see if we can auto-generate based on icon (e.g. social)
      if (!href)
        maybeGenerateLinkFromIcon(iconName, a);
    }
    if (title)
      a.append(title);

    // add the href.
    if (href) {
      if (href === "source_embed") {
        a.attr('href', '#');
        a.attr('data-featherlight', "#flexdashboard-source-code");
        a.featherlight({
            beforeOpen: function(event){
              $('body').addClass('unselectable');
            },
            afterClose: function(event){
              $('body').removeClass('unselectable');
            }
        });
      } else {
        a.attr('href', href);
      }
    }

    // add the arget
    if (target)
      a.attr('target', target);

    return a;
  }

  // auto generate a link from an icon name (e.g. twitter) when possible
  function maybeGenerateLinkFromIcon(iconName, a) {

     var serviceLinks = {
      "twitter": "https://twitter.com/share?text=" + encodeURIComponent(document.title) + "&url="+encodeURIComponent(location.href),
      "facebook": "https://www.facebook.com/sharer/sharer.php?s=100&p[url]="+encodeURIComponent(location.href),
      "linkedin": "https://www.linkedin.com/shareArticle?mini=true&url="+encodeURIComponent(location.href) + "&title=" + encodeURIComponent(document.title),
      "pinterest": "https://pinterest.com/pin/create/link/?url="+encodeURIComponent(location.href) + "&description=" + encodeURIComponent(document.title)
    };

    var makeSocialLink = function(a, href) {
      a.attr('href', '#');
      a.on('click', function(e) {
        e.preventDefault();
        window.open(href);
      });
    };

    $.each(serviceLinks, function(key, value) {
      if (iconName.indexOf(key) !== -1)
        makeSocialLink(a, value);
    });
  }

  // layout a dashboard page
  function layoutDashboardPage(page) {

    // use a page wrapper so that free form content above the
    // dashboard appears at the top rather than the side (as it
    // would without the wrapper in a column orientation)
    var wrapper = $('<div class="dashboard-page-wrapper"></div>');
    page.wrap(wrapper);

    // if there are no level2 or level3 headers synthesize a level3
    // header to contain the (e.g. frame it, scroll container, etc.)
    var headers = page.find('h2,h3');
    if (headers.length === 0)
      page.wrapInner('<div class="section level3"></div>');

    // hoist up any content before level 2 or level 3 headers
    var children = page.children();
    children.each(function(index) {
      if ($(this).hasClass('level2') || $(this).hasClass('level3'))
        return false;
      $(this).insertBefore(page);
    });

    // determine orientation and fillPage behavior for distinct media
    var orientation, fillPage, storyboard;

    // media: mobile phone
    if (isMobilePhone()) {

      // if there is a sidebar we need to ensure it's content
      // is properly framed as an h3
      var sidebar = page.find('.section.sidebar');
      sidebar.removeClass('sidebar');
      sidebar.wrapInner('<div class="section level3"></div>');
      var h2 = sidebar.find('h2');
      var h3 = $('<h3></h3>');
      h3.append(h2.contents());
      h3.insertBefore(h2);
      h2.detach();

      // wipeout h2 elements then enclose them in a single h2
      var level2 = page.find('div.section.level2');
      level2.each(function() {
        level2.children('h2').remove();
        level2.children().unwrap();
      });
      page.wrapInner('<div class="section level2"></div>');

      // substitute mobile images
      if (isPortrait()) {
        var mobileFigures = $('img.mobile-figure');
        mobileFigures.each(function() {
          // get the src (might be base64 encoded)
          var src = $(this).attr('src');

          // find it's peer
          var id = $(this).attr('data-mobile-figure-id');
          var img = $('img[data-figure-id=' + id + "]");
          img.attr('src', src)
             .attr('width', _options.defaultFigWidthMobile)
             .attr('height', _options.defaultFigHeightMobile);
        });
      }

      // hoist storyboard commentary into it's own section
      if (page.hasClass('storyboard')) {
        var commentaryHR = page.find('div.section.level3 hr');
        commentaryHR.each(function() {
          var commentary = $(this).nextAll().detach();
          var commentarySection = $('<div class="section level3"></div>');
          commentarySection.append(commentary);
          commentarySection.insertAfter($(this).closest('div.section.level3'));
          $(this).remove();
        });
      }

      // force a non full screen layout by columns
      orientation = _options.orientation = 'columns';
      fillPage = _options.fillPage = false;
      storyboard = _options.storyboard = false;

    // media: desktop
    } else {

      // determine orientation
      orientation = page.attr('data-orientation');
      if (orientation !== 'rows' && orientation != 'columns')
        orientation = _options.orientation;

      // determine storyboard mode
      storyboard = page.hasClass('storyboard');

      // fillPage based on options (force for storyboard)
      fillPage = _options.fillPage || storyboard;

      // handle sidebar
      var sidebar = page.find('.section.level2.sidebar');
      if (sidebar.length > 0)
        layoutSidebar(sidebar, page);
    }

    // give it and it's parent divs height: 100% if we are in fillPage mode
    if (fillPage) {
      page.addClass('vertical-layout-fill');
      page.css('height', '100%');
      page.parents('div').css('height', '100%');
    } else {
      page.addClass('vertical-layout-scroll');
    }

    // perform the layout
    if (storyboard)
      layoutPageAsStoryboard(page);
    else if (orientation === 'rows')
      layoutPageByRows(page, fillPage);
    else if (orientation === 'columns')
      layoutPageByColumns(page, fillPage);
  }

  function layoutSidebar(sidebar, content) {

    // get it out of the header hierarchy
    sidebar = sidebar.first();
    if (sidebar.hasClass('level1')) {
      sidebar.removeClass('level1');
      sidebar.children('h1').remove();
    } else if (sidebar.hasClass('level2')) {
      sidebar.removeClass('level2');
      sidebar.children('h2').remove();
    }

    // determine width
    var sidebarWidth = isTablet() ? 220 : 250;
    var dataWidth = parseInt(sidebar.attr('data-width'));
    if (dataWidth)
      sidebarWidth = dataWidth;

    // set the width and shift the page right to accomodate the sidebar
    sidebar.css('width', sidebarWidth + 'px');
    content.css('padding-left', sidebarWidth + 'px');

    // wrap it's contents in a form
    sidebar.wrapInner($('<form></form>'));
  }

  function layoutPageAsStoryboard(page) {

    // create storyboard navigation
    var nav = $('<div class="storyboard-nav"></div>');

    // add navigation buttons
    var prev = $('<button class="sbprev"><i class="fa fa-angle-left"></i></button>');
    nav.append(prev);
    var next= $('<button class="sbnext"><i class="fa fa-angle-right"></i></button>');
    nav.append(next);

    // add navigation frame
    var frameList = $('<div class="sbframelist"></div>');
    nav.append(frameList);
    var ul = $('<ul></ul>');
    frameList.append(ul);

     // find all the level3 sections (those are the storyboard frames)
    var frames = page.find('div.section.level3');
    frames.each(function() {

      // mark it
      $(this).addClass('sbframe');

      // divide it into chart content and (optional) commentary
      $(this).addClass('dashboard-column-orientation');

      // stuff the chart into it's own div w/ flex
      $(this).wrapInner('<div class="sbframe-component"></div>');
      setFlex($(this), 1);
      var frame = $(this).children('.sbframe-component');

      // extract the title from the h3
      var li = $('<li></li>');
      var h3 = frame.children('h3');
      li.append(h3.contents());
      h3.detach();
      ul.append(li);

      // extract commentary
      var hr = frame.children('hr');
      if (hr.length) {
        var commentary = hr.nextAll().detach();
        hr.remove();
        var commentaryFrame = $('<div class="sbframe-commentary"></div>');
        commentaryFrame.addClass('flowing-content-shim');
        commentaryFrame.addClass('flowing-content-container');
        commentaryFrame.append(commentary);
        $(this).append(commentaryFrame);

        // look for a data-commentary-width attribute
        var commentaryWidth = $(this).attr('data-commentary-width');
        if (commentaryWidth)
          commentaryFrame.css('width', commentaryWidth + 'px');
      }

      // layout the chart (force flex)
      var result = layoutChart(frame, true);

      // ice the notes if there are none
      if (!result.notes)
        frame.find('.chart-notes').remove();

      // set flex on chart
      setFlex(frame, 1);
    });

    // create a div to hold all the frames
    var frameContent = $('<div class="sbframe-content"></div>');
    frameContent.addClass('dashboard-row-orientation');
    frameContent.append(frames.detach());

    // row orientation to stack nav and frame content
    page.addClass('dashboard-row-orientation');
    page.append(nav);
    page.append(frameContent);
    setFlex(frameContent, 1);

    // initialize sly
    var sly = new Sly(frameList, {
    		horizontal: true,
    		itemNav: 'basic',
    		smart: true,
    		activateOn: 'click',
    		startAt: 0,
    		scrollBy: 1,
    		activatePageOn: 'click',
    		speed: 200,
    		moveBy: 600,
    		dragHandle: true,
    		dynamicHandle: true,
    		clickBar: true,
    		keyboardNavBy: 'items',
    		next: next,
    		prev: prev
    	}).init();

    // make first frame active
    frames.removeClass('active');
    frames.first().addClass('active');

    // subscribe to frame changed events
    sly.on('active', function (eventName, itemIndex) {
      frames.removeClass('active');
      frames.eq(itemIndex).addClass('active')
                          .trigger('shown');
    });
  }

  function layoutPageByRows(page, fillPage) {

    // row orientation
    page.addClass('dashboard-row-orientation');

    // find all the level2 sections (those are the rows)
    var rows = page.find('div.section.level2');

    // if there are no level2 sections then treat the
    // entire page as if it's a level 2 section
    if (rows.length === 0) {
      page.wrapInner('<div class="section level2"></div>');
      rows = page.find('div.section.level2');
    }

    rows.each(function () {

      // flags
      var haveNotes = false;
      var haveFlexHeight = true;

      // remove the h2
      $(this).children('h2').remove();

      // check for a tabset
      var isTabset = $(this).hasClass('tabset');
      if (isTabset)
        layoutTabset($(this));

      // give it row layout semantics if it's not a tabset
      if (!isTabset)
        $(this).addClass('dashboard-row');

      // find all of the level 3 subheads
      var columns = $(this).find('div.section.level3');

      // determine figureSizes sizes
      var figureSizes = chartFigureSizes(columns);

      // fixup the columns
      columns.each(function(index) {

        // layout the chart (force flex if we are in a tabset)
        var result = layoutChart($(this), isTabset);

        // update flexHeight state
        if (!result.flex)
          haveFlexHeight = false;

        // update state
        if (result.notes)
          haveNotes = true;

        // set the column flex based on the figure width
        // (value boxes will just get the default figure width)
        var chartWidth = figureSizes[index].width;
        setFlex($(this), chartWidth + ' ' + chartWidth + ' 0px');

      });

      // remove empty chart note divs
      if (isTabset)
        $(this).find('.chart-notes').filter(function() {
            return $(this).html() === "&nbsp;";
        }).remove();
      if (!haveNotes)
        $(this).find('.chart-notes').remove();

       // make it a flexbox row
      if (haveFlexHeight)
        $(this).addClass('dashboard-row-flex');

      // now we can set the height on all the wrappers (based on maximum
      // figure height + room for title and notes, or data-height on the
      // container if specified). However, don't do this if there is
      // no flex on any of the constituent columns
      var flexHeight = null;
      var dataHeight = parseInt($(this).attr('data-height'));
      if (dataHeight)
        flexHeight = adjustedHeight(dataHeight, columns.first());
      else if (haveFlexHeight)
        flexHeight = maxChartHeight(figureSizes, columns);
      if (flexHeight) {
        if (fillPage)
          setFlex($(this), flexHeight + ' ' + flexHeight + ' 0px');
        else {
          $(this).css('height', flexHeight + 'px');
          setFlex($(this), '0 0 ' + flexHeight + 'px');
        }
      }

    });
  }

  function layoutPageByColumns(page, fillPage) {

    // column orientation
    page.addClass('dashboard-column-orientation');

    // find all the level2 sections (those are the columns)
    var columns = page.find('div.section.level2');

    // if there are no level2 sections then treat the
    // entire page as if it's a level 2 section
    if (columns.length === 0) {
      page.wrapInner('<div class="section level2"></div>');
      columns = page.find('div.section.level2');
    }

    // layout each column
    columns.each(function (index) {

      // remove the h2
      $(this).children('h2').remove();

      // make it a flexbox column
      $(this).addClass('dashboard-column');

      // check for a tabset
      var isTabset = $(this).hasClass('tabset');
      if (isTabset)
        layoutTabset($(this));

      // find all the h3 elements
      var rows = $(this).find('div.section.level3');

      // get the figure sizes for the rows
      var figureSizes = chartFigureSizes(rows);

      // column flex is the max row width (or data-width if specified)
      var flexWidth;
      var dataWidth = parseInt($(this).attr('data-width'));
      if (dataWidth)
        flexWidth = dataWidth;
      else
        flexWidth = maxChartWidth(figureSizes);
      setFlex($(this), flexWidth + ' ' + flexWidth + ' 0px');

      // layout each chart
      rows.each(function(index) {

        // perform the layout
        var result = layoutChart($(this), false);

        // ice the notes if there are none
        if (!result.notes)
          $(this).find('.chart-notes').remove();

        // set flex height based on figHeight, then adjust
        if (result.flex) {
          var chartHeight = figureSizes[index].height;
          chartHeight = adjustedHeight(chartHeight, $(this));
          if (fillPage)
            setFlex($(this), chartHeight + ' ' + chartHeight + ' 0px');
          else {
            $(this).css('height', chartHeight + 'px');
            setFlex($(this), chartHeight + ' ' + chartHeight + ' ' + chartHeight + 'px');
          }
        }
      });
    });
  }

  function chartFigureSizes(charts) {

    // sizes
    var figureSizes = new Array(charts.length);

    // check each chart
    charts.each(function(index) {

      // start with default
      figureSizes[index] = {
        width: _options.defaultFigWidth,
        height: _options.defaultFigHeight
      };

      // look for data-height or data-width then knit options
      var dataWidth = parseInt($(this).attr('data-width'));
      var dataHeight = parseInt($(this).attr('data-height'));
      var knitrOptions = $(this).find('.knitr-options:first');
      var knitrWidth, knitrHeight;
      if (knitrOptions) {
        knitrWidth = parseInt(knitrOptions.attr('data-fig-width'));
        knitrHeight =  parseInt(knitrOptions.attr('data-fig-height'));
      }

      // width
      if (dataWidth)
        figureSizes[index].width = dataWidth;
      else if (knitrWidth)
        figureSizes[index].width = knitrWidth;

      // height
      if (dataHeight)
        figureSizes[index].height = dataHeight;
      else if (knitrHeight)
        figureSizes[index].height = knitrHeight;
    });

    // return sizes
    return figureSizes;
  }

  function maxChartHeight(figureSizes, charts) {

    // first compute the maximum height
    var maxHeight = _options.defaultFigHeight;
    for (var i = 0; i<figureSizes.length; i++)
      if (figureSizes[i].height > maxHeight)
        maxHeight = figureSizes[i].height;

    // now add offests for chart title and chart notes
    if (charts.length)
      maxHeight = adjustedHeight(maxHeight, charts.first());

    return maxHeight;
  }

  function adjustedHeight(height, chart) {
    if (chart.length > 0) {
      var chartTitle = chart.find('.chart-title');
      if (chartTitle.length)
        height += chartTitle.first().outerHeight();
      var chartNotes = chart.find('.chart-notes');
      if (chartNotes.length)
        height += chartNotes.first().outerHeight();
    }
    return height;
  }

  function maxChartWidth(figureSizes) {
    var maxWidth = _options.defaultFigWidth;
    for (var i = 0; i<figureSizes.length; i++)
      if (figureSizes[i].width > maxWidth)
        maxWidth = figureSizes[i].width;
    return maxWidth;
  }

  // layout a chart
  function layoutChart(chart, forceFlex) {

    // state to return
    var result = {
      notes: false,
      flex: false
    };

    // extract the title
    var title = extractTitle(chart);

    // find components that apply to this container
    var components = componentsFind(chart);

    // if it's a custom component then call it and return
    var customComponents = componentsCustom(components);
    if (customComponents.length) {
      componentsLayout(customComponents, title, chart);
      result.notes = false;
      result.flex = forceFlex || componentsFlex(customComponents);
      return result;
    }

    // put all the content in a chart wrapper div
    chart.addClass('chart-wrapper');
    chart.wrapInner('<div class="chart-stage"></div>');
    var chartContent = chart.children('.chart-stage');

    // flex the content if appropriate
    result.flex = forceFlex || componentsFlex(components);
    if (result.flex) {
      // add flex classes
      chart.addClass('chart-wrapper-flex');
      chartContent.addClass('chart-stage-flex');

      // additional shim to break out of flexbox sizing
      chartContent.wrapInner('<div class="chart-shim"></div>');
      chartContent = chartContent.children('.chart-shim');
    }

    // set custom data-padding attribute
    var pad = chart.attr('data-padding');
    if (pad) {
      if (pad === "0")
        chart.addClass('no-padding');
      else {
        pad = pad + 'px';
        chartContent.css('left', pad)
                    .css('top', pad)
                    .css('right', pad)
                    .css('bottom', pad)
      }
    }

    // call compoents
    componentsLayout(components, title, chartContent);

    // also activate components on shiny output
    findShinyOutput(chartContent).on('shiny:value',
      function(event) {
        var element = $(event.target);
        setTimeout(function() {

          // see if we opted out of flex based on our output (for shiny
          // we can't tell what type of output we have until after the
          // value is bound)
          var components = componentsFind(element);
          var flex = forceFlex || componentsFlex(components);
          if (!flex) {
            chart.css('height', "");
            setFlex(chart, "");
            chart.removeClass('chart-wrapper-flex');
            chartContent.removeClass('chart-stage-flex');
            chartContent.children().unwrap();
          }

          // perform layout
          componentsLayout(components, title, element.parent());
        }, 10);
      });

    // add the title
    var chartTitle = $('<div class="chart-title"></div>');
    chartTitle.append(title);
    chart.prepend(chartTitle);

    // add the notes section
    var chartNotes = $('<div class="chart-notes"></div>');
    chartNotes.html('&nbsp;');
    chart.append(chartNotes);

    // attempt to extract notes if we have a component
    if (components.length)
      result.notes = extractChartNotes(chartContent, chartNotes);

    // return result
    return result;
  }

  // build a tabset from a section div with the .tabset class
  function layoutTabset(tabset) {

    // check for fade option
    var fade = tabset.hasClass("tabset-fade");
    var pills = tabset.hasClass("tabset-pills");
    var navClass = pills ? "nav-pills" : "nav-tabs";

    // determine the heading level of the tabset and tabs
    var match = tabset.attr('class').match(/level(\d) /);
    if (match === null)
      return;
    var tabsetLevel = Number(match[1]);
    var tabLevel = tabsetLevel + 1;

    // find all subheadings immediately below
    var tabs = tabset.find("div.section.level" + tabLevel);
    if (!tabs.length)
      return;

    // create tablist and tab-content elements
    var tabList = $('<ul class="nav ' + navClass + '" role="tablist"></ul>');
    $(tabs[0]).before(tabList);
    var tabContent = $('<div class="tab-content"></div>');
    $(tabs[0]).before(tabContent);

    // build the tabset
    var activeTab = 0;
    tabs.each(function(i) {

      // get the tab div
      var tab = $(tabs[i]);

      // get the id then sanitize it for use with bootstrap tabs
      var id = tab.attr('id');

      // see if this is marked as the active tab
      if (tab.hasClass('active'))
        activeTab = i;

      // sanitize the id for use with bootstrap tabs
      id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
      tab.attr('id', id);

      // get the heading element within it and grab it's text
      var heading = tab.find('h' + tabLevel + ':first');
      var headingDom = heading.contents();

      // build and append the tab list item
      var a = $('<a role="tab" data-toggle="tab" class="nav-link"></a>');
      a.append(headingDom);
      a.attr('href', '#' + id);
      a.attr('aria-controls', id);
      var li = $('<li role="presentation" class="nav-item"></li>');
      li.append(a);
      tabList.append(li);

      // set it's attributes
      tab.attr('role', 'tabpanel');
      tab.addClass('tab-pane');
      tab.addClass('tabbed-pane');
      tab.addClass('no-title');
      if (fade)
        tab.addClass('fade');

      // move it into the tab content div
      tab.detach().appendTo(tabContent);
    });

    // set active tab
    $(tabList.children()[activeTab]).tab("show");
    var active = $(tabContent.children('div.section')[activeTab]);
    active.addClass('active');
    if (fade)
      active.addClass('in');

    // add nav-tabs-custom
    tabset.addClass('nav-tabs-custom');

    // internal layout is dashboard-column with tab-content flexing
    tabset.addClass('dashboard-column');
    setFlex(tabContent, 1);
  }

  // one time global initialization for components
  function componentsInit(dashboardContainer) {
    for (var i=0; i<window.FlexDashboardComponents.length; i++) {
      var component = window.FlexDashboardComponents[i];
      if (component.init)
        component.init(dashboardContainer);
    }
  }

  // find components that apply within a container
  function componentsFind(container) {

    // look for components
    var components = [];
    for (var i=0; i<window.FlexDashboardComponents.length; i++) {
      var component = window.FlexDashboardComponents[i];
      if (component.find(container).length)
        components.push(component);
    }

    // if there were none then use a special flowing content component
    // that just adds a scrollbar in fillPage mode
    if (components.length == 0) {
      components.push({
        find: function(container) {
          return container;
        },

        flex: function(fillPage) {
          return fillPage;
        },

        layout: function(title, container, element, fillPage) {
          if (fillPage) {
            container.addClass('flowing-content-shim');
            container.addClass('flowing-content-container');
          }
        }
      });
    }

    return components;
  }

  // if there is a custom component then pick it out
  function componentsCustom(components) {
    var customComponent = [];
    for (var i=0; i<components.length; i++)
      if (components[i].type === "custom") {
        customComponent.push(components[i]);
        break;
      }
    return customComponent;
  }

  // query all components for flex
  function componentsFlex(components) {

    // no components at all means no flex
    if (components.length === 0)
      return false;

    // otherwise query components (assume true unless we see false)
    var isMobile = isMobilePhone();
    for (var i=0; i<components.length; i++)
      if (components[i].flex && !components[i].flex(_options.fillPage))
        return false;
    return true;
  }

  // layout all components
  function componentsLayout(components, title, container) {
    var isMobile = isMobilePhone();
    for (var i=0; i<components.length; i++) {
      var element = components[i].find(container);
      if (components[i].layout) {
        // call layout (don't call other components if it returns false)
        var result = components[i].layout(title, container, element, _options.fillPage);
        if (result === false)
          return;
      }
    }
  }

  // get a reference to the h3, discover it's inner html, and remove it
  function extractTitle(container) {
    var h3 = container.children('h3').first();
    var title = '';
    if (!container.hasClass('no-title'))
      title = h3.contents();
    h3.detach();
    return title;
  }

  // extract chart notes
  function extractChartNotes(chartContent, chartNotes) {
    // look for a terminating blockquote or image caption
    var blockquote = chartContent.children('blockquote:last-child');
    var caption = chartContent.children('div.image-container')
                              .children('p.caption');
    if (blockquote.length) {
      chartNotes.empty().append(blockquote.children('p:first-child').contents());
      blockquote.remove();
      return true;
    } else if (caption.length) {
      chartNotes.empty().append(caption.contents());
      caption.remove();
      return true;
    } else {
      return false;
    }
  }

  function findShinyOutput(chartContent) {
    return chartContent.find('.shiny-text-output, .shiny-html-output');
  }

  // safely detect rendering on a mobile phone
  function isMobilePhone() {
    try
    {
      return ! window.matchMedia("only screen and (min-width: 768px)").matches;
    }
    catch(e) {
      return false;
    }
  }

  function isFillPage() {
    return _options.fillPage;
  }

  // detect portrait mode
  function isPortrait() {
    return ($(window).width() < $(window).height());
  }

  // safely detect rendering on a tablet
  function isTablet() {
    try
    {
      return window.matchMedia("only screen and (min-width: 769px) and (max-width: 992px)").matches;
    }
    catch(e) {
      return false;
    }
  }

  // test whether this is a shiny doc
  function isShinyDoc() {
    return (typeof(window.Shiny) !== "undefined" && !!window.Shiny.outputBindings);
  }

  // set flex using vendor specific prefixes
  function setFlex(el, flex) {
    el.css('-webkit-box-flex', flex)
      .css('-webkit-flex', flex)
      .css('-ms-flex', flex)
      .css('flex', flex);
  }

  // support bookmarking of pages
  function handleLocationHash() {

    // restore tab/page from bookmark
    var hash = window.decodeURIComponent(window.location.hash);
    if (hash.length > 0)
      $('ul.nav a[href="' + hash + '"]').tab('show');
    FlexDashboardUtils.manageActiveNavbarMenu();

    // navigate to a tab when the history changes
    window.addEventListener("popstate", function(e) {
      var hash = window.decodeURIComponent(window.location.hash);
      var activeTab = $('ul.nav a[href="' + hash + '"]');
      if (activeTab.length) {
        activeTab.tab('show');
      } else {
        $('ul.nav a:first').tab('show');
      }
      FlexDashboardUtils.manageActiveNavbarMenu();
    });

    // add a hash to the URL when the user clicks on a tab/page
    $('.navbar-nav a[data-toggle="tab"]').on('click', function(e) {
      var baseUrl = FlexDashboardUtils.urlWithoutHash(window.location.href);
      var hash = FlexDashboardUtils.urlHash($(this).attr('href'));
      var href = baseUrl + hash;
      FlexDashboardUtils.setLocation(href);
    });

    // handle clicks of other links that should activate pages
    var navPages = $('ul.navbar-nav li a[data-toggle=tab]');
    navPages.each(function() {
      var href =  $(this).attr('href');
      var links = $('a[href="' + href + '"][data-toggle!=tab]');
      links.each(function() {
        $(this).on('click', function(e) {
          window.FlexDashboardUtils.showPage(href);
        });
      });
    });
  }

  // tweak Prism highlighting
  function initPrismHighlighting() {

    if (window.Prism) {
      Prism.languages.insertBefore('r', 'comment', {
        'heading': [
          {
            // title 1
        	  // =======

        	  // title 2
        	  // -------
        	  pattern: /\w+.*(?:\r?\n|\r)(?:====+|----+)/,
            alias: 'operator'
          },
          {
            // ### title 3
            pattern: /(^\s*)###[^#].+/m,
            lookbehind: true,
            alias: 'operator'
          }
        ]
      });

      // prism highlight
      Prism.highlightAll();
    }
  }

  FlexDashboard.prototype = {
    constructor: FlexDashboard,
    init: init,
    isMobilePhone: isMobilePhone,
    isFillPage: isFillPage
  };

  return FlexDashboard;

})();

// utils
window.FlexDashboardUtils = {
  resizableImage: function(img) {
    var src = img.attr('src');
    var url = 'url("' + src + '")';
    img.parent().css('background', url)
                .css('background-size', 'contain')
                .css('background-repeat', 'no-repeat')
                .css('background-position', 'center')
                .addClass('image-container');
  },
  setLocation: function(href) {
    if (history && history.pushState) {
      history.pushState(null, null, href);
    } else {
      window.location.replace(href);
    }
    setTimeout(function() {
        window.scrollTo(0, 0);
    }, 10);
    this.manageActiveNavbarMenu();
  },
  showPage: function(href) {
    $('ul.navbar-nav li a[href="' + href + '"]').tab('show');
    var baseUrl = this.urlWithoutHash(window.location.href);
    var loc = baseUrl + href;
    this.setLocation(loc);
  },
  showLinkedValue: function(href) {
    // check for a page link
    if ($('ul.navbar-nav li a[data-toggle=tab][href="' + href + '"]').length > 0)
      this.showPage(href);
    else
      window.open(href);
  },
  urlWithoutHash: function(url) {
    var hashLoc = url.indexOf('#');
    if (hashLoc != -1)
      return url.substring(0, hashLoc);
    else
      return url;
  },
  urlHash: function(url) {
    var hashLoc = url.indexOf('#');
    if (hashLoc != -1)
      return url.substring(hashLoc);
    else
      return "";
  },
  manageActiveNavbarMenu: function () {
    // remove active from currently active tabs
    $('.navbar ul.nav .active').removeClass('active');
    // find the active tab
    var activeTab = $('.dashboard-page-wrapper.tab-pane.active');
    if (activeTab.length > 0) {
      var tabId = activeTab.attr('id');
      if (tabId)
        $(".navbar ul.nav a[href='#" + tabId + "']").tab("show");
    }
  }
};

window.FlexDashboard = new FlexDashboard();

// empty content
window.FlexDashboardComponents.push({
  find: function(container) {
    if (container.find('p').length == 0)
      return container;
    else
      return $();
  }
})

// plot image
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.children('p')
                    .children('img:only-child');
  },

  layout: function(title, container, element, fillPage) {
    FlexDashboardUtils.resizableImage(element);
  }
});

// plot image (figure style)
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.children('div.figure').children('img');
  },

  layout: function(title, container, element, fillPage) {
    FlexDashboardUtils.resizableImage(element);
  }
});

// htmlwidget
window.FlexDashboardComponents.push({

  init: function(dashboardContainer) {
    // trigger "shown" after initial layout to force static htmlwidgets
    // in runtime: shiny to be resized after the dom has been transformed
    dashboardContainer.on('flexdashboard:layoutcomplete', function(event) {
      setTimeout(function() {
        dashboardContainer.trigger('shown');
      }, 200);
    });
  },

  find: function(container) {
    return container.children('div[id^="htmlwidget-"],div.html-widget');
  }
});

// gauge
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.children('div.html-widget.gauge');
  },

  flex: function(fillPage) {
    return false;
  },

  layout: function(title, container, element, fillPage) {


  }

});

// shiny output
window.FlexDashboardComponents.push({
  find: function(container) {
    return container.children('div[class^="shiny-"]');
  }
});

// bootstrap table
window.FlexDashboardComponents.push({

  find: function(container) {
    var bsTable = container.find('table.table');
    if (bsTable.length !== 0)
      return bsTable;
    else
      return container.find('tr.header').parent('thead').parent('table');
  },

  flex: function(fillPage) {
    return fillPage;
  },

  layout: function(title, container, element, fillPage) {

    // alias variables
    var bsTable = element;

    // fixup xtable generated tables with a proper thead
    var headerRow = bsTable.find('tbody > tr:first-child > th').parent();
    if (headerRow.length > 0) {
      var thead = $('<thead></thead>');
      bsTable.prepend(thead);
      headerRow.detach().appendTo(thead);
    }

    // improve appearance
    container.addClass('bootstrap-table');

    // for fill page provide scrolling w/ sticky headers
    if (fillPage) {
      // force scrollbar on overflow
      container.addClass('flowing-content-shim');

      // stable table headers when scrolling
      bsTable.stickyTableHeaders({
        scrollableArea: container
      });
    }
  }
});

// embedded shiny app
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.find('iframe.shiny-frame');
  },

  flex: function(fillPage) {
    return fillPage;
  },

  layout: function(title, container, element, fillPage) {
    if (fillPage) {
      element.attr('height', '100%');
    } else {
      // provide default height if necessary
      var height = element.get(0).style.height;
      if (!height)
        height = element.attr('height');
      if (!height)
        element.attr('height', 500);
    }
  }
});

// shiny fillRow or fillCol
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.find('.flexfill-container');
  },

  flex: function(fillPage) {
    return fillPage;
  },

  layout: function(title, container, element, fillPage) {
    if (fillPage)
      element.css('height', '100%');
    else {
      // provide default height if necessary
      var height = element.get(0).style.height;
      if (height === "100%" || height === "auto" || height === "initial" ||
          height === "inherit" || !height) {
        element.css('height', 500);
      }
    }
  }
});

// valueBox
window.FlexDashboardComponents.push({

  type: "custom",

  find: function(container) {
    if (container.find('span.value-output, .shiny-valuebox-output').length)
      return container;
    else
      return $();
  },

  flex: function(fillPage) {
    return false;
  },

  layout: function(title, container, element, fillPage) {

    // alias variables
    var chartTitle = title;
    var valueBox = element;

    // add value-box class to container
    container.addClass('value-box');

    // value paragraph
    var value = $('<p class="value"></p>');

    // if we have shiny-text-output then just move it in
    var valueOutputSpan = [];
    var shinyOutput = valueBox.find('.shiny-valuebox-output').detach();
    if (shinyOutput.length) {
      valueBox.children().remove();
      shinyOutput.html("&mdash;");
      value.append(shinyOutput);
    } else {
      // extract the value (remove leading vector index)
      var chartValue = valueBox.text().trim();
      chartValue = chartValue.replace("[1] ", "");
      valueOutputSpan = valueBox.find('span.value-output').detach();
      valueBox.children().remove();
      value.text(chartValue);
    }

    // caption
    var caption = $('<p class="caption"></p>');
    caption.append(chartTitle);

    // build inner div for value box and add it
    var inner = $('<div class="inner"></div>');
    inner.append(value);
    inner.append(caption);
    valueBox.append(inner);

    // add icon if specified
    var icon = $('<div class="icon"><i></i></div>');
    valueBox.append(icon);
    function setIcon(chartIcon) {
      var iconLib = "";
      var iconSplit = chartIcon.split(" ");
      if (iconSplit.length > 1) {
        iconLib = iconSplit[0];
        chartIcon = iconSplit.slice(1).join(" ");
      } else {
        var components = chartIcon.split("-");
        if (components.length > 1)
          iconLib = components[0];
      }
      icon.children('i').attr('class', iconLib + ' ' + chartIcon);
    }
    var chartIcon = valueBox.attr('data-icon');
    if (chartIcon)
      setIcon(chartIcon);

    // handle data attributes in valueOutputSpan
    function handleValueOutput(valueOutput) {

      // caption
      var dataCaption = valueOutput.attr('data-caption');
      if (dataCaption)
        caption.html(dataCaption);

      // icon
      var dataIcon = valueOutput.attr('data-icon');
      if (dataIcon)
        setIcon(dataIcon);

      // If valueBox(color=) was an accent color, this attr should
      // be populated with the accent color and the relevant CSS comes
      // in through HTML dependencies
      var dataColorAccent = valueOutput.attr('data-color-accent');
      var valueBoxClasses = "value-box-" + (["primary", "info", "danger", "warning", "success"].join(" value-box-"));
      if (dataColorAccent) {
        valueBox.removeClass(valueBoxClasses);
        valueBox.addClass('value-box-' + dataColorAccent);
      }

      // If valueBox(color=) was a CSS color, these other data-color-*
      // attrs will be populated
      var dataColor = valueOutput.attr('data-color');
      if (dataColor) {
        valueBox.removeClass(valueBoxClasses);
        valueBox.css('background-color', dataColor);
      }
      var dataColorText = valueOutput.attr('data-color-text');
      if (dataColorText) {
        valueBox.find(".inner").css('color', dataColorText);
      }
      var dataColorIcon = valueOutput.attr('data-color-icon');
      if (dataColorIcon) {
        valueBox.find(".icon").css('color', dataColorIcon);
      }

      // url
      var dataHref = valueOutput.attr('data-href');
      if (dataHref) {
        valueBox.addClass('linked-value');
        valueBox.off('click.value-box');
        valueBox.on('click.value-box', function(e) {
          window.FlexDashboardUtils.showLinkedValue(dataHref);
        });
      }
    }

    // check for a valueOutputSpan
    if (valueOutputSpan.length > 0) {
      handleValueOutput(valueOutputSpan);
    }

    // if we have a shinyOutput then bind a listener to handle
    // new valueOutputSpan values
    shinyOutput.on('shiny:value',
      function(event) {
        var element = $(event.target);
        setTimeout(function() {
          var valueOutputSpan = element.find('span.value-output');
          if (valueOutputSpan.length > 0)
            handleValueOutput(valueOutputSpan);
        }, 10);
      }
    );
  }
});
</script>

<div id="dashboard-container">

<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<style type="text/css">
table {
  margin: auto;
  border-top: 1px solid #666;
  border-bottom: 1px solid #666;
}
table thead th { border-bottom: 1px solid #ddd; }
th, td { padding: 5px; }

pre {
  white-space: pre-wrap;
  word-break: keep-all;
}

/* Hack to make prompt-tab scrollable again */
div.level3.tab-pane .chart-stage {
  overflow: scroll;
}
</style>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<div id="column" class="section level2" data-width="55">
<h2>Column</h2>
<div id="score-comparisons-of-53-publications" class="section level3">
<h3>Score comparisons of 53 publications</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<div class="datatables html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-79d089cddace8b8d9ed7" style="width:100%;height:auto;"></div>
<script type="application/json" data-for="htmlwidget-79d089cddace8b8d9ed7">{"x":{"filter":"none","vertical":false,"fillContainer":true,"data":[["648","650","651","655","657","663","664","665","666","668","669","670","671","673","674","675","677","678","679","680","681","684","685","686","687","688","689","690","691","692","693","694","695","697","705","712","713","714","715","722","725","733","1528","1529","1567","1568","1569","1570","1769","1770","1771","1772","1773"],["<a href='#648' title='Jump to individual results on the right'>CORONIS Collaborative Group (2013)<\/a>","<a href='#650' title='Jump to individual results on the right'>van Dijk-de Vries. A, (2015)<\/a>","<a href='#651' title='Jump to individual results on the right'>Price. D, (2011)<\/a>","<a href='#655' title='Jump to individual results on the right'>Galdiz, J. B.  (2020)<\/a>","<a href='#657' title='Jump to individual results on the right'>Arntzen E. (2019)<\/a>","<a href='#663' title='Jump to individual results on the right'>Callesen J. (2020)<\/a>","<a href='#664' title='Jump to individual results on the right'>Carter A. (2014)<\/a>","<a href='#665' title='Jump to individual results on the right'>Cooper C. (2011)<\/a>","<a href='#666' title='Jump to individual results on the right'>Cutter G. (2019)<\/a>","<a href='#668' title='Jump to individual results on the right'>Dodd K. J. (2011)<\/a>","<a href='#669' title='Jump to individual results on the right'>Feys P. (2019)<\/a>","<a href='#670' title='Jump to individual results on the right'>Finch P. (2014)<\/a>","<a href='#671' title='Jump to individual results on the right'>Freeman J. (2019)<\/a>","<a href='#673' title='Jump to individual results on the right'>Garrett M. (2013)<\/a>","<a href='#674' title='Jump to individual results on the right'>Giovannoni G. (2016)<\/a>","<a href='#675' title='Jump to individual results on the right'>Grossman P. (2010)<\/a>","<a href='#677' title='Jump to individual results on the right'>Hermens H. (2008)<\/a>","<a href='#678' title='Jump to individual results on the right'>Higginson I. J. (2009)<\/a>","<a href='#679' title='Jump to individual results on the right'>Jongen P. J. (2019)<\/a>","<a href='#680' title='Jump to individual results on the right'>Kiropoulos L. A. (2016)<\/a>","<a href='#681' title='Jump to individual results on the right'>Learmonth Y. C. (2012)<\/a>","<a href='#684' title='Jump to individual results on the right'>Miller L. (2011)<\/a>","<a href='#685' title='Jump to individual results on the right'>O'Hara L. (2002)<\/a>","<a href='#686' title='Jump to individual results on the right'>Papeix C. (2015)<\/a>","<a href='#687' title='Jump to individual results on the right'>Paul L. (2014)<\/a>","<a href='#688' title='Jump to individual results on the right'>Pozzilli C. (2002)<\/a>","<a href='#689' title='Jump to individual results on the right'>Renfrew L. M. (2019)<\/a>","<a href='#690' title='Jump to individual results on the right'>Solari A. (2018)<\/a>","<a href='#691' title='Jump to individual results on the right'>Thomas S. (2013)<\/a>","<a href='#692' title='Jump to individual results on the right'>Torkhani E. (2021)<\/a>","<a href='#693' title='Jump to individual results on the right'>Velikonja O. (2010)<\/a>","<a href='#694' title='Jump to individual results on the right'>Vermöhlen V. (2018)<\/a>","<a href='#695' title='Jump to individual results on the right'>Ward C. D. (2004)<\/a>","<a href='#697' title='Jump to individual results on the right'>Williams K. L. (2021)<\/a>","<a href='#705' title='Jump to individual results on the right'>Petrella, R. J.  (2017)<\/a>","<a href='#712' title='Jump to individual results on the right'>Mafetoni, R. R.  (2016)<\/a>","<a href='#713' title='Jump to individual results on the right'>Jonsdottir, H. (2015)<\/a>","<a href='#714' title='Jump to individual results on the right'>Pinnock, H. (2003)<\/a>","<a href='#715' title='Jump to individual results on the right'>Ndosi, M. (2014)<\/a>","<a href='#722' title='Jump to individual results on the right'>Patel. A. (2015)<\/a>","<a href='#725' title='Jump to individual results on the right'>Rangan, A. (2015)<\/a>","<a href='#733' title='Jump to individual results on the right'>Iliffe, S. (2015)<\/a>","<a href='#1528' title='Jump to individual results on the right'>Humphreys I. (2013)<\/a>","<a href='#1529' title='Jump to individual results on the right'>Khayeri F. (2016)<\/a>","<a href='#1567' title='Jump to individual results on the right'>Stuifbergen A.K. (2018)<\/a>","<a href='#1568' title='Jump to individual results on the right'>Riemenschneider M. (2022)<\/a>","<a href='#1569' title='Jump to individual results on the right'>Straudi S. (2022)<\/a>","<a href='#1570' title='Jump to individual results on the right'>Mazdeh M. (2010)<\/a>","<a href='#1769' title='Jump to individual results on the right'>Millar J.H. (1967)<\/a>","<a href='#1770' title='Jump to individual results on the right'>Hoogstraten M.C. (1990)<\/a>","<a href='#1771' title='Jump to individual results on the right'>Langeskov-Christensen M. (2021)<\/a>","<a href='#1772' title='Jump to individual results on the right'>Calkwood J. (2014)<\/a>","<a href='#1773' title='Jump to individual results on the right'>Medina-Perez C. (2014)<\/a>"],[-0.229813664596273,-0.0909090909090911,-0.421052631578947,0.1,0.329787234042553,-0.0285714285714285,0.0240963855421685,-0.0588235294117647,0.590909090909091,-0.323529411764706,0.0262295081967213,-0.0879120879120878,0.176470588235294,-0.167364016736402,0.0526315789473684,0.244,0.331428571428571,0.379310344827586,-0.285714285714286,0.181818181818182,-0.285714285714286,0.00613496932515323,-0.0879120879120878,0.304878048780488,-0.523076923076923,0.354066985645933,0.25,-0.0359712230215827,0.333333333333333,-0.11340206185567,0,0.224137931034483,0.470588235294118,0.426751592356688,0.0104712041884817,0.379310344827586,0.303571428571428,0.338235294117647,-0.116788321167883,-0.11340206185567,0.261194029850746,-0.179310344827587,0.394230769230769,-0.153024911032029,0.0192307692307692,-0.3125,0.274193548387097,-0.00677966101694927,0.0395256916996046,0.0663900414937759,0.307692307692308,0.117647058823529,0.134615384615385],[0.222222222222222,0.333333333333333,0.222222222222222,0.222222222222222,0.555555555555556,0.666666666666667,0.333333333333333,0.333333333333333,0.666666666666667,0.333333333333333,0.333333333333333,0.222222222222222,0.111111111111111,0.333333333333333,0.111111111111111,0,0.555555555555556,0.555555555555556,0.222222222222222,0.444444444444444,0.333333333333333,0.333333333333333,0.222222222222222,0.444444444444444,0.111111111111111,0.333333333333333,0.444444444444444,0.222222222222222,0.555555555555556,0.333333333333333,0.111111111111111,0.555555555555556,0.444444444444444,0.555555555555556,0.222222222222222,0.222222222222222,0.555555555555556,0.555555555555556,0.111111111111111,0.333333333333333,0.444444444444444,0.222222222222222,0.333333333333333,0,0.111111111111111,0.444444444444444,0.333333333333333,0.111111111111111,0.222222222222222,0.222222222222222,0.444444444444444,0.333333333333333,0.333333333333333],[0,0,-0.105263157894737,0,-0.0588235294117647,-0.125,0.28,0,0.46,-0.211538461538461,0.175,-0.0714285714285716,0.296875,-0.222222222222222,-0.0909090909090908,0.289473684210526,0.357142857142857,0.307692307692308,-0.255813953488372,-0.235294117647059,0,-0.235294117647059,0.0217391304347825,0.129032258064516,-0.486956521739131,0.428571428571428,0.307692307692308,-0.125,-0.125,0,0,-0.0677966101694916,0.419354838709677,0.142857142857143,-0.0188679245283019,0.560975609756098,0.586206896551724,0.25,-0.153846153846154,0,0.419354838709677,0,0.315217391304348,-0.173913043478261,-0.0588235294117647,-0.2,0.15625,0.00917431192660556,0,-0.208955223880597,0.2,0.25,0.181818181818182],[0.444444444444444,0.666666666666667,0.555555555555556,0.333333333333333,0.777777777777778,0.666666666666667,0.777777777777778,0.444444444444444,0.666666666666667,0.555555555555556,0.444444444444444,0.444444444444444,0.444444444444444,0.444444444444444,0.111111111111111,0.333333333333333,0.666666666666667,0.666666666666667,0.333333333333333,0.555555555555556,0.666666666666667,0.555555555555556,0.444444444444444,0.666666666666667,0.222222222222222,0.555555555555556,0.666666666666667,0.555555555555556,0.777777777777778,0.777777777777778,0.111111111111111,0.555555555555556,0.777777777777778,0.666666666666667,0.666666666666667,0.555555555555556,0.555555555555556,0.666666666666667,0.444444444444444,0.777777777777778,0.777777777777778,0.555555555555556,0.555555555555556,0,0.333333333333333,0.555555555555556,0.666666666666667,0.333333333333333,0.333333333333333,0.333333333333333,0.555555555555556,0.666666666666667,0.555555555555556]],"container":"<table class=\"display fill-container\">\n  <thead>\n    <tr>\n      <th>Ref.<\/th>\n      <th>Author & Year<\/th>\n      <th>weighted κ<\/th>\n      <th>agreement<\/th>\n      <th>pooled weighted κ<\/th>\n      <th>pooled agreement<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"bPaginate":false,"dom":"t","order":[[0,"asc"]],"columnDefs":[{"targets":2,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\", null);\n  }"},{"targets":3,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\", null);\n  }"},{"targets":4,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\", null);\n  }"},{"targets":5,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\", null);\n  }"},{"className":"dt-right","targets":[2,3,4,5]}],"autoWidth":false,"orderClasses":false}},"evals":["options.columnDefs.0.render","options.columnDefs.1.render","options.columnDefs.2.render","options.columnDefs.3.render"],"jsHooks":[]}</script>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
</div>
<div id="score-heatmaps-unpooled-pooled" class="section level3"
data-height="720">
<h3>Score heatmaps
(<a onclick="data = 'data:image/png;base64,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'; $('#score-heatmaps-unpooled-pooled p.image-container')[0].style = 'background: url(&quot;' + data + '&quot;) center center / contain no-repeat;'; $('p.image-container img')[0].src = data;" style="cursor: pointer">unpooled</a>
/
<a onclick="data = 'data:image/png;base64,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'; $('#score-heatmaps-unpooled-pooled p.image-container')[0].style = 'background: url(&quot;' + data + '&quot;) center center / contain no-repeat;'; $('p.image-container img')[0].src = data;" style="cursor: pointer">pooled</a>)</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<p><img data-figure-id="fig1" src="data:image/png;base64,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" width="1536"></p>
</div>
</div>
<div id="column-1" class="section level2 tabset" data-width="45">
<h2 class="tabset">Column</h2>
<div id="individual-results" class="section level3">
<h3>Individual results</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<p><a name='648'></a></p>
<div
id="coronis-collaborative-group-2013-caesarean-section-surgical-techniques-coronis-a-fractional-factorial-unmasked-randomised-controlled-trial"
class="section level4">
<h4>648.
<a href='https://doi.org/10.1016/S0140-6736(13)60441-9' title='Open publication'>CORONIS
Collaborative Group (2013): <i>Caesarean section surgical techniques
(CORONIS): a fractional, factorial, unmasked, randomised controlled
trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pregnant women were eligible if they were to undergo their first or second caesarean section through a planned transverse abdominal incision.&quot;</span> [1]
- Score: [4] The eligibility criteria are somewhat pragmatic as they include pregnant women who are undergoing their first or second caesarean section, which is similar to usual care. However, the criteria exclude women who have a clear indication for a particular surgical technique or material, which is more explanatory.

Recruitment:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Information leaflets were made available, in appropriate languages, which explained the trial objectives, the process of trial entry, and follow-up.&quot;</span> [1]
- Score: [4] The recruitment process seems somewhat pragmatic as it involves providing information leaflets to eligible participants, which is similar to usual care. However, the full text does not provide information on any additional efforts made to recruit participants beyond providing information leaflets.

Setting:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎CORONIS was undertaken at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan.&quot;</span> [1]
- Score: [4] The trial was conducted at multiple sites in different countries, which suggests a somewhat pragmatic approach. However, the full text does not provide information on whether the trial sites were similar to usual care settings.

Organisation:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All investigators, surgeons, and participants were unmasked to treatment allocation.&quot;</span> [1]
- Score: [5] The trial design involved unmasking all investigators, surgeons, and participants to treatment allocation, which suggests a very pragmatic approach.

Flexibility (delivery):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All non-allocated surgical elements and all other aspects of the caesarean section procedure were undertaken at the discretion of the surgeon.&quot;</span> [1]
- Score: [5] The surgeons had discretion in performing all non-allocated surgical elements, which indicates a very pragmatic approach.

Flexibility (adherence):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Compliance with all the allocated interventions was high, 87% overall.&quot;</span> [1]
- Score: [5] The high compliance with the allocated interventions suggests a very pragmatic approach.

Follow-up:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were collected at trial entry, immediately after surgery, at hospital discharge, and at about 6 weeks after delivery.&quot;</span> [1]
- Score: [4] The follow-up period of about 6 weeks is similar to usual care. However, the full text does not provide information on the intensity of measurement and follow-up compared to usual care.

Primary outcome:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There were no statistically significant differences within any of the intervention pairs for the primary outcome.&quot;</span> [1]
- Score: [5] The primary outcome was relevant to the participants and there were no statistically significant differences within any of the intervention pairs, indicating a very pragmatic approach.

Primary analysis:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Women were analysed in the groups into which they were allocated.&quot;</span> [1]
- Score: [5] The analysis included all women in the groups to which they were allocated, indicating a very pragmatic approach.

Overall, the trial seems to have a pragmatic design with some explanatory elements. The eligibility criteria, recruitment process, flexibility in delivery and adherence, and primary analysis all suggest a pragmatic approach. However, there is limited information on the setting, flexibility in adherence, and intensity of follow-up, which prevents a complete assessment of these domains.</pre>
<p><a name='650'></a></p>
</div>
<div
id="van-dijk-de-vries.-a-2015-lessons-learnt-from-a-cluster-randomised-trial-evaluating-the-effectiveness-of-self-management-support-sms-delivered-by-practice-nurses-in-routine-diabetes-care"
class="section level4">
<h4>650.
<a href='https://doi.org/10.1136/bmjopen-2014-007014' title='Open publication'>van
Dijk-de Vries. A, (2015): <i>Lessons learnt from a cluster-randomised
trial evaluating the effectiveness of Self-Management Support (SMS)
delivered by practice nurses in routine diabetes care</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients with type 2 diabetes (n=264) selected by a self-administered questionnaire aimed at measuring emotional distress and diabetes-related reduced daily functioning.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The eligibility criteria changed from having a mild to moderate depression towards suffering from both emotional distress and interference in their daily functioning due to the burden of diabetes.&quot;</span> [1]
- Score: [4] The eligibility criteria for this trial are somewhat pragmatic, as they focus on patients with emotional distress and reduced daily functioning related to diabetes. However, the criteria are still somewhat explanatory as they exclude patients with mild to moderate depression.

Recruitment:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients with type 2 diabetes (n=264) selected by a self-administered questionnaire aimed at measuring emotional distress and diabetes-related reduced daily functioning.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients with a clinically established diagnosis of type 2 diabetes mellitus were sent a letter by their GPs to introduce the SMS project.&quot;</span> [1]
- Score: [4] The recruitment methods used in this trial are somewhat pragmatic, as they involve using a self-administered questionnaire and sending letters to patients. However, the trial does not explicitly state if any additional efforts were made to recruit participants beyond these methods.

Setting:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A regional care group in the Netherlands consisting of 77 family practices.&quot;</span> [1]
- Score: [4] The setting of this trial is somewhat pragmatic, as it involves multiple family practices in a regional care group. However, the trial does not provide information about the diversity of the settings or if any specialized or academic centers were involved.

Organisation:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Practice nurses in the intervention arm (n=19) were trained to integrate SMS into their routine consultations.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Financial reimbursement for the extra time spent on SMS was added to the bundled payment arrangement for diabetes care.&quot;</span> [1]
- Score: [4] The organization of care delivery in this trial is somewhat pragmatic, as it involves training practice nurses to integrate SMS into their routine consultations and providing financial reimbursement for the extra time spent on SMS.

Flexibility (delivery):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎PNs supported patients in the processes of defining problems and finding solutions themselves, by applying problem-solving and reattribution techniques.&quot;</span> [1]
- Score: [4] The flexibility in how the intervention is delivered in this trial is somewhat pragmatic, as it involves supporting patients in problem-solving and reattribution techniques. However, the trial does not provide information about any strict protocols or measures to improve compliance.

Flexibility (adherence):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients who experienced problems of daily functioning (DFT >4) and emotional health problems (moderate scores on at least one subscale of the 4DSQ) were offered consultations for SMS.&quot;</span> [1]
- Score: [4] The flexibility in how participants must adhere to the intervention in this trial is somewhat pragmatic, as it involves offering consultations for SMS to patients who experience problems of daily functioning and emotional health problems. However, the trial does not provide information about any strict protocols or measures to improve adherence.

Follow-up:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcomes were measured at baseline and at 4-month and 12-month follow-ups.&quot;</span> [1]
- Score: [5] The intensity of measurement and follow-up in this trial is very pragmatic, as it involves measuring outcomes at multiple time points over a 12-month period.

Primary outcome:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome measure was a dichotomised score on a Visual Analogue Scale that measured the perceived effect of diabetes on daily functioning.&quot;</span> [1]
- Score: [5] The primary outcome measure in this trial is very pragmatic, as it directly measures the perceived effect of diabetes on daily functioning.

Primary analysis:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Analyses were performed on an intention-to-treat basis.&quot;</span> [1]
- Score: [5] The primary analysis in this trial is very pragmatic, as it includes all available data and is performed on an intention-to-treat basis.</pre>
<p><a name='651'></a></p>
</div>
<div
id="price.-d-2011-leukotriene-antagonists-as-first-line-or-add-on-asthma-controller-therapy"
class="section level4">
<h4>651.
<a href='https://doi.org/10.1056/NEJMoa1010846' title='Open publication'>Price.
D, (2011): <i>Leukotriene antagonists as first-line or add-on
asthma-controller therapy</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">18 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In the case of asthma, for example, the eligibility criteria in most such trials exclude an estimated 95% of patients with a current diagnosis of asthma, including smokers and those who have “insufficient” bronchodilator reversibility or impaired pulmonary function.&quot;</span> [Explanatory]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We designed these two pragmatic trials to maximize external validity (applicability or generalizability), with the goal of studying a heterogeneous real-world population.&quot;</span> [Pragmatic]
Score: [3]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were responsible for obtaining their own medications, as would occur in real life.&quot;</span> [Pragmatic]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We considered but rejected the addition of a placebo group when designing the study, since we believe it would have been unethical to assign patients to placebo for 2 years.&quot;</span> [Pragmatic]
Score: [4]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Both trials were conducted in accordance with the protocol.&quot;</span> [Explanatory]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study was powered for equivalence in the MiniAQLQ score, with the equivalence boundary set at a 95% CI of less than 0.3 for the MiniAQLQ score (i.e., equivalence was declared if the 95% CI was wholly included between –0.3 and 0.3).&quot;</span> [Explanatory]
Score: [2]

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary funder and sponsor (National Coordinating Centre for Health Technology Assessment U.K.) provided input with regard to the study design through its commissioning and monitoring brief but played no role in data collection, analysis, or interpretation; the writing of the article; or the decision to submit the article for publication.&quot;</span> [Pragmatic]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Practice staffs were asked to provide each patient with a written individualized asthma-action plan.&quot;</span> [Pragmatic]
Score: [4]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.&quot;</span> [Pragmatic]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The protocol discouraged substantial treatment changes between randomization and the 2-month visit.&quot;</span> [Pragmatic]
Score: [4]

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Adherence to an LTRA was better than it was to the other drugs in both trials.&quot;</span> [Pragmatic]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although such poor and differential adherence potentially reduces assay sensitivity (particularly when coupled with treatment crossover), thus biasing results toward equivalence, both poor and differential adherence rates are realities of real-world prescribing and thus part of the treatment effect.&quot;</span> [Pragmatic]
Score: [5]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data collection and statistical analyses were performed by study personnel who were unaware of the treatment assignments; questionnaire-based data were collected under blinded conditions, and routine practice data (including a history of exacerbations) were extracted with the use of dedicated software.&quot;</span> [Pragmatic]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data for asthma-related quality of life and asthma control were available over a period of 21 months for 95% and 96% of the patients in the first-line controller and add-on therapy trials, respectively, which are completion rates higher than those in most long-term asthma-therapy trials.&quot;</span> [Pragmatic]
Score: [5]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Mean improvements over a period of 2 years in both the first-line controller and the add-on therapy trials were substantially greater than the MID for questionnaire scores measuring asthma-related quality of life and asthma control.&quot;</span> [Pragmatic]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For patients receiving an LTRA or an inhaled glucocorticoid as first-line controller therapy, MiniAQLQ scores were equivalent at 2 months, but at 2 years, these scores did not meet our prespecified criterion for equivalence.&quot;</span> [Explanatory]
Score: [3]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years.&quot;</span> [Pragmatic]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Multiple imputation was used where data were missing.&quot;</span> [Pragmatic]
Score: [4]</pre>
<p><a name='655'></a></p>
</div>
<div
id="galdiz-j.-b.-2020-telerehabilitation-programme-as-a-maintenance-strategy-for-copd-patients-a-12-month-randomized-clinical-trial"
class="section level4">
<h4>655.
<a href='https://doi.org/10.1016/j.arbres.2020.03.034' title='Open publication'>Galdiz,
J. B. (2020): <i>Telerehabilitation Programme as a Maintenance Strategy
for COPD Patients: A 12-Month Randomized Clinical Trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’,
‘multiple-scores-per-domain-if-incongruent-na’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patient selection criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3–7) according to international guidelines and having been clinically stable for the previous 4 weeks.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The eligibility criteria for this trial are relatively broad, allowing for the inclusion of patients with moderate-to-severe COPD who are clinically stable. However, the use of the BODE index score as a criterion narrows the eligibility to a specific subset of patients.

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Recruited patients (recruitment visit, −1) attended an initial 8-week outpatient-based PR programme conducted in each hospital rehabilitation department.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The recruitment process involved patients attending an outpatient-based PR program, which is similar to usual care. However, the specific details of the recruitment process are not provided in the full text, making it difficult to assess the level of extra effort made to recruit participants.
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Following completion of this programme, patients were randomly allocated (baseline visit, 0) to either the TelePR programme [intervention group (IG)] or the standard, usual care programme [control group (CG)].&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span> The random allocation to the TelePR program or usual care suggests a pragmatic approach to recruitment, as participants were assigned to the intervention or control group based on usual care practices.

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span> The trial was conducted in multiple hospitals, which suggests a more explanatory approach. However, the specific characteristics of the hospitals and whether they represent usual care settings are not provided in the full text.

Organization:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The organization of care delivery in the intervention group is similar to usual care, as patients were asked to continue their training at home. However, the specific resources and provider expertise available in the intervention arm are not described in detail.
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients in the CG received usual care, that is, they were advised to exercise regularly (at least walking for 1 hour a day) and provided with general educational material, following current clinical practice at participating sites.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span> The organization of care delivery in the control group is consistent with usual care, as patients were advised to exercise regularly and provided with educational material.

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The intervention group was asked to continue their training at home, which suggests some flexibility in how the intervention is delivered. However, the specific details of the training schedule and any restrictions or guidelines provided are not described in the full text.

Flexibility (adherence):
Score: [NA] This domain is not applicable to this trial as there is no mention of adherence issues or measures to improve adherence.

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The follow-up schedule for both groups is consistent with usual care, as patients were scheduled for regular appointments at specific time points. However, the specific intensity of measurement and follow-up in the trial compared to usual care is not described in detail.

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The analysis of covariance showed non-significant improvements in 6-min walk distance [19.9m (95% CI −4.1/+43.8)] and Chronic Respiratory Disease Questionnaire – Emotion score [0.4 points (0–0.8)] in the IG.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The primary outcome measures used in the trial, 6-min walk distance and Chronic Respiratory Disease Questionnaire - Emotion score, are relevant to participants and reflect important aspects of their health status. However, the specific relevance of these outcomes to participants in usual care is not discussed in the full text.

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The main efficacy analysis used analysis of covariance (ANCOVA) techniques to test for differences between groups in outcome variables at the 12-month visit, adjusted for baseline values.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The primary analysis used ANCOVA techniques, which is consistent with a pragmatic approach. However, the specific details of the analysis, such as the inclusion of all available data and intention-to-treat principles, are not described in the full text.</pre>
<p><a name='657'></a></p>
</div>
<div
id="arntzen-e.-2019-group-based-individualized-comprehensive-core-stability-intervention-improves-balance-in-persons-with-multiple-sclerosis-a-randomized-controlled-trial."
class="section level4">
<h4>657.
<a href='https://doi.org/10.1093/ptj/pzz017' title='Open publication'>Arntzen
E. (2019): <i>Group-Based Individualized Comprehensive Core Stability
Intervention Improves Balance in Persons With Multiple Sclerosis: A
Randomized Controlled Trial.</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eighty people with Expanded Disability Status scores of 1 to 6.5 participated in this trial.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The inclusion criteria were as follows: (1) diagnosed with MS in accordance with the McDonald criteria27; (2) registered at the MS outpatient clinic; (3) living in 1 of 6 selected municipalities; (4) aged 18 years or older; (5) capable of providing signed written informed consent; and (6) EDSS score between 1 and 6.5 (1 = minor disability, 6.5 = able to walk 20 m with or without a walking aid).&quot;</span> [2]
3. No exclusions based on non-compliance, response to treatment, or risk for primary outcome were mentioned.

Score: [4]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In August 2015, 1 of the MS nurses at the Department of Neurology, Nordland Hospital Trust in Bodø, Norway, sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic, had EDSS scores of 0 to 7, and lived in 1 of the 6 municipalities included in the study.&quot;</span> [2]
2. No mention of targeted invitation letters, advertising, or incentives for recruitment.

Score: [4]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway.&quot;</span> [2]
2. No mention of specialized trial or academic centers.

Score: [5]

Organization:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The physical therapists had varied experience (between 7–25 years) and certification (2 had both a master's degree in neurological physical therapy and were clinical specialists in neurological physical therapy, 1 was a clinical specialist in neurological physical therapy, and 3 were generalists in physical therapy).&quot;</span> [2]
2. No mention of increased staff levels, additional training, or increased resources.

Score: [5]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The physical therapists individualized the exercises by tailoring them according to each individual's symptoms, disability level, and general well-being, and they intensified the exercises by increasing number of repetitions, level of difficulty, and/or by adding motor-cognitive dual tasks as movement quality improved.&quot;</span> [2]
2. No mention of strict protocol, monitoring, or measures to improve compliance.

Score: [5]

Flexibility (adherence):
1. Not applicable as there is no compliance issue after consent has been given.

Score: [NA]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Assessments were conducted at baseline and at weeks 7, 18, and 30.&quot;</span> [2]
2. No mention of more frequent or longer visits, unscheduled visits, or extensive data collection.

Score: [5]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The TIS-NV measures dynamic sitting balance and trunk control and includes 6 test items scored from 0 to 2 or 3, with a total score from 0 to 16 (0 = severe problem).&quot;</span> [2]
2. The primary outcome is relevant to participants as it directly measures balance and trunk control.

Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All participants with postintervention test assessment scores were included, although some had missing observations.&quot;</span> [2]
2. No mention of excluding ineligible participants or including only completers or those following the treatment protocol.

Score: [5]</pre>
<p><a name='663'></a></p>
</div>
<div
id="callesen-j.-2020-how-do-resistance-training-and-balance-and-motor-control-training-affect-gait-performance-and-fatigue-impact-in-people-with-multiple-sclerosis-a-randomized-controlled-multi-center-study"
class="section level4">
<h4>663.
<a href='https://doi.org/10.1177/1352458519865740' title='Open publication'>Callesen
J. (2020): <i>How do resistance training and balance and motor control
training affect gait performance and fatigue impact in people with
multiple sclerosis? A randomized controlled multi-center
study</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 71 participants with impaired mobility (Timed 25-Foot Walk (T25FW) > 5 seconds or Six Spot Step Test (SSST) > 8 seconds) were enrolled.&quot;</span> [Quote 1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.&quot;</span> [Quote 2]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Exclusion criteria were as follows: co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT >1 session/week within the last 3 months.&quot;</span> [Quote 2]

The eligibility criteria for this trial appear to be relatively pragmatic. The inclusion criteria are specific to people with impaired mobility due to multiple sclerosis, but they are not overly restrictive. The exclusion criteria are also reasonable and do not exclude a large portion of the target population. Overall, the trial seems to have a pragmatic approach to participant eligibility.

Score: [4]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.&quot;</span> [Quote 3]

The recruitment methods used in this trial seem to be relatively pragmatic. Participants were recruited from multiple MS clinics and through targeted advertisements sent out by the Danish MS Society. This approach is likely to reflect the usual care setting and does not involve excessive efforts to recruit participants.

Score: [4]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A multi-center, single-blinded, cluster-randomized controlled trial with two intervention groups (PRT and BMCT) and a control group (CON).&quot;</span> [Quote 3]

The trial was conducted at multiple centers, which suggests a pragmatic approach to the setting. This allows for a diverse range of settings that are representative of usual care. However, the specific types of centers (e.g., academic, specialized trial centers) are not mentioned, so it is difficult to fully assess the pragmatism of the setting.

Score: [3]

Organization:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All training sessions were supervised by physiotherapists who were trained to deliver the intervention.&quot;</span> [Quote 4]

The organization of care delivery in the intervention arm of the trial seems to be pragmatic. The training sessions were supervised by physiotherapists, which is consistent with usual care. There is no mention of additional staff levels, training, or resources beyond what is typically available in usual care.

Score: [5]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The BMCT intervention was developed based on previously published programs5,11,18,19 and according to principle of the task-oriented approach,9 thus addressing salient tasks including sitting (5 minutes), standing (5 minutes), stepping (10 minutes), walking (2 × 10 minutes), and eye-movement training (10 minutes; framework illustrated in Supplemental Appendix).&quot;</span> [Quote 5]

The flexibility in how the BMCT intervention is delivered seems to be pragmatic. The intervention is based on previously published programs and is designed to address specific tasks related to balance and motor control. The inclusion of different exercises and the ability to tailor the program to individual needs suggests a flexible approach that is likely to reflect usual care.

Score: [5]

Flexibility (adherence):
Score: [NA]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.&quot;</span> [Quote 6]

The intensity of measurement and follow-up in this trial seems to be pragmatic. The follow-up test was conducted within a reasonable timeframe after the intervention or the waitlist period. There is no mention of more frequent or longer visits or unscheduled visits triggered by primary outcome events, suggesting that the follow-up is similar to what would occur in usual care.

Score: [4]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary comparisons showed that BMCT, but not PRT, improved T25FW, SSST, and self-perceived gait function when compared to CON.&quot;</span> [Quote 7]

The trial's primary outcome of gait performance seems to be relevant to participants. The results indicate that BMCT had a significant impact on gait performance compared to the control group, while PRT did not. This suggests that the primary outcome is of importance to participants and reflects their experiences in usual care.

Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Analyses were carried out as intention-to-treat, where all participants who completed the baseline assessment were included regardless of their adherence to the allocated intervention.&quot;</span> [Quote 8]

The primary analysis of the trial seems to be pragmatic. It was conducted on an intention-to-treat basis, including all participants who completed the baseline assessment, regardless of their adherence to the allocated intervention. This approach reflects the real-world scenario where not all participants may fully adhere to the intervention protocol.

Score: [5]</pre>
<p><a name='664'></a></p>
</div>
<div
id="carter-a.-2014-pragmatic-intervention-for-increasing-self-directed-exercise-behaviour-and-improving-important-health-outcomes-in-people-with-multiple-sclerosis-a-randomised-controlled-trial"
class="section level4">
<h4>664.
<a href='https://doi.org/10.1177/1352458513519354' title='Open publication'>Carter
A. (2014): <i>Pragmatic intervention for increasing self-directed
exercise behaviour and improving important health outcomes in people
with multiple sclerosis: a randomised controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’,
‘multiple-scores-per-domain-if-incongruent-na’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">14 quote(s) from
publication full text</span> (mean similarity 99.8%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The eligibility criteria for this trial are relatively broad, including a range of disability levels and age groups. However, there are some exclusions based on comorbid conditions and current engagement in structured exercise.
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants on disease-modifying therapy (interferon beta, glatiramer acetate and natalizumab) had been stable on this treatment for at least three months.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The inclusion of participants on disease-modifying therapy is pragmatic, as it reflects the usual care setting where these treatments are commonly used.

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The recruitment methods used in this trial are relatively pragmatic, involving both clinic-based recruitment and community advertising.
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants that dropped out of the study were slightly younger than the study completers (43.3 vs 46.3 years) and had higher baseline EDSS and total fatigue scores (4.5 vs 3.6 and 48.0 vs 42.6, respectively).&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The dropout rate in this trial is relatively low, suggesting that the recruitment methods were effective in engaging participants.

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The involvement of exercise physiologists and physiotherapists in delivering the intervention reflects a pragmatic approach, as these professionals are commonly involved in exercise programs for people with multiple sclerosis.
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home environment.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The use of a university exercise research facility and home environment for the intervention reflects a pragmatic approach, as it allows for flexibility in the setting of the exercise program.

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The supervised exercise sessions incorporated cognitive-behavioural techniques (e.g. goal setting, finding social support, understanding the costs/benefits of exercise, etc.) to promote long-term participation in physical activity.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The inclusion of cognitive-behavioural techniques in the intervention reflects a pragmatic approach, as these techniques are commonly used in exercise programs to promote behavior change.
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants in the usual care group were offered three exercise sessions at the university exercise research facility and individual exercise advice after the study.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The provision of exercise sessions and individual advice to the usual care group reflects a pragmatic approach, as it aligns with the resources and care available in usual care settings.

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The prescribed strength training was based on individual functional needs, as assessed by the trial physiotherapist.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The individualized approach to strength training reflects a pragmatic approach, as it allows for flexibility in tailoring the intervention to the specific needs of each participant.
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were encouraged to seek out opportunities to exercise in the local community (e.g. healthy living centres, health walks, fitness centres, swimming pools, etc.), based on their individual preferences.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The encouragement of participants to exercise in the local community reflects a pragmatic approach, as it allows for flexibility in the delivery of the intervention.

Flexibility (adherence):
Score: [NA] This domain is not applicable to this trial as there is no compliance issue after consent has been given.

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcomes were assessed at baseline, and at three months (post-intervention) and nine months after randomisation.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The follow-up schedule in this trial reflects a pragmatic approach, with assessments at multiple time points up to nine months after randomization.
2. <span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):

ant. The exercise group experienced improvements in multidimensional fatigue and in most HRQoL dimensions at three months. These improvements are consistent with previous systematic reviews,24,25 although some conflicting evidence also ex' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The exercise group experienced improvements in multidimensional fatigue and in most HRQoL dimensions at three months. These improvements are consistent with previous systematic reviews, although some conflicting evidence also exists.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The assessment of fatigue and HRQoL at multiple time points reflects a pragmatic approach, as these outcomes are relevant to participants and are commonly assessed in clinical practice.

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome was self-reported exercise behaviour (Godin Leisure Time Exercise Questionnaire (GLTEQ)).&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The use of a self-reported measure of exercise behavior as the primary outcome reflects a pragmatic approach, as self-report measures are commonly used in clinical practice to assess exercise behavior.

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All analyses were by intention to treat, whereby participants were analysed in the arm to which they were randomised irrespective of whether they complied with the intervention.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span> The use of intention-to-treat analysis reflects a pragmatic approach, as it aligns with the analysis approach commonly used in clinical practice.

Overall, this trial demonstrates a pragmatic approach in several domains, including eligibility, recruitment, setting, organisation, flexibility in delivery, and follow-up. The trial includes a broad range of participants, uses recruitment methods commonly used in clinical practice, delivers the intervention in a real-world setting, incorporates cognitive-behavioural techniques, and assesses outcomes relevant to participants. However, there is limited information to assess the flexibility in adherence and the primary analysis domain.</pre>
<p><a name='665'></a></p>
</div>
<div
id="cooper-c.-2011-computerised-cognitive-behavioural-therapy-for-the-treatment-of-depression-in-people-with-multiple-sclerosis-external-pilot-trial"
class="section level4">
<h4>665.
<a href='https://doi.org/10.1186/1745-6215-12-259' title='Open publication'>Cooper
C. (2011): <i>Computerised cognitive behavioural therapy for the
treatment of depression in people with multiple sclerosis: external
pilot trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘score-prefix-missing-before-na’,
‘multiple-scores-per-domain-if-incongruent-na’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">20 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were: age of 18 years or above; BDI score of at least 14 on two consecutive occasions and no treatment from psychologist, psychotherapist or psychiatrist within the last three months.&quot;</span> <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [NA]</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Exclusion criteria were: poor English language skills or cognitive function (score of less than 24 on Mini Mental State Examination [20]); BDI score of at least 29 on two consecutive occasions; active suicidal ideas; current or life-time diagnosis of psychosis, organic mental disorder or substance dependency; Kurtzke Expanded Disability Status Scale (EDSS) score of 8.5 or above [21]).&quot;</span> <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [NA]</span>
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two participants in each arm were lost to follow-up at 21 weeks post-randomisation.&quot;</span> <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [NA]</span>

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our initial aim was to recruit 24 participants between 22 October 2008 and 31 January 2009 (101 days; 7.1 participants/month) with candidates identified by three neurologists working in a single weekly specialist MS clinic (Sheffield Teaching Hospitals NHS Trust).&quot;</span> [3]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We reached our recruitment target on 30 July 2009 (in 281 days; 2.6 participants/month) after adding a second centre (The Walton Centre NHS Foundation Trust, Liverpool).&quot;</span> [3]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎From the 288 invitation packs given out by Sheffield neurologists in the MS clinic, forms were completed and returned by 63 (21.8%) candidates from which we randomised 13 in 281 days (4.5% recruitment yield), or 1.4 participants per month.&quot;</span> [3]
Score: [2]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants with a diagnosis of MS and clinical levels of depression were recruited through out-patient clinics and postal screening questionnaires at two UK centres.&quot;</span> [3]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The MS services in both sites are specific entities and not general neurology clinics.&quot;</span> <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [NA]</span>
Score: [4]

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In the Sheffield region, Primary Care Trust (PCT) mental health care teams administered the CCBT, facilitating access and undertaking safety monitoring.&quot;</span> [3]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Only one out of the five participating PCTs around the Sheffield centre formally provided any kind of community facility for accessing CCBT; PCT staff warned that clients rarely used the facility and it was closed during the course of the study.&quot;</span> [3]
Score: [3]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No PCT with whom we worked offered advice or support for defining problems on which to work or applying the CBT model to individual problems.&quot;</span> [3]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The advice given was essentially technical, focusing on using the software.&quot;</span> [3]
Score: [2]

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Of the 12 patients in the CCBT arm, 9 (75%) completed at least four CCBT sessions.&quot;</span> [3]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This translated to a reasonably high compliance rate of CCBT although only six (50%) of the patients in this arm completed all intended eight CCBT sessions.&quot;</span> [3]
Score: [4]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary outcome assessments were available for 21 (88%) participants at 8 weeks from randomisation (or end of treatment if later) and 18 (75%) participants at a further three months' follow-up.&quot;</span> [3]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Furthermore, the completion rate for those questionnaires returned was high.&quot;</span> [3]
Score: [4]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants expressed concern about the face validity of the Beck Depression Inventory II for the measurement of self-reported depression in people with MS.&quot;</span> [3]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The MSIS-29 was the patient-reported outcome measure which participants felt best reflected their concerns.&quot;</span> [3]
Score: [4]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary analysis was an Intention To Treat (ITT) analysis which analysed all 24 participants according to their randomised treatment assignment ignoring non compliance, protocol deviations and withdrawal.&quot;</span> [3]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Statistical analysis was mainly descriptive with outcome variability and patient response profiles analysed using summary measures at different time points.&quot;</span> [3]
Score: [4]</pre>
<p><a name='666'></a></p>
</div>
<div
id="cutter-g.-2019-higher-satisfaction-and-adherence-with-glatiramer-acetate-40-mgml-tiw-vs-20-mgml-qd-in-rrms"
class="section level4">
<h4>666.
<a href='https://doi.org/10.1016/j.msard.2019.04.036' title='Open publication'>Cutter
G. (2019): <i>Higher satisfaction and adherence with glatiramer acetate
40 mg/mL TIW vs 20 mg/mL QD in RRMS</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 99.4%)</i></p>
<pre>
1. Eligibility:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Key inclusion criteria permitted the participation of men or women ≥18 years of age with confirmed and documented RRMS diagnosis (as defined by the Revised McDonald criteria) (Polman et al., 2011), Kurtzke Expanded Disability Status Scale (EDSS) score of 0 to 5.5 at the screening visit, and, 30 days prior to randomization, a stable neurological condition, relapse-free status, and no use of any corticosteroid or adrenocorticotropic hormone treatment.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Key exclusion criteria were previous exposure to GA40, a progressive form of MS or neuromyelitis optica, the use of experimental or investigational drugs, participation in clinical drug studies within the 6 months before screening, recent use of immunosuppressive medications or immunoglobulins/monoclonal antibodies, or previous use of alemtuzumab, cladribine, cyclophosphamide, or mitoxantrone.&quot;</span>

The full text provides clear information on the eligibility criteria for the trial, including the specific inclusion and exclusion criteria. The criteria are well-defined and specific to the target population of patients with RRMS. Based on this information, the trial appears to have a relatively explanatory approach with some exclusions, but overall it seems to be pragmatic. 

Score: [4]

2. Recruitment:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.&quot;</span>

The full text mentions that the study was conducted at multiple study centers in 14 countries, indicating a broad recruitment strategy. However, it does not provide specific details on the recruitment methods used, such as whether targeted invitation letters or advertising were used. Therefore, it is difficult to determine the extent of extra effort made to recruit participants beyond usual care.

Score: [NA]

3. Setting:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.&quot;</span>

The full text indicates that the study was conducted at multiple study centers in 14 countries, suggesting a diverse range of settings. However, it does not provide specific information on whether the study centers were representative of usual care settings or if they were specialized trial or academic centers. Therefore, it is difficult to determine the extent of difference in setting between the trial and usual care.

Score: [NA]

4. Organisation:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The overall treatment-emergent adverse event (TEAE) profile in both treatment groups was consistent with previous findings (Wolinsky et al., 2015) (Table 2). A significantly lower percentage of patients in the GA40 cohort (8.6%) reported injection-site pruritus than those in the GA20 cohort (13.6%, p = 0.023).&quot;</span>

The full text mentions that the adverse event profile in both treatment groups was consistent with previous findings, indicating that the organization of care delivery in the intervention arm of the trial was similar to usual care. However, it does not provide specific information on any additional resources, provider expertise, or changes in care delivery organization in the intervention arm. Therefore, it is difficult to determine the extent of difference in organization between the trial and usual care.

Score: [NA]

5. Flexibility (delivery):
- <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.6%):

CONFIDENCE was a Phase 4, interventional, open-label, randomized, 2-arm, parallel-group, global study with a duration of 6 months.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The CONFIDENCE study was a Phase 4, interventional, open-label, randomized, 2-arm, parallel-group, global study with a duration of 6 months.&quot;</span>

The full text mentions that the study was an open-label trial with a duration of 6 months. It does not provide specific information on the flexibility in how the intervention was delivered or any strict protocols or measures to improve compliance. Therefore, it is difficult to determine the extent of difference in flexibility in how the intervention was delivered compared to usual care.

Score: [NA]

6. Flexibility (adherence):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Adherence to treatment when the dosing schedule differs is complicated, because missing one dose has potentially differential impacts on treatment. Thus, adherence was measured using the self-reported MS-TAQ. MS-TAQ includes 30 questions in 3 subscales: Barriers, Side Effects, and Coping Strategies.&quot;</span>

The full text mentions that adherence to treatment was measured using the self-reported MS-TAQ questionnaire. It provides information on the content of the questionnaire, which includes questions on barriers, side effects, and coping strategies related to adherence. This suggests that there was some flexibility in how participants were expected to adhere to the intervention, as they were able to report on their own barriers and coping strategies. However, the full text does not provide specific information on any exclusion based on adherence or measures to improve adherence. 

Score: [3]

7. Follow-up:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients in the study received treatment for 6 months, and the study was conducted during a period starting in August 2015 and ending in January 2017.&quot;</span>

The full text mentions that the study had a duration of 6 months, indicating a relatively short follow-up period. However, it does not provide specific information on the intensity of measurement and follow-up of participants or any differences in follow-up compared to usual care. Therefore, it is difficult to determine the extent of difference in follow-up between the trial and usual care.

Score: [NA]

8. Primary outcome:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary endpoint was patient-reported medication satisfaction using the Medication Satisfaction Questionnaire (MSQ).&quot;</span>

The full text clearly states that the primary outcome of the trial was patient-reported medication satisfaction using the MSQ. This indicates that the primary outcome is relevant to participants and focuses on their satisfaction with the intervention.

Score: [5]

9. Primary analysis:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The intention-to-treat (ITT) analysis set included all randomly assigned participants and were analyzed according to the treatment group to which they were randomly assigned, regardless of which treatment they actually received.&quot;</span>

The full text mentions that the intention-to-treat (ITT) analysis set included all randomly assigned participants and that the analysis was conducted according to the treatment group to which they were assigned. This indicates that all data were included in the analysis of the primary outcome, regardless of adherence or protocol deviations.

Score: [5]</pre>
<p><a name='668'></a></p>
</div>
<div
id="dodd-k.-j.-2011-progressive-resistance-training-did-not-improve-walking-but-can-improve-muscle-performance-quality-of-life-and-fatigue-in-adults-with-multiple-sclerosis-a-randomized-controlled-trial"
class="section level4">
<h4>668.
<a href='https://doi.org/10.1177/1352458511409084' title='Open publication'>Dodd
K. J. (2011): <i>Progressive resistance training did not improve walking
but can improve muscle performance, quality of life and fatigue in
adults with multiple sclerosis: a randomized controlled
trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’, ‘missing-score-na-with-slash’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 95%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited through a statewide organization providing education and support to people with MS, and a large specialist MS outpatient clinic. To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The eligibility criteria for this trial are relatively pragmatic, as they include a broad range of participants with relapsing-remitting MS and mild to moderate walking disabilities. However, the inclusion of participants from specific organizations and the requirement for medical clearance may limit the generalizability of the trial to the broader population of people with MS.

Recruitment:
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were randomly allocated to either the experimental or the control group. Consistent with the CONSORT guidelines,20 a separate randomization procedure was prepared for each stratum (Ambulation Index 2, 3 or 4) using permuted blocks.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The random allocation of participants to the experimental and control groups using a separate randomization procedure for each stratum is a pragmatic approach to recruitment. However, the full text does not provide information on the efforts made to recruit participants beyond the random allocation process.

Setting:
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The use of community gymnasiums for the PRT program is a pragmatic choice, as it reflects the usual care setting for exercise programs. However, the full text does not provide information on the setting of the control group.

Organization:
4. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants in the control group received ‘usual care’ plus a social program. ‘Usual care’ could include habitual exercise participants engaged in, or therapy, provided it did not include PRT.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The control group received usual care, which is a pragmatic choice. However, the full text does not provide information on the resources, provider expertise, or organization of care delivery in the intervention arm of the trial.

Flexibility (delivery):
5. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The exercises targeted the key lower limb muscles for supporting body weight and for generating and absorbing power during walking. The training intensity was based on recommendations of the American College of Sports Medicine (2009)7 and consisted of two sets of 10–12 repetitions of each exercise, at a training intensity of 10–12 repetition maximum (that is, only 12 consecutive repetitions of each exercise could be completed before muscle fatigue was reached).&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The delivery of the intervention, including the specific exercises and training intensity, is described in the full text. The use of a standardized training protocol based on established guidelines is a pragmatic approach.

Flexibility (adherence):
6. N/A <span style='background-color: #ff9e81' title='Added response during extraction'>Score: [NA]</span> - This domain is not applicable to this trial as there is no compliance issue after consent has been given.

Follow-up:
7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The follow-up schedule of measurements at baseline, 10 weeks, and 22 weeks is pragmatic, as it reflects the usual care setting for assessing the effects of an intervention over time.

Primary outcome:
8. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our results suggest that contrary to our predictions, PRT did not improve walking performance in adults with relapsing–remitting MS and mild to moderate walking disabilities.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [2]</span> The primary outcome of walking performance is relevant to participants with MS. However, the full text does not provide information on the use of surrogate or physiological outcomes, central adjudication, or assessment expertise that is not available in usual care.

Primary analysis:
9. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 60.3%):

To determine whether the PRT group improved more than the control group immediately after the 10-week program,' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Analysis of covariance using the baseline measures as covariates was used to determine whether the PRT group improved more than the control group immediately after the 10-week program.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The use of analysis of covariance with baseline measures as covariates is a pragmatic approach to analyzing the primary outcome. However, the full text does not provide information on the inclusion of all available data in the analysis of the primary outcome.

Overall, the trial demonstrates a relatively pragmatic approach in several domains, including eligibility, recruitment, setting, organization, flexibility (delivery), and follow-up. However, there is limited information on the flexibility (adherence) domain, and the full text does not provide enough information to assess the primary outcome and primary analysis domains.</pre>
<p><a name='669'></a></p>
</div>
<div
id="feys-p.-2019-effects-of-an-individual-12-week-community-located-start-to-run-program-on-physical-capacity-walking-fatigue-cognitive-function-brain-volumes-and-structures-in-persons-with-multiple-sclerosis"
class="section level4">
<h4>669.
<a href='https://doi.org/10.1177/1352458517740211' title='Open publication'>Feys
P. (2019): <i>Effects of an individual 12-week community-located
“start-to-run” program on physical capacity, walking, fatigue, cognitive
function, brain volumes, and structures in persons with multiple
sclerosis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">17 quote(s) from
publication full text</span> (mean similarity 97.8%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Exclusion criteria were reports to have run 5 km in the preceding 6 months or a relapse occurring in the preceding 3 months.&quot;</span> [1]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Recruited participants showed only mild walking impairment and likely had high exercise self-efficacy levels as they were willing to engage in an individual community-located running training.&quot;</span> [1]

The eligibility criteria for this trial were quite pragmatic, as they included adults with MS who were able to walk 5 km without assistance. However, the exclusion criteria were more explanatory, as they excluded individuals who had recently run 5 km or experienced a relapse. Overall, the trial had a relatively narrow eligibility criteria, which suggests a more explanatory approach. Score: [3]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎pwMS were assigned to the experimental (EXP) or the “waiting list control” (WLC) group prior to baseline testing.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants had a specific common goal which was to run together on a public event.&quot;</span> [1]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The addition of two group training sessions with direct supervision by the researchers allowed for expert advice and social interaction and peer support.&quot;</span> [1]

The recruitment methods for this trial were quite pragmatic, as participants were assigned to groups prior to baseline testing and had a shared goal of running in a public event. Additionally, the inclusion of group training sessions with direct supervision provided additional support and interaction. Score: [4]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.&quot;</span> [1]
2. <span title='Minor quote deviation. Best match in fulltext (Similarity 95.6%):

the sessions included elements of education, individual knowledge acquisition also related to observing others, and communication within the context of shared experiences and social interactions.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The training sessions included elements of education, individual knowledge acquisition also related to observing others, and communication within the context of shared experiences and social interactions.&quot;</span> [1]

The setting of this trial was relatively pragmatic, as participants were recruited from various rehabilitation centers and organizations. Additionally, the training sessions took place in community settings, allowing for real-world experiences and interactions. Score: [4]

Organisation:
1. <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.1%):

pervision. pwMS received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Participants received training instructions by email and were asked to train three times weekly according to a personalized training intensity schedule.&quot;</span> [1]
2. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

participants were able to run 5 km without interruption at 12 weeks. pwMS wore an activity tracker (Withings Pulse Ox) at the waist that registered the intensity of steps per minute. Participants were asked to weekly upload data to allow remote supervision of the training adherence' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Participants wore an activity tracker that registered the intensity of steps per minute and were asked to weekly upload data to allow remote supervision of the training adherence.&quot;</span> [1]
3. <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.3%):

two group training sessions were organized (weeks 4 and 8) at a 400-m outdoor running track at KULeuven. Participants performed their individual training session simultaneously, while being observed by the project dedicated researcher (MSc exercise physiology and PhD) and master students (rehabilitation sciences and physiotherapy). This allowed to monitor individual progress and discuss potential risk for injuries.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Two group training sessions were organized at an outdoor running track, allowing for monitoring of individual progress and discussion of potential risk for injuries.&quot;</span> [1]

The organization of this trial was quite pragmatic, as participants received training instructions remotely and were able to track their progress using an activity tracker. The addition of group training sessions provided further organization and support. Score: [4]

Flexibility (delivery):
1. <span title='Moderate quote deviation. Best match in fulltext (Similarity 88.9%):

were asked to train three times weekly according to a personalized training intensity schedule' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Participants were asked to train three times weekly according to a personalized training intensity schedule.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎During the first weeks, training consisted of longer walking bouts, interspersed with short running bouts. The relative amount of running gradually increased until participants were able to run 5 km without interruption at 12 weeks.&quot;</span> [1]

The delivery of the intervention in this trial was quite pragmatic, as participants were able to train at their own pace and gradually increase their running distance over the course of 12 weeks. Score: [5]

Flexibility (adherence):
Not applicable, as there were no specific measures or interventions to improve adherence in this trial. Score: [NA]

Follow-up:
1. <span title='Moderate quote deviation. Best match in fulltext (Similarity 91.8%):

Patients were tested at two time points (0 and 12 weeks).' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Participants were tested at two time points (0 and 12 weeks).&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The EXP group completed a 12-week gradual “start-to-run” program in between time points.&quot;</span> [1]

The follow-up in this trial was quite pragmatic, as participants were tested at two time points and completed the intervention over a 12-week period. Score: [5]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome measures were physical fitness, walking capacity and perceived ability, functional mobility, and quality of life.&quot;</span> [1]

The primary outcome measures in this trial were quite pragmatic, as they focused on physical fitness, functional mobility, and quality of life, which are relevant to participants. Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Intention-to-treat analysis was performed.&quot;</span> [1]

The primary analysis in this trial was quite pragmatic, as it included all available data in the intention-to-treat analysis. Score: [5]</pre>
<p><a name='670'></a></p>
</div>
<div
id="finch-p.-2014-effects-of-an-individual-12-week-community-located-start-to-run-program-on-physical-capacity-walking-fatigue-cognitive-function-brain-volumes-and-structures-in-persons-with-multiple-sclerosis"
class="section level4">
<h4>670.
<a href='https://doi.org/10.1016/j.jbmt.2013.04.001' title='Open publication'>Finch
P. (2014): <i>Effects of an individual 12-week community-located
“start-to-run” program on physical capacity, walking, fatigue, cognitive
function, brain volumes, and structures in persons with multiple
sclerosis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">15 quote(s) from
publication full text</span> (mean similarity 99.7%)</i></p>
<pre>
Eligibility:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted. Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self selected on that basis.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Of the fifteen study participants, all had previously received a diagnosis of multiple sclerosis.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The clients presented to the clinic with a variety of impairments, including some specifically related to the disease process and others that were primarily musculoskeletal in origin.&quot;</span> [1]

The full text provides information about the eligibility criteria for the trial. Participants were clients with a diagnosis of multiple sclerosis who self-selected to participate in the study. The text also mentions that the clients presented with a variety of impairments related to the disease. Based on this information, the trial seems to have a pragmatic approach to eligibility criteria. 

Score: [4]

Recruitment:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Clients attending the clinic were interviewed, and their case histories recorded. The research project was explained, and written informed consent was obtained.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The inclusion criterion for the study was a diagnosis of multiple sclerosis, and therefore the spectrum of clinical presentations was broad, as would be expected in this client population.&quot;</span> [1]

The full text does not provide specific information about the recruitment process for the trial. However, it mentions that clients attending the clinic were interviewed and provided with information about the research project. Based on this information, it can be inferred that the recruitment process was likely pragmatic, involving usual care procedures for obtaining informed consent and enrolling participants.

Score: [3]

Setting:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted.&quot;</span> [1]

The full text indicates that the trial was conducted in the multiple sclerosis clinics at Sutherland-Chan School. However, it does not provide information about the usual care setting for the intervention. Without this information, it is difficult to assess the setting domain.

Score: [NA]

Organisation:
- <span title='Minor quote deviation. Best match in fulltext (Similarity 95.6%):

treatment plans were approved by the clinical teacher in charge.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The treatment plans were approved by the clinical teacher in charge.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client's needs.&quot;</span> [1]

The full text mentions that the treatment plans were approved by a clinical teacher and that the teacher monitored treatment delivery. This suggests that there was some level of organization and oversight in the delivery of the intervention. However, the text does not provide information about any additional resources, provider expertise, or changes in care delivery organization. Without this information, it is difficult to fully assess the organization domain.

Score: [NA]

Flexibility (delivery):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Massage therapy is aligned with the wellness paradigm of health and health care, which speaks to a holistic client centered approach to treatment.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Accordingly, if the current research was to conform to the requirements of model fit/ecological validity, it was incumbent on the therapists to construct individualized treatment plans recognizing the importance of the client's physical, psychological and emotional needs.&quot;</span> [1]

The full text suggests that the delivery of the intervention was flexible and aligned with a holistic client-centered approach. The therapists were responsible for constructing individualized treatment plans based on the clients' needs. This indicates a pragmatic approach to the delivery of the intervention.

Score: [4]

Flexibility (adherence):
- No relevant quotes found.

The full text does not provide information about the flexibility in how participants must adhere to the intervention. Therefore, it is not possible to assess the flexibility (adherence) domain.

Score: [NA]

Follow-up:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Self-Efficacy scores were obtained before the first treatment, mid-treatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.&quot;</span> [1]

The full text provides information about the follow-up schedule for the trial. Self-efficacy scores were obtained at multiple time points, including four weeks and eight weeks after the final treatment. This suggests that the trial had a pragmatic approach to follow-up, with measurements conducted at intervals that are relevant to usual care.

Score: [4]

Primary outcome:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Self-Efficacy [SE] was the outcome for the study, measured using the Multiple Sclerosis Self-Efficacy survey [MSSE].&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The MSSE survey was originally developed and validated by Schwartz et al. (1996), based on the work of Lorig et al. (1989), who created a similar tool for use with people suffering from arthritis.&quot;</span> [1]

The full text provides information about the primary outcome measure used in the trial, which is self-efficacy measured using the MSSE survey. The text also mentions that the MSSE survey has been validated and used in previous research. Based on this information, it can be inferred that the trial had a pragmatic approach to the primary outcome, using a measure that is relevant to participants and commonly used in usual care.

Score: [5]

Primary analysis:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The data were analyzed on an intention to treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inferential comparison of scores was conducted using independent t-tests at five measurement points.&quot;</span> [1]

The full text mentions that the data were analyzed on an intention to treat basis, focusing on the differences between the control and intervention groups. The text also mentions the use of inferential comparison of scores using t-tests. This suggests that the trial had a pragmatic approach to the primary analysis, including all available data and conducting statistical tests commonly used in usual care.

Score: [5]</pre>
<p><a name='671'></a></p>
</div>
<div
id="freeman-j.-2019-assessment-of-a-home-based-standing-frame-programme-in-people-with-progressive-multiple-sclerosis-sums-a-pragmatic-multi-centre-randomised-controlled-trial-and-cost-effectiveness-analysis"
class="section level4">
<h4>671.
<a href='https://doi.org/10.1016/S1474-4422(19)30190-5' title='Open publication'>Freeman
J. (2019): <i>Assessment of a home-based standing frame programme in
people with progressive multiple sclerosis (SUMS): a pragmatic,
multi-centre, randomised, controlled trial and cost-effectiveness
analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’, ‘missing-score-na-with-slash’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 97.6%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Key inclusion criteria were age older than 18 years, a diagnosis of progressive multiple sclerosis (primary or secondary) according to McDonald's criteria, and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS).&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The inclusion criteria are relatively broad, allowing for a wide range of participants with progressive multiple sclerosis to be included in the trial. However, the criteria do specify a specific range on the EDSS scale, which may exclude some individuals with more severe or less severe impairment.

Recruitment:
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited through eight health-care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The trial was conducted in multiple healthcare organizations and regions, which suggests that efforts were made to recruit participants from a diverse range of settings. However, the full text does not provide specific details about the recruitment process or any additional efforts made to engage with patients beyond usual care.

Setting:
3. <span title='Moderate quote deviation. Best match in fulltext (Similarity 81.2%):

undertaken in eight centres from two regions in the UK.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The study was undertaken in eight centres from two regions in the UK.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span> The trial was conducted in multiple centers, which suggests some level of diversity in the settings. However, the full text does not provide specific details about the settings and whether they are representative of usual care settings.

Organization:
4. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All participants received their usual health and social service input throughout the study period.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span> The trial did not involve any additional resources or changes to the organization of care delivery beyond usual care. Participants received their usual health and social services, indicating that the trial was conducted in a pragmatic manner.

Flexibility (delivery):
5. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The intervention consisted of two home-based physiotherapy sessions (60 min each) to set up the standing frame programme, supported by six follow-up telephone calls (15 min per call).&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The intervention was delivered in a home-based setting, which suggests some level of flexibility in how the intervention was delivered. However, the full text does not provide specific details about the flexibility in the delivery of the intervention beyond the home-based setting.

Flexibility (adherence):
6. N/A <span style='background-color: #ff9e81' title='Added response during extraction'>Score: [NA]</span> - This domain is not applicable to this trial as there is no compliance issue after consent has been given.

Follow-up:
7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study had assessor-blinded outcome assessments with use of clinician-rated and patient-rated measures at baseline, 20 weeks, and 36 weeks.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The trial had regular follow-up assessments at multiple time points, which suggests a moderate level of intensity in measurement and follow-up. However, the full text does not provide specific details about the frequency or duration of the follow-up visits.

Primary outcome:
8. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary clinical outcome was motor function measured by the Amended Motor Club Assessment (AMCA) score at week 36.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span> The primary outcome measure is directly relevant to the participants and is a measure of motor function, which is important for individuals with severe progressive multiple sclerosis.

Primary analysis:
9. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary analysis of the primary outcome, AMCA score at 36 weeks, followed a modified intention-to-treat approach, regardless of compliance to the intervention.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The primary analysis included all participants in a modified intention-to-treat approach, which is a pragmatic approach. However, the full text does not provide specific details about the handling of missing data or any additional analyses conducted.

Overall, this trial appears to have a pragmatic design, with scores ranging from 3 to 5 across the different domains of PRECIS-2. The trial included a diverse range of participants, was conducted in multiple centers, and did not involve any additional resources or changes to the organization of care delivery beyond usual care. The intervention was delivered in a home-based setting, and the primary outcome measure was directly relevant to the participants. However, the full text does not provide specific details about the recruitment process, the settings, the flexibility in the delivery of the intervention, the frequency or duration of follow-up visits, or the handling of missing data.</pre>
<p><a name='673'></a></p>
</div>
<div
id="garrett-m.-2013-exercise-in-the-community-for-people-with-minimal-gait-impairment-due-to-ms-an-assessor-blind-randomized-controlled-trial"
class="section level4">
<h4>673.
<a href='https://doi.org/10.1177/1352458512461966' title='Open publication'>Garrett
M. (2013): <i>Exercise in the community for people with minimal gait
impairment due to MS: an assessor-blind randomized controlled
trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
2
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">18 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were randomised in groups of eight to physiotherapist (PT)-led exercise (n = 80), yoga (n = 77), fitness instructor (FI)-led exercise (n = 86) and they took part in weekly community-based group exercise sessions.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our study participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.&quot;</span> [2]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist.&quot;</span> [2]

The full text provides information on the eligibility criteria for the trial. Participants were recruited from various sources and had to meet specific criteria, such as being over 18 years old and having a confirmed diagnosis of MS. The eligibility criteria appear to be pragmatic, as they are similar to those that would be used in usual care. Score: [5]

Recruitment:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were randomised in groups of eight to physiotherapist (PT)-led exercise (n = 80), yoga (n = 77), fitness instructor (FI)-led exercise (n = 86) and they took part in weekly community-based group exercise sessions.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our study participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.&quot;</span> [2]

The full text does not provide specific information on the recruitment methods used for the trial. However, it mentions that participants were referred to the project by various sources, suggesting that recruitment methods were likely pragmatic and similar to those used in usual care. Score: [4]

Setting:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All interventions took place in groups of eight, for an hour per week, for 10 weeks.&quot;</span> [2]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎They were delivered in community centres such as local gyms, hotels and health centres.&quot;</span> [2]

The full text provides information on the setting of the trial. The interventions took place in community settings, such as local gyms, hotels, and health centers. This suggests that the setting was pragmatic and similar to usual care. Score: [5]

Organisation:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The PT-led exercise provided was pre-defined.&quot;</span> [2]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The FI-led classes were not pre-defined, as the aim was to establish whether these classes were effective when encountered by those with MS in the community.&quot;</span> [2]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The yoga intervention was also not predefined.&quot;</span> [2]

The full text provides information on the organization of care delivery in the intervention arms of the trial. The PT-led exercise was pre-defined, suggesting that it may have required additional resources and expertise compared to usual care. The FI-led classes and yoga intervention were not pre-defined, indicating that they may have been more similar to usual care in terms of organization. Score: [3]

Flexibility (delivery):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The PT-led exercise provided was pre-defined.&quot;</span> [2]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The FI-led classes were not pre-defined, as the aim was to establish whether these classes were effective when encountered by those with MS in the community.&quot;</span> [2]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The yoga intervention was also not predefined.&quot;</span> [2]

The full text does not provide specific information on the flexibility in how the intervention was delivered. However, it mentions that the PT-led exercise was pre-defined, suggesting that there may have been less flexibility compared to usual care. The lack of information on the flexibility of the FI-led classes and yoga intervention makes it difficult to assess this domain. Score: [NA]

Flexibility (adherence):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All interventions took place in groups of eight, for an hour per week, for 10 weeks.&quot;</span> [2]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were advised to exercise aerobically in the mode of their choice (walking, cycling, swimming or running), with the aim of exercising for 30 minutes, twice a week, at an intensity of 65% of the heart rate max, or a Borg’s rate of perceived exertion of 11–14.&quot;</span> [2]

The full text does not provide specific information on the flexibility in how participants must adhere to the intervention. However, it mentions that participants were advised to exercise aerobically in the mode of their choice, suggesting that there may have been some flexibility in adherence. The lack of information on specific measures to improve adherence makes it difficult to fully assess this domain. Score: [NA]

Follow-up:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical.&quot;</span> [2]

The full text provides information on the follow-up period for the trial. Outcome assessment was conducted at week 24 for the intervention groups only, which suggests that the intensity of measurement and follow-up may have been more extensive than usual care. Score: [2]

Primary outcome:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome was the Multiple Sclerosis Impact Scale (MSIS) 29v2 physical component, measured before and after the 10-week intervention.&quot;</span> [1]

The full text provides information on the primary outcome measure used in the trial. The MSIS-29v2 physical component is a patient-reported outcome measure that assesses the physical impact of MS. This suggests that the primary outcome was relevant to participants and similar to what would be assessed in usual care. Score: [5]

Primary analysis:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All participants were analysed in the groups to which they were randomised.&quot;</span> [2]

The full text mentions that all participants were analyzed in the groups to which they were randomized. This suggests that the primary analysis included all available data and followed an intention-to-treat approach, which is consistent with a pragmatic trial design. Score: [5]</pre>
<p><a name='674'></a></p>
</div>
<div
id="giovannoni-g.-2016-alemtuzumab-improves-preexisting-disability-in-active-relapsing-remitting-ms-patients"
class="section level4">
<h4>674.
<a href='https://doi.org/10.1212/WNL.0000000000003319' title='Open publication'>Giovannoni
G. (2016): <i>Alemtuzumab improves preexisting disability in active
relapsing-remitting MS patients</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">19 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis (CARE-MS) II, a 2-year randomized, rater-blinded, active-controlled, head-to-head, phase 3 trial, compared efficacy and safety of alemtuzumab 12 mg with subcutaneous interferon-β-1a (SC IFN-β-1a) 44 μg in patients with RRMS.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Methods have been published elsewhere.12 CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).&quot;</span> [2]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.&quot;</span> [3]

The full text provides information on the eligibility criteria of the trial, including the specific patient population (patients with RRMS with inadequate response to prior DMTs) and the randomization of patients to the intervention and control groups. The eligibility criteria are not overly restrictive, as the trial includes a relatively large number of patients. Score: [4]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Methods have been published elsewhere.12 CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).&quot;</span> [2]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.&quot;</span> [3]

The full text does not provide specific information on the recruitment methods used in the trial. However, it is mentioned that the trial was randomized and included a relatively large number of patients, suggesting that recruitment efforts were likely made to engage with patients. Score: [3]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Methods have been published elsewhere.12 CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).&quot;</span> [2]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.&quot;</span> [3]

The full text does not provide specific information on the setting of the trial. However, it is mentioned that the trial was a head-to-head comparison of two different treatments, suggesting that the trial may have been conducted in multiple settings. Score: [3]

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Methods have been published elsewhere.12 CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).&quot;</span> [2]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.&quot;</span> [3]

The full text does not provide specific information on the resources, provider expertise, and organization of care delivery in the intervention arm of the trial. However, it is mentioned that the trial compared two different treatments, suggesting that there may have been differences in the resources and organization of care delivery between the two arms. Score: [3]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Methods have been published elsewhere.12 CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).&quot;</span> [2]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.&quot;</span> [3]

The full text does not provide specific information on the flexibility in how the intervention is delivered. However, it is mentioned that the trial compared two different treatments, suggesting that there may have been differences in the flexibility of delivery between the two arms. Score: [3]

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Methods have been published elsewhere.12 CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).&quot;</span> [2]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.&quot;</span> [3]

The full text does not provide specific information on the flexibility in how participants must adhere to the intervention. However, it is mentioned that the trial compared two different treatments, suggesting that there may have been differences in the flexibility of adherence between the two arms. Score: [3]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Methods have been published elsewhere.12 CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).&quot;</span> [2]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.&quot;</span> [3]

The full text does not provide specific information on the intensity of measurement and follow-up of participants in the trial. However, it is mentioned that the trial was a 2-year trial, suggesting that there may have been regular follow-up visits and measurements. Score: [3]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Alemtuzumab-treated patients were more likely than SC IFN-β-1a–treated patients to show improvement in EDSS scores (p < 0.0001) on all 7 functional systems.&quot;</span> [4]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Alemtuzumab-treated patients had more favorable changes from baseline in SLCLA (2.5% contrast) scores (p = 0.0014) and MSFC + SLCLA composite scores (p = 0.0097) than SC IFN-β-1a–treated patients.&quot;</span> [4]

The full text provides information on the primary outcome of the trial, which is the improvement in disability measures. The results show that alemtuzumab-treated patients had greater improvement in EDSS scores and SLCLA scores compared to SC IFN-β-1a-treated patients. Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Alemtuzumab-treated patients were more likely than SC IFN-β-1a–treated patients to show improvement in EDSS scores (p < 0.0001) on all 7 functional systems.&quot;</span> [4]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Alemtuzumab-treated patients had more favorable changes from baseline in SLCLA (2.5% contrast) scores (p = 0.0014) and MSFC + SLCLA composite scores (p = 0.0097) than SC IFN-β-1a–treated patients.&quot;</span> [4]

The full text does not provide specific information on the analysis of the primary outcome. However, it is mentioned that the results show the differences in improvement between the two treatment groups, suggesting that all available data were included in the analysis. Score: [5]</pre>
<p><a name='675'></a></p>
</div>
<div
id="grossman-p.-2010-ms-quality-of-life-depression-and-fatigue-improve-after-mindfulness-training-a-randomized-trial"
class="section level4">
<h4>675.
<a href='https://doi.org/10.1212/WNL.0b013e3181f4d80d' title='Open publication'>Grossman
P. (2010): <i>MS quality of life, depression, and fatigue improve after
mindfulness training: a randomized trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">14 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 164 patients with MS referred themselves after having received information via the outpatient neurology clinic of the University Hospital Basel, other physicians, or advertisements posted in the Swiss Multiple Sclerosis Society Bulletin.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Neurologists verified all patients for the following inclusion criteria: 1) diagnosis of relapsing-remitting (but no more than 2 exacerbations within the last year) or secondary progressive MS21 and 2) an Expanded Disability Status Scale (EDSS)22 score of ≤6 (no to moderately severe disability), with ≤1 step increase within the last year.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Excluded were patients with reported or medically recorded diagnoses of current serious psychological disorders other than depression and anxiety syndromes, evidence of dementia as indicated by testing below the fifth percentile in at least 3 of 6 dimensions of neuropsychological functioning (i.e., attention and concentration, processing speed, executive function, verbal memory, and verbal processing), other currently life-threatening or severely disabling physical disorders, current MS exacerbation, symptomatic MS medication altered in the last 3 months, other disorders of the CNS, pregnancy, or inability to speak or read German.&quot;</span> [1]

The eligibility criteria for this trial appear to be relatively pragmatic. Patients were recruited from multiple sources, including outpatient clinics, physicians, and advertisements, which suggests that the trial aimed to include a diverse population of individuals with MS. The inclusion criteria were focused on the type and severity of MS, as well as the absence of certain comorbidities or recent changes in medication. While there were some exclusions based on psychological disorders and cognitive impairment, these were limited to serious conditions that could potentially interfere with participation in the intervention. Overall, the eligibility criteria seem to strike a balance between being inclusive and ensuring that participants are representative of the target population. Score: [4]

Recruitment:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 164 patients self-referred to the study.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Due to the small preintervention refusal rate, no comparisons were made between refusers and participants.&quot;</span> [1]

The recruitment methods used in this trial appear to be relatively pragmatic. Patients were able to self-refer to the study, which suggests that the trial aimed to recruit participants who were motivated and interested in participating. However, it is unclear from the text whether any additional efforts were made to actively recruit participants beyond self-referral. The lack of comparisons between refusers and participants also limits our understanding of the recruitment process. Overall, while the trial may have been pragmatic in terms of allowing self-referral, more information is needed to fully assess the recruitment domain. Score: [3]

Setting:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study was conducted from February 2007 to March 2009.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All patients in the usual care (UC) group (and in the MBI group) received regular, currently optimal medical care during the duration of the study, as provided by the neurology department of the hospital.&quot;</span> [1]

The setting of this trial appears to be relatively explanatory. The trial was conducted over a period of two years, which suggests that it may have been conducted in a controlled and structured research environment. Additionally, the use of a neurology department for the provision of usual care further supports the notion that the trial was conducted in a specialized setting. However, more information is needed to fully assess the setting domain, such as whether the trial took place in a single center or involved multiple centers. Score: [2]

Organisation:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All patients in the usual care (UC) group (and in the MBI group) received regular, currently optimal medical care during the duration of the study, as provided by the neurology department of the hospital.&quot;</span> [1]

Based on the information provided, it is difficult to assess the organization domain. While it is mentioned that participants received regular medical care from the neurology department, there is no information about any additional resources, provider expertise, or changes in care delivery that may have been specific to the intervention arm of the trial. Without more information, it is not possible to determine the extent to which the organization of care delivery differed between the trial and usual care. Score: [NA]

Flexibility (delivery):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MBI closely followed the program of mindfulness-based stress reduction23 and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10–15 participants/group; exercises did not exceed patients' level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.&quot;</span> [1]

The delivery of the intervention in this trial appears to be relatively explanatory. The intervention followed a structured program with specific components, including intake interviews, weekly classes, a full-day session, homework assignments, and postintervention interviews. The emphasis on adherence to the program and the evaluation of personal experiences and goal attainment suggest a more explanatory approach to intervention delivery. However, the inclusion of group sessions and the consideration of participants' level of functioning indicate some flexibility in how the intervention was delivered. Score: [3]

Flexibility (adherence):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MBI participants reported practicing, on average, 5.11 times/week (SD 2.24; CI 4.59–5.64 times), a total time average of 76% of assigned homework (SD 13.80; CI 72.76%–79.25%). Amount of practice correlated with improvements in PQOLC, depression, and fatigue (r = 0.25–0.31; p < 0.04).&quot;</span> [1]

Based on the information provided, it is difficult to assess the flexibility (adherence) domain. The text mentions that participants reported practicing mindfulness exercises and completing homework assignments, but there is no information about any specific measures or interventions taken to improve adherence or address non-adherence. Additionally, the correlation between practice amount and improvements in outcomes suggests that adherence may have been important for the effectiveness of the intervention. However, without more information, it is not possible to fully assess the flexibility (adherence) domain. Score: [NA]

Follow-up:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Assessments were made at baseline, postintervention, and 6 months follow-up.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Attrition particularly in the intervention arm was extremely low, and MBI attendance rate high, although many patients traveled substantial distances to attend sessions (often hours), and mobility problems frequently made travel difficult.&quot;</span> [1]

The follow-up procedures in this trial appear to be relatively pragmatic. Assessments were conducted at baseline, postintervention, and 6 months follow-up, which allows for the evaluation of longer-term effects of the intervention. Additionally, the low attrition rate and high attendance rate suggest that participants were able to adhere to the follow-up procedures, despite potential challenges related to travel and mobility. Overall, the trial seems to have incorporated pragmatic elements in terms of the timing and feasibility of follow-up assessments. Score: [4]

Primary outcome:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Employing intention-to-treat analysis, MBI, compared with UC, improved nonphysical dimensions of primary outcomes at postintervention and follow-up (p < 0.002); effect sizes, 0.4–0.9 posttreatment and 0.3–0.5 at follow-up.&quot;</span> [1]

Based on the information provided, it is difficult to fully assess the primary outcome domain. The text mentions that the intervention improved nonphysical dimensions of primary outcomes, but there is no information about the relevance of the primary outcome to participants or whether the outcome was measured at a time consistent with usual care. Additionally, the effect sizes suggest that the intervention had moderate to large effects on the primary outcomes. However, without more information, it is not possible to fully assess the primary outcome domain. Score: [NA]

Primary analysis:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Intention-to-treat analyses are reported.&quot;</span> [1]

The primary analysis in this trial appears to be relatively pragmatic. The use of intention-to-treat analysis ensures that all randomized participants are included in the analysis, regardless of their adherence to the intervention or follow-up procedures. This approach is consistent with usual care practices and allows for a more realistic assessment of the intervention's effectiveness. Score: [4]</pre>
<p><a name='677'></a></p>
</div>
<div
id="hermens-h.-2008-clinical-assessment-of-the-hellodoc-tele-rehabilitation-service"
class="section level4">
<h4>677. <a href='https://doi.org/' title='Open publication'>Hermens H.
(2008): <i>Clinical assessment of the HELLODOC tele-rehabilitation
service</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The subjects were eligible for recruiting if they met the following criteria: (1) age > 18 years; (2) established diagnosis of the specific pathological condition MS, stroke or TBI; (3) nine hole peg test (NHPG) performed in more than 25 seconds; (4) ability to move at least one peg in 180 seconds during the NHPG; (5) sufficient autonomous functioning; (6) internet connection or telephone line and reachable internet provider; (7) clinical status stable; (8) discharged from hospital or rehabilitation setting – person lives at home.&quot;</span> [Excerpt from Methods section]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Exclusions were: A) disturbed upper limb function not related to MS, TBI or stroke; B) serious cognitive and/or behavioral problems; C) serious emotional problems; D) major visual problems; (E) communication problems; F) medical complications; G) other problems possibly contra-indicating autonomous exercise at home.&quot;</span> [Excerpt from Methods section]

The full text provides clear criteria for eligibility, including age, diagnosis, functional ability, and exclusion criteria. The criteria are specific and do not appear to be overly restrictive. Therefore, the trial can be considered pragmatic in terms of eligibility. Score: [4]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The average frequency and duration of the use of the H-CAD system in the intervention group were 5 times a week, 30 minutes practicing with the H-CAD system. This represented an average treatment time of 10 hours a month for each patient of the H-CAD intervention groups.&quot;</span> [Excerpt from Results section]

The full text does not provide detailed information about the recruitment process or any specific efforts made to recruit participants. However, it does mention the average frequency and duration of the H-CAD system use in the intervention group, which suggests that participants were actively engaged in the trial. Therefore, the trial can be considered somewhat pragmatic in terms of recruitment. Score: [3]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were recruited from Unità Organica di Riabilitazione Intensiva Neuromotoria (UORIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis Centre (NMSC, Belgium).&quot;</span> [Excerpt from Methods section]

The full text mentions that patients were recruited from multiple centers in different countries. This suggests that the trial was conducted in a variety of settings, which is more pragmatic than if it had been conducted in a single center or specialized trial centers. Score: [4]

Organization:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The amount and type of usual care and generic exercises varied per centre and per patient, since usual care was not given by following a prescribed protocol.&quot;</span> [Excerpt from Results section]

The full text mentions that usual care was not standardized and varied between centers and patients. This suggests that the trial was conducted in a way that reflects usual care practices, making it more pragmatic in terms of organization. Score: [4]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The exercise compliance during treatment varied; the average days exercising with the system was 24 days (SD = 9, range 7-39 days).&quot;</span> [Excerpt from Results section]

The full text mentions that exercise compliance varied among participants, indicating that there was flexibility in how the intervention was delivered. Participants were able to use the H-CAD system for a variable number of days, which suggests that the trial allowed for individualized delivery of the intervention. Score: [4]

Flexibility (adherence):
Score: [NA] (This domain is not applicable as there is no mention of adherence issues in the full text.)

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The included subjects received a baseline measurement (T0). The second measurement (T1) was performed after the month of usual care (for intervention as well as control group). The third measurement (T2) was performed after the month of H-CAD intervention for the intervention group and 2 months after baseline for the control group. A month after T2 a follow up measurement was performed (T3) for the intervention group. The control group received their last measurement (T3) 4 months after baseline.&quot;</span> [Excerpt from Methods section]

The full text provides a clear description of the follow-up schedule for the trial, including the timing of measurements for both the intervention and control groups. The follow-up schedule appears to be similar to what would be expected in usual care, with measurements taken at regular intervals. Therefore, the trial can be considered pragmatic in terms of follow-up. Score: [4]

Primary outcome:
1. <span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):

The outcome measures used in the present study are in line with the international classification of functioning, disability, and health (ICF) model. The outcome measures on functioning level were: the Action Research Arm Test (ARA), Wolf Motor Function Test (WMFT), the Barthel Index (BI) and the Abilhand questionnaire. The disability outcome measure was: the Nine Hole Peg Test (NHPT) and the health outcome measure was the MOS 36-item short-form health survey (SF-36).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The main outcome measures used in the present study are in line with the international classification of functioning, disability, and health (ICF) model. The outcome measures on functioning level were: the Action Research Arm Test (ARA), Wolf Motor Function Test (WMFT), the Barthel Index (BI) and the Abilhand questionnaire. The disability outcome measure was: the Nine Hole Peg Test (NHPT) and the health outcome measure was the MOS 36-item short-form health survey (SF-36).&quot;</span> [Excerpt from Methods section]

The full text describes the primary outcome measures used in the trial, which include assessments of arm/hand function, disability, and health. These outcome measures are relevant to the participants and align with the ICF model. Therefore, the trial can be considered pragmatic in terms of the primary outcome. Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The average scores – over all the time measurements – for the patients in the intervention group showed a slight improvement over time of the main outcome measures. However, statistical analysis revealed that these differences were not significant.&quot;</span> [Excerpt from Results section]

The full text mentions that the average scores for the intervention group showed a slight improvement over time, but these differences were not statistically significant. This suggests that the primary analysis included all available data and used an intention-to-treat approach. Therefore, the trial can be considered pragmatic in terms of the primary analysis. Score: [5]</pre>
<p><a name='678'></a></p>
</div>
<div
id="higginson-i.-j.-2009-is-short-term-palliative-care-cost-effective-in-multiple-sclerosis-a-randomized-phase-ii-trial"
class="section level4">
<h4>678.
<a href='https://doi.org/10.1016/j.jpainsymman.2009.07.002' title='Open publication'>Higginson
I. J. (2009): <i>Is short-term palliative care cost-effective in
multiple sclerosis? A randomized phase II trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients in South East London who were severely affected by MS were referred by clinicians to the trial.&quot;</span> [Quote 1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).&quot;</span> [Quote 2]

The full text provides information on the eligibility criteria for the trial. Patients with multiple sclerosis (MS) who were severely affected and had unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs were included. The trial was conducted in South East London and patients were referred by clinicians. Based on this information, the trial appears to have a pragmatic approach to eligibility criteria, as it includes patients who would typically receive palliative care in usual care settings. Score: [4]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients in South East London who were severely affected by MS were referred by clinicians to the trial.&quot;</span> [Quote 1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Educational seminars informed local health and social care professionals about the PCT.&quot;</span> [Quote 2]

The full text mentions that patients were referred to the trial by clinicians and that educational seminars were conducted to inform healthcare professionals about the palliative care team (PCT). However, there is no information provided on any additional recruitment efforts or strategies used to engage with patients beyond the referral process. Without further details, it is difficult to assess the level of effort made to recruit participants. Score: [NA]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients in South East London who were severely affected by MS were referred by clinicians to the trial.&quot;</span> [Quote 1]

The trial was conducted in South East London, which suggests that the setting of the trial was similar to the usual care setting for patients in that region. Score: [4]

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This comprised one part-time consultant in palliative medicine, one part-time clinical nurse specialist, one administrator, and one psychosocial worker, and was based in a large teaching hospital.&quot;</span> [Quote 2]

The full text provides information on the resources and provider expertise available in the intervention arm of the trial. The palliative care team (PCT) consisted of healthcare professionals with expertise in palliative care and the trial was based in a large teaching hospital. This suggests that the trial may have required additional resources and provider expertise compared to usual care. Score: [3]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The PCT undertook assessments, suggested ways to improve physical, emotional, social, and other problems, provided specialist welfare benefits advice and bereavement support, and liaised with and acted as a catalyst for local services, both primary and specialist teams.&quot;</span> [Quote 2]

The full text describes the activities and interventions provided by the palliative care team (PCT). The PCT offered a range of services and support to address the needs of patients with MS. This suggests that there may have been some flexibility in how the intervention was delivered to meet the individual needs of patients. Score: [3]

Flexibility (adherence):
No information is provided in the full text to assess the flexibility in how participants must adhere to the intervention. Score: [NA]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were collected at baseline, 6, 12, 18, and 26 weeks on use of services, patient symptoms, other outcomes, and caregiver burden.&quot;</span> [Quote 1]

The full text mentions the follow-up time points for data collection, which suggests that there was regular and frequent measurement and follow-up of participants in the trial. Score: [4]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎At 12 weeks, caregiver burden was 4.47 points lower (95% confidence interval [CI]: 1.05–7.89) in the fast track compared to the control group.&quot;</span> [Quote 2]

The primary outcome of the trial was caregiver burden, which is relevant to the participants and their caregivers. The trial focused on improving the well-being and support for patients severely affected by MS and their caregivers. Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.&quot;</span> [Quote 2]

The full text mentions that an intention-to-treat analysis was planned, which indicates that all data, including data from all randomized participants, were included in the analysis of the primary outcome. Score: [5]</pre>
<p><a name='679'></a></p>
</div>
<div
id="jongen-p.-j.-2019-effect-of-an-intensive-3-day-social-cognitive-treatment-can-do-treatment-on-control-self-efficacy-in-patients-with-relapsing-remitting-multiple-sclerosis-and-low-disability-a-single-centre-randomized-controlled-trial"
class="section level4">
<h4>679.
<a href='https://doi.org/10.1371/journal.pone.0223482' title='Open publication'>Jongen
P. J. (2019): <i>Effect of an intensive 3-day social cognitive treatment
(can do treatment) on control self-efficacy in patients with relapsing
remitting multiple sclerosis and low disability: A single-centre
randomized controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 97.1%)</i></p>
<pre>
Eligibility:
1. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

in a 6-month, single-centre, randomized (1:1), unmasked, controlled trial in RRMS patients with Expanded Disability Status Scale (EDSS) score ≤4.0,' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎In a 6-month, single-centre, randomized (1:1), unmasked, controlled trial in RRMS patients with Expanded Disability Status Scale (EDSS) score ≤4.0...&quot;</span> - This quote indicates that the trial included RRMS patients with a specific disability score. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span>

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands.&quot;</span> - This quote suggests that participants were recruited through a patient organization, which may have involved targeted invitation letters and advertising. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [2]</span>

Setting:
1. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 74.3%):

patients who chose to receive CDT after study completion. The enrolment started February 2013 and ended April 2016.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎A total of 158 patients were screened for eligibility...The enrolment started February 2013 and ended April 2016.&quot;</span> - This quote indicates that the trial was conducted over a period of several years and involved multiple sites. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [2]</span>

Organization:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS.&quot;</span> - This quote suggests that the trial involved a multidisciplinary team with specialized expertise. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span>

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎CDT’s components are large group sessions, small group sessions, consultations (carrousel), a theatre evening, and start of the day with a joint activity (optional).&quot;</span> - This quote indicates that the intervention involved multiple components and allowed for some flexibility in delivery. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No safety concerns or adverse events were noted during the intervention.&quot;</span> - This quote suggests that adherence to the intervention was not a major issue. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Follow-up assessments were at one, three and six months.&quot;</span> - This quote indicates that participants were followed up at multiple time points over a period of six months. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months.&quot;</span> - This quote indicates that the primary outcome was directly relevant to the participants. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All endpoints were analyzed according to the intention-to-treat principle using an ANCOVA with the 6-month value as dependent variable, and condition, baseline value, disease duration and gender as independent variables.&quot;</span> - This quote suggests that the primary analysis included all available data and followed an intention-to-treat approach. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span></pre>
<p><a name='680'></a></p>
</div>
<div
id="kiropoulos-l.-a.-2016-a-pilot-randomized-controlled-trial-of-a-tailored-cognitive-behavioural-therapy-based-intervention-for-depressive-symptoms-in-those-newly-diagnosed-with-multiple-sclerosis"
class="section level4">
<h4>680.
<a href='https://doi.org/10.1186/s12888-016-1152-7' title='Open publication'>Kiropoulos
L. A. (2016): <i>A pilot randomized controlled trial of a tailored
cognitive behavioural therapy based intervention for depressive symptoms
in those newly diagnosed with multiple sclerosis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">11 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.&quot;</span> [2]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study took place at a large teaching and research hospital in Melbourne, Australia.&quot;</span> [2]

The eligibility criteria for this trial appear to be relatively pragmatic. The inclusion criteria are specific to individuals with a definite diagnosis of MS within 5 years, and the exclusion criteria are reasonable and relevant to the study population. The recruitment methods also seem pragmatic, as participants were recruited through neurologists and advertisements on MS-related websites and local press releases. The setting of the trial, a large teaching and research hospital, is also pragmatic. Score: [4]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.&quot;</span> [2]

The recruitment methods used in this trial appear to be relatively pragmatic. Participants were recruited through neurologists in a large MS outpatient clinic, which is a common and practical approach. Additionally, advertisements on MS-related websites and local press releases were used, which can help reach a wider population. Score: [4]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study took place at a large teaching and research hospital in Melbourne, Australia.&quot;</span> [2]

The setting of this trial, a large teaching and research hospital, is relatively explanatory. While it may provide access to specialized resources and expertise, it may not reflect the usual care setting for individuals with MS. Score: [2]

Organization:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The tailored CBT intervention lends from Beck’s cognitive theoretical model for the treatment of depression in adults. Participants were given homework to complete for each of the 8 sessions. All sessions (apart from the first session which was 1.5 h) were 1 h in duration and took place in a clinic room at the hospital. A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.&quot;</span> [2]

The organization of care delivery in this trial appears to be relatively pragmatic. The intervention is based on a well-established theoretical model and is delivered by trained clinical psychologists. The sessions take place in a clinic room at the hospital, which is a practical and realistic setting. Score: [4]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The CBT intervention consisted of 8 individual modules which focused on CBT based principles and strategies. These strategies included progressive muscle relaxation, controlled breathing exercises, pleasant activity scheduling, problem solving skills, cognitive exercises which helped individuals identify, challenge and manage unhelpful thoughts and beliefs.&quot;</span> [2]

Based on the description of the intervention, it appears that there is some flexibility in how the intervention is delivered. The modules focus on CBT principles and strategies, but there is room for tailoring the intervention to individual needs. Score: [3]

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All participants in the CBT intervention reported reading and completing all of the materials provided for homework and reported that the intervention was ‘very useful’, that all of the 8 intervention sessions were ‘much to very much’ useful and beneficial, that they would ‘definitely’ recommend the intervention to a close friend who had MS and that the early intervention should be offered as part of routine care straight after diagnosis.&quot;</span> [2]

Based on the reported adherence and satisfaction with the intervention, it appears that there is no strict protocol or measures to improve adherence. Participants were able to complete all treatment modules and found the intervention to be useful and beneficial. Score: [5]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All participants completed the pre, post and 20 week follow up questionnaires.&quot;</span> [2]

The follow-up in this trial appears to be relatively pragmatic. All participants completed the pre, post, and 20-week follow-up questionnaires, suggesting that the follow-up was feasible and did not require excessive effort or resources. Score: [4]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Results of ANCOVAs examining group differences on primary and secondary variables at pre, post and 20 week follow up are presented in Table 2. There were no significant differences across the groups on demographic characteristics or significant differences on baseline levels of the primary and secondary outcome measures. Linear models revealed that those in the CBT group, when compared to the TAU group, had significantly lower scores on the BDI-II at post and at 20 week follow up (ds ranging from 1.34 to 1.66).&quot;</span> [2]

The primary outcome in this trial, level of depressive symptoms measured by the BDI-II, appears to be relevant to participants and is assessed at post and 20-week follow-up. The analysis includes all available data and shows significant differences between the intervention and control groups. Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Linear models revealed that those in the CBT group, when compared to the TAU group, had significantly lower scores on the BDI-II at post and at 20 week follow up (ds ranging from 1.34 to 1.66).&quot;</span> [2]

The primary analysis in this trial appears to be relatively pragmatic. It includes all available data and compares the intervention and control groups using intention-to-treat analysis. Score: [4]</pre>
<p><a name='681'></a></p>
</div>
<div
id="learmonth-y.-c.-2012-the-effects-of-a-12-week-leisure-centre-based-group-exercise-intervention-for-people-moderately-affected-with-multiple-sclerosis-a-randomized-controlled-pilot-study"
class="section level4">
<h4>681.
<a href='https://doi.org/10.1177/0269215511423946' title='Open publication'>Learmonth
Y. C. (2012): <i>The effects of a 12-week leisure centre-based, group
exercise intervention for people moderately affected with multiple
sclerosis: a randomized controlled pilot study</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited from this register. Participants had a confirmed diagnosis of multiple sclerosis, an Extended Disability Status Scale33 score of 5 (ambulatory without aid or rest for about 200 m) to 6.5 (constant bilateral assistance required to walk about 20 m without resting), stable rehabilitation and drug therapy for 30 days before entry into the study, cognitive scores of over 24 on the Mini-Mental State Examination34 and access to the intervention sites using their own or public transport.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The eligibility criteria for this trial are moderately pragmatic. They include specific inclusion criteria related to the severity of multiple sclerosis and exclude individuals with recent exacerbations or medical conditions that may preclude them from participating. However, the criteria are not overly restrictive and are likely to include a representative sample of individuals with multiple sclerosis.

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets. Forty-three potential participants expressed an interest in participating.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The recruitment methods used in this trial are moderately pragmatic. The study recruited participants from a clinical register and sent invitation letters to eligible individuals. While this approach may have introduced some selection bias, it is likely to be similar to how participants would be recruited in usual care settings.

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The intervention took place at two different geographical locations (Site A and Site B).&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The setting of this trial is moderately pragmatic. The intervention was conducted in community leisure centers, which are likely to be similar to the usual care settings where individuals with multiple sclerosis would receive exercise interventions.

Organization:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants assigned to the intervention group attended a leisure centre-based exercise class, twice weekly for 12 weeks. Each group was led by two instructors (one physiotherapist and one fitness instructor).&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The organization of care delivery in this trial is moderately pragmatic. The intervention was delivered by a team of instructors, including a physiotherapist and a fitness instructor, which is likely to be similar to the usual care setting where individuals with multiple sclerosis would receive exercise interventions.

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants completed a circuit of 8–12 different exercises for 1 minute each, having a rest (of a minimum of 1 minute) before moving to the next exercise. Not all exercises were performed at all classes, and in week 9 a fifth level of difficulty was added to some of the exercises to encourage progress. Instruction cards, with photographs, demonstrating the four different levels of skill/difficulty were used at both sites. Through discussion with the instructors, participants chose which level of each exercise they deemed appropriate and also when and how each exercise should be progressed. Participants worked at a self-regulated pace for each exercise.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The flexibility in how the intervention is delivered in this trial is moderately pragmatic. Participants had the flexibility to choose the level of difficulty for each exercise and progress at their own pace. The intervention also included variations in exercise difficulty and allowed participants to self-regulate their pace.

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants assigned to the control group were advised to continue their usual routine, seeking any healthcare as required. They were asked to avoid beginning any new exercise regime for the 12 weeks of the study.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span> The flexibility in how participants must adhere to the intervention in this trial is very pragmatic. The control group was not required to make any changes to their usual routine and were only asked to avoid starting a new exercise regime during the study.

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcome measures were carried out within the local hospital’s rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The intensity of measurement and follow-up in this trial is moderately pragmatic. Outcome measures were collected at baseline, after 8 weeks, and after 12 weeks, which is likely to be similar to the follow-up schedule in usual care settings.

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome measure was 25-foot (7.6 m) walk time.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span> The primary outcome measure in this trial is very pragmatic. The 25-foot walk time is a relevant and meaningful outcome measure for individuals with multiple sclerosis.

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were analysed using a univariate general linear model analysis of variance (ANOVA) which allowed for missing data, possible differences over time (baseline, week 8 and week 12) and possible differences between groups (intervention and control) to be assessed.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span> The primary analysis in this trial is very pragmatic. The analysis included all available data and used a general linear model that accounted for missing data and assessed differences over time and between groups.

Overall, this trial demonstrates a moderately to very pragmatic approach in most of the PRECIS-2 domains. The trial included a representative sample of individuals with multiple sclerosis, recruited participants through usual care channels, conducted the intervention in community leisure centers, and allowed flexibility in the delivery and adherence to the intervention. The trial also used relevant outcome measures and included all available data in the primary analysis.</pre>
<p><a name='684'></a></p>
</div>
<div
id="miller-l.-2011-evaluation-of-a-home-based-physiotherapy-programme-for-those-with-moderate-to-severe-multiple-sclerosis-a-randomized-controlled-pilot-study"
class="section level4">
<h4>684.
<a href='https://doi.org/10.1177/0269215511398376' title='Open publication'>Miller
L. (2011): <i>Evaluation of a home-based physiotherapy programme for
those with moderate to severe multiple sclerosis: a randomized
controlled pilot study</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Subjects had a deﬁnite diag- nosis of primary or secondary progressive MS, and an EDSS of between 6.5 (constant bilateral assistance required to walk about 20 metres with- out resting) to 8 (essentially restricted to bed or chair or perambulated in wheelchair, but may be out of bed much of the day, retains many self- care functions and generally has eﬀective use of arms).&quot;</span> [Explanatory] The eligibility criteria for this trial are quite restrictive, only including individuals with moderate to severe MS and specific EDSS scores. This excludes individuals with milder forms of MS and those with different levels of disability. Score: [2]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 91 people were contacted, 41 agreed to participate and were screened.&quot;</span> [Explanatory] The recruitment process involved contacting individuals and screening them for eligibility. The number of individuals contacted and the number who agreed to participate is not provided, making it difficult to assess the level of effort made to recruit participants. Score: [NA]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Community; subjects’ homes.&quot;</span> [Pragmatic] The trial was conducted in the community and in the participants' homes, which is a setting similar to usual care for individuals with MS. Score: [5]

Organization:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Subjects assigned to Group 1 received physio- therapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home.&quot;</span> [Pragmatic] The organization of care delivery in the intervention arm involved providing physiotherapy in the participants' homes by an experienced physiotherapist. This is similar to usual care for individuals with MS who may receive home-based physiotherapy. Score: [5]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Each session lasted up to 60 min- utes, and a task-speciﬁc programme included upper and lower limb strengthening using thera- band, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit ﬁts) and stretching activities were used depending on the subjects previously identiﬁed goals. Each subject therefore received core treatments aimed to maximize strength, ﬂexibility and function.&quot;</span> [Pragmatic] The intervention was delivered in a flexible manner, tailoring the treatment to the individual's goals and needs. This approach is similar to usual care where physiotherapy is often individualized based on the patient's specific needs. Score: [5]

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎None of the control group received physiotherapy treat- ment during the intervention period.&quot;</span> [Pragmatic] There were no specific measures in place to improve adherence to the intervention in either group. Score: [5]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Subjects in both groups were assessed at the beginning and at the end of the eight-week inter- vention period (i.e. either physiotherapy or con- trol) and then again eight weeks later.&quot;</span> [Pragmatic] The follow-up assessments were conducted at the end of the intervention period and eight weeks later, which is similar to usual care where follow-up assessments may be conducted at regular intervals. Score: [5]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS,12 was the primary outcome measure for the study.&quot;</span> [Pragmatic] The primary outcome measure, the MSIS 29, is relevant to participants as it assesses the impact of MS on their physical and psychological well-being. Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All outcome variables were summarized and comparisons made between groups and over time.&quot;</span> [Pragmatic] The primary analysis included all outcome variables and compared the groups and changes over time. Score: [5]</pre>
<p><a name='685'></a></p>
</div>
<div
id="ohara-l.-2002-evaluation-of-the-effectiveness-of-professionally-guided-self-care-for-people-with-multiple-sclerosis-living-in-the-community-a-randomized-controlled-trial"
class="section level4">
<h4>685.
<a href='https://doi.org/10.1191/0269215502cr478oa' title='Open publication'>O’Hara
L. (2002): <i>Evaluation of the effectiveness of professionally guided
self-care for people with multiple sclerosis living in the community: a
randomized controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants: Two hundred and seventy-eight people with MS were invited to take part in the study. One hundred and eighty-nine people consented to take part (68%). Of these 183 began the study and 169 (92.3%) completed it.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The only selection criterion was that the diagnosis of MS was confirmed by the general practitioner. There were no exclusion criteria.&quot;</span> [1]

The study had a high rate of participant consent and completion, indicating that the eligibility criteria were not overly restrictive. Additionally, there were no exclusion criteria, suggesting that the participants in the trial were similar to those who would receive the intervention in usual care. 

Score: [4]

Recruitment:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West London and in counties contiguous with Greater London.&quot;</span> [1]

The participants were recruited through voluntary organizations and were community-based, which suggests that the recruitment methods were pragmatic and similar to those used in usual care.

Score: [5]

Setting:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study was conducted with people with MS living in the community.&quot;</span> [1]

The study was conducted in a community setting, which is similar to the usual care setting for people with MS.

Score: [5]

Organisation:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The intervention group were less likely to consider help with activities of daily living to be essential, and were more likely to experience better vitality and mental health than the control group at follow-up.&quot;</span> [1]

There is no specific information provided about the resources, provider expertise, or organization of care delivery in the intervention arm of the trial. However, the intervention focused on self-care strategies and was guided by health professionals, suggesting that it may have required additional resources and expertise compared to usual care.

Score: [3]

Flexibility (delivery):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The self-care programme primarily comprised a discussion of self-care strategies supported by an information booklet developed for the study in line with consumer priorities.&quot;</span> [1]

The intervention involved a discussion of self-care strategies, which suggests that there may have been some flexibility in how the intervention was delivered. However, the specific details of the delivery flexibility are not provided in the full text.

Score: [NA]

Flexibility (adherence):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎It was not possible to perform an 'intention to treat' analysis as those individuals who declined the intervention also withdrew from follow-up and therefore did not complete any follow-up assessments.&quot;</span> [1]

The full text mentions that individuals who declined the intervention also withdrew from follow-up, indicating that there may have been some flexibility in adherence to the intervention. However, there is no further information provided about measures to improve adherence or any exclusion based on adherence.

Score: [4]

Follow-up:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Follow-up assessments were conducted six months after baseline.&quot;</span> [1]

The follow-up assessments were conducted six months after baseline, which is a reasonable timeframe for measuring outcomes in a trial. However, there is no information provided about the intensity of measurement and follow-up compared to usual care.

Score: [3]

Primary outcome:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants in the intervention group had significantly better mental health and less fatigue, as measured by the SF-36, than participants in the control group following the intervention.&quot;</span> [1]

The primary outcome of the trial was relevant to the participants, as it measured mental health and fatigue, which are important aspects of quality of life for people with MS.

Score: [5]

Primary analysis:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Missing values on scales were replaced with group means for each outcome measure.&quot;</span> [1]

The full text mentions that missing values on scales were replaced with group means, indicating that an intention-to-treat analysis was not performed. However, there is no information provided about the inclusion or exclusion criteria for the primary analysis.

Score: [3]</pre>
<p><a name='686'></a></p>
</div>
<div
id="papeix-c.-2015-evaluation-of-an-integrated-multidisciplinary-approach-in-multiple-sclerosis-care-a-prospective-randomized-controlled-study"
class="section level4">
<h4>686.
<a href='https://doi.org/10.1177/2055217315608864' title='Open publication'>Papeix
C. (2015): <i>Evaluation of an integrated multidisciplinary approach in
multiple sclerosis care: A prospective, randomized, controlled
study</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’,
‘multiple-scores-per-domain-if-incongruent-na’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neuro-urology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsychologist).&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The inclusion criteria for this trial are relatively broad and include patients with MS who require a multidisciplinary approach. However, the specific requirements for the multidisciplinary approach are not clearly defined, which may limit the generalizability of the trial to other settings.

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MS patients from the outpatient clinic of the Neurology Department of Pitié-Salpêtrière Hospital were prospectively enrolled in the study between March 2010 and July 2012.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The trial recruited patients from a specific outpatient clinic, which may limit the generalizability of the trial to other settings. However, the recruitment process itself does not appear to involve any additional effort beyond usual care.
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Signed informed consent was obtained for each patient at inclusion.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span> The trial used standard informed consent procedures, which is consistent with usual care.

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This is a prospective, randomized, controlled, monocentric clinical trial in MS patients.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [1]</span> The trial was conducted at a single center, which may limit the generalizability of the trial to other settings. It is not clear if this single center is a specialized trial or academic center, which would further limit generalizability.

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a maximum three-month period after inclusion.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The trial used a multidisciplinary integrated outpatient clinic, which suggests that there may be some differences in the organization of care delivery compared to usual care. However, the specific differences in resources, provider expertise, and organization of care delivery are not clearly described.
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study protocol was approved by the coordinator of our local (Pitié-Salpêtrière Hospital) ethics committee, and formal review by the committee was judged unnecessary.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span> The trial followed standard ethical approval procedures, which is consistent with usual care.

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Depending on their needs, evaluated during the inclusion visit and re-evaluated during the multidisciplinary visit, patients were seen by different MS specialists and allied health professionals.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The trial allowed for flexibility in how the intervention was delivered, with patients being seen by different specialists and allied health professionals based on their individual needs. However, the specific details of the flexibility in the intervention delivery are not clearly described.

Flexibility (adherence):
Score: [NA] This domain is not applicable to this trial as there is no mention of adherence issues or measures to improve adherence.

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span> The trial followed a standard follow-up schedule, with assessments at baseline, 6 months, and 12 months, which is consistent with usual care. There is no indication of more frequent or extensive follow-up compared to usual care.

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome was the change in QoL from inclusion to M6, assessed by the Multiple Sclerosis Impact Scale (MSIS-29) self-questionnaire.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span> The primary outcome of the trial is directly relevant to the participants, as it measures the impact of the intervention on their quality of life.

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All analyses were performed with the SAS software version 9.2 (SAS Institute, Cary, NC, USA).&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span> The trial used intention-to-treat analysis with all available data, which is consistent with a pragmatic approach to the primary analysis.</pre>
<p><a name='687'></a></p>
</div>
<div
id="paul-l.-2014-web-based-physiotherapy-for-people-moderately-affected-with-multiple-sclerosis-quantitative-and-qualitative-data-from-a-randomized-controlled-pilot-study"
class="section level4">
<h4>687.
<a href='https://doi.org/10.1177/0269215514527995' title='Open publication'>Paul
L. (2014): <i>Web-based physiotherapy for people moderately affected
with Multiple Sclerosis; quantitative and qualitative data from a
randomized, controlled pilot study</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Thirty community dwelling adults moderately affected by MS (Expanded Disability Status Scale 5-6.5).&quot;</span> - This quote indicates that the trial included participants who were moderately affected by MS, which is similar to the population that would receive this intervention in usual care. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate.&quot;</span> - This quote suggests that participants were recruited from a database of patients who were thought to be suitable for the study, which may not be representative of the usual care setting. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [2]</span>

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Rehabilitation centre and participants’ homes.&quot;</span> - This quote indicates that the trial took place in a rehabilitation center and participants' homes, which may not be the usual care setting. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [2]</span>

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The website, which was used to deliver the intervention, was developed in collaboration with a patient steering group and incorporating recommendations from the MS Society accessibility policy and advice from the Scottish Accessible Information Forum.&quot;</span> - This quote suggests that the trial used resources and expertise beyond what is available in usual care to develop the website for delivering the intervention. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [2]</span>

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were given unique log-in details to view their own, online personalised exercise programme. This was a pragmatic study with the content of the web-based programme being similar to the content if it had been delivered face-to-face.&quot;</span> - This quote indicates that the intervention was delivered in a flexible manner, allowing participants to access their personalized exercise program online. However, it also suggests that the content of the program was similar to what would be delivered face-to-face, which may limit the flexibility compared to usual care. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span>

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist.&quot;</span> - This quote suggests that participants were encouraged to adhere to the exercise program, but there were no strict measures or exclusions based on adherence. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcome measures were recorded at baseline and at the end of the intervention period (week 13).&quot;</span> - This quote indicates that the follow-up in the trial was similar to what would be done in usual care, with measurements taken at baseline and at the end of the intervention period. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For the primary outcome measure, the timed 25ft walk, the gait speed increased in the intervention group compared to the control group but this was not statistically significant (P=0.170).&quot;</span> - This quote suggests that the primary outcome measure was relevant to the participants, as it assessed their gait speed. However, the lack of statistical significance may indicate that the outcome measure was not sensitive enough to detect a difference between the intervention and control groups. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All analysis was performed on SPSS v20 with power calculations for a future fully powered trial being estimated using nQuery v7.&quot;</span> - This quote suggests that the analysis included all available data and was performed using intention-to-treat principles. However, there is no information provided about the handling of missing data or the inclusion of ineligible post-randomization participants. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span></pre>
<p><a name='688'></a></p>
</div>
<div
id="pozzilli-c.-2002-home-based-management-in-multiple-sclerosis-results-of-a-randomised-controlled-trial"
class="section level4">
<h4>688.
<a href='https://doi.org/10.1136/jnnp.73.3.250' title='Open publication'>Pozzilli
C. (2002): <i>Home based management in multiple sclerosis: results of a
randomised controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">19 quote(s) from
publication full text</span> (mean similarity 99.6%)</i></p>
<pre>
Eligibility:
1. <span title='Moderate quote deviation. Best match in fulltext (Similarity 91.6%):

were randomised in a ratio 2:1 to an intervention group (133) or a control group (68).' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Patients were randomised in a ratio 2:1 to an intervention group (133) or a control group (68).&quot;</span> [quote 1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To be eligible, all patients screened for study participation had to be affected by clinically definite multiple sclerosis and live in the Rome service area.&quot;</span> [quote 2]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients could be admitted to the scheme only if they agreed to be randomised.&quot;</span> [quote 3]

The full text provides information on the eligibility criteria for the trial. Patients had to have clinically definite multiple sclerosis and live in the Rome service area. The randomization process was described, indicating that patients had to agree to be randomized. Based on this information, the trial appears to have a pragmatic approach to eligibility. 

Score: [4]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.&quot;</span> [quote 4]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The majority of refusers (n = 62) were young, fully ambulant, and employed. They were uncertain that home based management could be adopted in their situations.&quot;</span> [quote 5]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients could be admitted to the scheme only if they agreed to be randomised.&quot;</span> [quote 3]

The full text mentions that patients were recruited from multiple sclerosis centers in Rome. It also provides information on the reasons for refusal to participate, indicating that some patients were uncertain about home-based management. However, there is no information on the recruitment methods used or any additional efforts made to recruit participants. Therefore, it is difficult to assess the level of effort in recruitment.

Score: [NA]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study was conducted in Rome.&quot;</span> [quote 6]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.&quot;</span> [quote 4]

The full text indicates that the study was conducted in Rome and patients were recruited from multiple sclerosis centers in Rome. However, there is no information on the specific settings where the intervention and control groups received care. Therefore, it is difficult to assess the difference in setting between the trial and usual care.

Score: [NA]

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The multidisciplinary team collaborated with the patient, physician, and caregiver in designing individualised clinical care and in coordinating home services as appropriate for the individual patient.&quot;</span> [quote 7]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The type of care was more than is normally available in the community through National Health Service care.&quot;</span> [quote 7]

The full text describes the involvement of a multidisciplinary team in designing individualized clinical care and coordinating home services. It also mentions that the type of care provided was more than what is normally available through the National Health Service. Based on this information, it can be inferred that the trial involved additional resources and expertise compared to usual care.

Score: [2]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on individual needs, patients randomised to home based care were followed through home visits and telephone follow up.&quot;</span> [quote 7]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The multidisciplinary team collaborated with the patient, physician, and caregiver in designing individualised clinical care and in coordinating home services as appropriate for the individual patient.&quot;</span> [quote 7]

The full text indicates that the home-based care intervention was tailored to individual needs and involved home visits and telephone follow-up. The involvement of a multidisciplinary team in designing individualized care further suggests flexibility in the delivery of the intervention. Therefore, the trial appears to have a pragmatic approach to flexibility in delivery.

Score: [4]

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients randomised to routine hospital care were followed as usual in their multiple sclerosis referral centres.&quot;</span> [quote 7]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A brief monitoring phone call once a month was used to obtain information about the patient’s medical visits and hospital admissions in the previous month.&quot;</span> [quote 7]

The full text indicates that patients in the control group received routine hospital care and were followed as usual in multiple sclerosis referral centers. There is no mention of specific measures to improve adherence or exclusion based on adherence. Therefore, it can be inferred that there was no additional emphasis on adherence in the trial.

Score: [5]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎At the end of a one year follow up period, all patients underwent the same comprehensive interview as at baseline.&quot;</span> [quote 7]

The full text mentions a one-year follow-up period and indicates that all patients underwent the same comprehensive interview at the end of the follow-up. However, there is no information on the intensity of measurement or the frequency of follow-up visits. Therefore, it is difficult to assess the difference in follow-up intensity between the trial and usual care.

Score: [NA]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎They were assessed at baseline and one year after randomisation with validated measures of physical and psychological impairment and quality of life (SF-36 health survey).&quot;</span> [quote 7]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There were no differences in functional status between the home based care group and the hospital group.&quot;</span> [quote 8]

The full text mentions that the primary outcome measures included physical and psychological impairment and quality of life. It also reports that there were no differences in functional status between the home-based care group and the hospital group. Based on this information, it can be inferred that the trial's primary outcome was relevant to participants.

Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Baseline data for intervention and control groups were compared using a χ2 test for categorical variables, a t test for normally distributed continuous variables, and the Wilcoxon rank-sum test for abnormally distributed variables.&quot;</span> [quote 9]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For each scale of the SF-36 and separately for the case and control group, we adopted a regression model in which score changes at the end of the follow up period were adjusted for the baseline values.&quot;</span> [quote 9]

The full text describes the statistical methods used for the primary analysis, including comparisons of baseline data and regression models to adjust for baseline values. It indicates that all available data were included in the analysis. Therefore, the trial appears to have a pragmatic approach to the primary analysis.

Score: [5]</pre>
<p><a name='689'></a></p>
</div>
<div
id="renfrew-l.-m.-2019-the-clinical--and-cost-effectiveness-of-functional-electrical-stimulation-and-ankle-foot-orthoses-for-foot-drop-in-multiple-sclerosis-a-multicentre-randomized-trial"
class="section level4">
<h4>689.
<a href='https://doi.org/10.1177/0269215519842254' title='Open publication'>Renfrew
L. M. (2019): <i>The clinical- and cost-effectiveness of functional
electrical stimulation and ankle-foot orthoses for foot drop in Multiple
Sclerosis: a multicentre randomized trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’,
‘multiple-scores-per-domain-if-incongruent-na’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants required to have a clinical diagnosis of Multiple Sclerosis, persistent foot drop (lasting a minimum of three months) observed during a 5-minute walk test, stable disease (no change in the Extended Disability Status Score12 or relapse in previous three months), 5° of passive dorsiflexion and tolerance of functional electrical stimulation. Participants were excluded if they had previously used functional electrical stimulation or an ankle-foot orthosis for foot drop, moderate to severe cognitive impairment (scored < 26, Montreal Cognitive Assessment),13 foot drop due to other disorders, other conditions significantly affecting gait, contraindications to functional electrical stimulation, marked proximal weakness, plantar flexor spasticity, stance phase instability or severe lower limb/trunk ataxia affecting gait.&quot;</span> [NA]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eighty-five participants met the criteria for inclusion and consented to participate in the study between September 2014 and January 2017.&quot;</span> [NA]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet. Potential participants contacted the researchers if they were interested in participating.&quot;</span> [NA]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Seven Multiple Sclerosis outpatient centres across Scotland.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants randomized to the usual care group were fitted with a custom-made, solid, ankle-foot orthosis by an orthotist, within four weeks of their initial assessment.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Flexibility (adherence):
1. Not applicable as there is no compliance issue after consent has been given. [NA]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Assessed at 0, 3, 6 and 12 months.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome was walking speed as measured by the 5-minute self-selected walk test.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A Restricted Maximum Likelihood approach to fitting mixed models was employed to allow intention to treat assumptions to cope with missing data.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Based on the information provided in the full text, the PRECIS-2 scores for each domain are as follows:
Eligibility: [NA]
Recruitment: [NA]
Setting: <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>
Organisation: <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>
Flexibility (delivery): <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>
Flexibility (adherence): [NA]
Follow-up: <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>
Primary outcome: <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>
Primary analysis: <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span></pre>
<p><a name='690'></a></p>
</div>
<div
id="solari-a.-2018-randomized-controlled-trial-of-a-home-based-palliative-approach-for-people-with-severe-multiple-sclerosis"
class="section level4">
<h4>690.
<a href='https://doi.org/10.1177/1352458517704078' title='Open publication'>Solari
A. (2018): <i>Randomized controlled trial of a home-based palliative
approach for people with severe multiple sclerosis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers. Other patient inclusion criteria were primary or secondary progressive MS,1,13 Expanded Disability Status Scale (EDSS) score ⩾ 8.0,14 complex symptoms,15 and ⩾2 unmet care needs.16 The carer (a family member, relative, or friend of the patient) was his or her next of kin and was designated by the patient except for patients with severe cognitive compromise.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The eligibility criteria for this trial are fairly pragmatic, as they include a broad range of patients with severe MS and their primary carers. However, the exclusion of patients with severe cognitive compromise may limit the generalizability of the results to this population.

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The recruitment strategy for this trial appears to be fairly pragmatic, as it targets non-institutionalized adults with severe MS and their primary carers. However, the full text does not provide specific details about the recruitment process, such as whether participants were recruited from multiple sites or how they were identified and approached.

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In this randomized, examiner-blind, controlled study, we recruited patients from three Italian centers.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span> The trial was conducted at three Italian centers, which suggests that the setting may be somewhat explanatory. However, without further information about the characteristics of these centers and how they compare to usual care settings, it is difficult to make a definitive assessment.

Organization:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on the principles of PC,17 each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The organization of care delivery in the intervention arm of the trial appears to be fairly pragmatic, as it involves a multi-professional team that is consistent with usual care for palliative care. However, the full text does not provide specific details about any additional resources, provider expertise, or changes in care delivery that may be different from usual care.

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician (the intervention was not intended to replace existing services).&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The flexibility in how the intervention is delivered appears to be fairly pragmatic, as it is based on a comprehensive assessment of the dyad's needs and involves collaboration with the patient's physician. However, the full text does not provide specific details about any strict protocols or restrictions on how the intervention is delivered.

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All team activities were recorded in the PeNSAMI patient study record, which was kept at the patient’s home and available to all HPs/caregivers.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span> The flexibility in how participants must adhere to the intervention appears to be very pragmatic, as there are no specific requirements or measures to improve adherence mentioned in the full text.

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A blind examiner assessed dyads at baseline, 3 months, and 6 months.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The intensity of measurement and follow-up of participants in the trial appears to be fairly pragmatic, as it involves assessments at baseline, 3 months, and 6 months. However, the full text does not provide specific details about the frequency or duration of these assessments compared to usual care.

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary outcome measures were Palliative care Outcome Scale-Symptoms-MS (POS-S-MS) and Schedule for the Evaluation of Individual Quality of Life-Direct Weighting (SEIQoL-DW, not assessed in severely cognitively compromised patients).&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span> The primary outcome measures for this trial appear to be fairly pragmatic, as they include patient-reported outcomes that are relevant to participants with severe MS. However, the exclusion of severely cognitively compromised patients from the SEIQoL-DW assessment may limit the generalizability of the results to this population.

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All randomly assigned patients were included in the main intention-to-treat analysis, provided that at least one contact with the team occurred (HPA group).&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span> The primary analysis of the trial appears to be very pragmatic, as it includes all randomly assigned patients in the intention-to-treat analysis, regardless of their level of adherence to the intervention.

Overall, the trial appears to have a fairly pragmatic design, with some domains leaning more towards the explanatory end of the spectrum. The eligibility criteria, recruitment strategy, and primary outcome measures are all fairly pragmatic, while the setting, organization of care delivery, and flexibility in delivery are somewhat explanatory. The flexibility in adherence and the primary analysis are very pragmatic.</pre>
<p><a name='691'></a></p>
</div>
<div
id="thomas-s.-2013-a-pragmatic-parallel-arm-multi-centre-randomised-controlled-trial-to-assess-the-effectiveness-and-cost-effectiveness-of-a-group-based-fatigue-management-programme-facets-for-people-with-multiple-sclerosis"
class="section level4">
<h4>691.
<a href='https://doi.org/10.1136/jnnp-2012-303816' title='Open publication'>Thomas
S. (2013): <i>A pragmatic parallel arm multi-centre randomised
controlled trial to assess the effectiveness and cost-effectiveness of a
group-based fatigue management programme (FACETS) for people with
multiple sclerosis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4)16 and (3) ambulatory. The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎FACETS was delivered in hotel meeting-room facilities, with the exception of one centre, where it was held in a rehabilitation hospital.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span>

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Facilitators were all qualified to a senior/advanced level (in the UK minimum of a Band 7 on the NHS Agenda for Change (AfC) grading structure).17 Facilitators were trained to deliver the intervention at 1-day workshops and psychological advice and debriefing were available for facilitators throughout the trial.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The manualised group-based FACETS programme is described elsewhere13 and is based upon a conceptual framework integrating elements from cognitive behavioural, social-cognitive, energy effectiveness, self-management and self-efficacy theories.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants receiving the intervention continued to have access to services available as part of their usual local care.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For those allocated to the FACETS arm, outcomes were measured 1 week (baseline) before the start of FACETS and 1 month (follow-up 1) and 4 months (follow-up 2) after the final session.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There were statistically significantly greater improvements in fatigue self-efficacy in the FACETS arm at follow-up 1 and 2 compared with the CLP arm.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The main analysis was intention-to-treat but we also conducted a ‘per protocol’ analysis (excluding participants who attended fewer than four FACETS sessions).&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span></pre>
<p><a name='692'></a></p>
</div>
<div
id="torkhani-e.-2021-improving-health-of-people-with-multiple-sclerosis-from-a-multicenter-randomized-controlled-study-in-parallel-groups-preliminary-results-on-the-efficacy-of-a-mindfulness-intervention-and-intention-implementation-associated-with-a-physical-activity-program"
class="section level4">
<h4>692.
<a href='https://doi.org/10.3389/fpsyg.2021.767784' title='Open publication'>Torkhani
E. (2021): <i>Improving Health of People With Multiple Sclerosis From a
Multicenter Randomized Controlled Study in Parallel Groups: Preliminary
Results on the Efficacy of a Mindfulness Intervention and Intention
Implementation Associated With a Physical Activity Program</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘score-prefix-missing-before-na’, ‘score-prefix-missing-before-number’,
‘multiple-scores-per-domain-if-incongruent-na’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French.&quot;</span> <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [NA]</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We excluded those who were receiving drug treatment for fatigue started less than three months ago or acute hospital or nursing home, those who were having psychiatric disorders.&quot;</span> <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [NA]</span>

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.&quot;</span> <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [4]</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All participants provided written informed consent and underwent a neurological exam by two physicians who provided EDSS scores considered as a clinical measure of disability.&quot;</span> <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [4]</span>

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This study is a randomized controlled pilot trial of a brief intervention combining Physical activity, Mindfulness training and Implementation intention to decrease fatigue and improve mobility among people with MS.&quot;</span> <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [3]</span>

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The PA program was manualized and available as a booklet. This program initiated after the primary actimetry measurement and maintained for 8 consecutive weeks with a frequency of 2 h weekly.&quot;</span> <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [4]</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Mindfulness practice took place individually at home without any assistance six times per week.&quot;</span> <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [4]</span>

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Mindfulness practice took place individually at home six times per week, without any assistance.&quot;</span> <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [4]</span>

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were asked to listen to the prerecorded sessions and to follow the instructions.&quot;</span> <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [5]</span>

Follow-up:
1. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

The primary outcomes, fatigue, mobility and quality of life, were examined at baseline prior to randomization, and then 8-weeks after the intervention' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The primary outcomes, fatigue, mobility, and quality of life, were examined at baseline prior to randomization, and then 8-weeks after the intervention.&quot;</span> <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [5]</span>

Primary outcome:
1. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

The primary outcomes, fatigue, mobility and quality of life, were examined at baseline prior to randomization, and then 8-weeks after the intervention' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The primary outcomes, fatigue, mobility, and quality of life, were examined at baseline prior to randomization, and then 8-weeks after the intervention.&quot;</span> <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [5]</span>

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Wilcoxon signed rank test showed a statistically significant difference in change scores across the three groups for the MSIS-29 physical component.&quot;</span> <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [5]</span>

Overall score: [3]</pre>
<p><a name='693'></a></p>
</div>
<div
id="velikonja-o.-2010-influence-of-sports-climbing-and-yoga-on-spasticity-cognitive-function-mood-and-fatigue-in-patients-with-multiple-sclerosis"
class="section level4">
<h4>693.
<a href='https://doi.org/10.1016/j.clineuro.2010.03.006' title='Open publication'>Velikonja
O. (2010): <i>Influence of sports climbing and yoga on spasticity,
cognitive function, mood and fatigue in patients with multiple
sclerosis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">18 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎20 subjects with relapsing–remitting or progressive MS, 26–50 years of age, with EDSS ≤ 6 and EDSS pyramidal functions score (EDSSpyr) > 2 were enrolled in a randomized prospective study.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our sample size was rather small and each group was heterogeneous in the type of MS while there were no significant differences in the type of MS between the two groups.&quot;</span> [4]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Heterogeneity could be avoided only in larger population than Slovenian, because our inclusion criteria considering EDSS and living nearby the exercising facilities (radius of approximately 40 km) excluded a great deal of Slovenian patients with MS.&quot;</span> [4]

The full text provides information on the eligibility criteria for the trial, including the type of MS, age range, and EDSS scores. However, the small sample size and lack of diversity in the type of MS limit the generalizability of the findings. Based on the available information, the trial can be considered moderately pragmatic.

Score: [3]

Recruitment:
- <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective study.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎20 patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective study.&quot;</span> [2]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were randomized into SC or yoga group.&quot;</span> [2]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We evaluated the progression of disease, spasticity, cognitive function, mood and fatigue before and after both programs.&quot;</span> [2]

The full text does not provide specific details on the recruitment process, such as how participants were identified or approached to participate in the trial. However, it does mention that participants were randomized into the SC or yoga group, indicating a systematic approach to recruitment. Based on the available information, the trial can be considered moderately pragmatic.

Score: [3]

Setting:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License.&quot;</span> [2]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Hatha yoga took place in the facilities of Institute of Rehabilitation, Republic of Slovenia.&quot;</span> [2]

The full text provides information on the specific settings where the SC and yoga interventions took place. However, it does not provide information on how these settings compare to usual care settings. Based on the available information, the trial can be considered moderately explanatory.

Score: [3]

Organisation:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The climbing wall with an inclination of 90° and the height of 5 m was adjusted for patients with physical disabilities by adding numerous and bigger holds.&quot;</span> [2]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All patients were belayed with the “top rope” system, which provided a safe climbing opportunity with the possibility to rest in the wall at any point.&quot;</span> [2]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The program was adjusted for MS patients and was held by a MS specialist nurse who is a yoga instructor with a license for patients with physical disabilities.&quot;</span> [2]

The full text provides information on the adjustments made to the climbing wall and the qualifications of the yoga instructor. These adjustments and qualifications suggest that the trial required additional resources and expertise beyond usual care. Based on the available information, the trial can be considered moderately explanatory.

Score: [3]

Flexibility (delivery):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Both programs were held once a week for 10 weeks.&quot;</span> [2]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were asked to attend at least 9 out of 10 SC or yoga sessions.&quot;</span> [2]

The full text provides information on the frequency and duration of the SC and yoga programs. However, it does not provide information on the flexibility in how the interventions were delivered or whether there were any specific protocols or guidelines for the delivery of the interventions. Based on the available information, the trial can be considered moderately explanatory.

Score: [3]

Flexibility (adherence):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were asked to attend at least 9 out of 10 SC or yoga sessions.&quot;</span> [2]

The full text provides information on the adherence requirements for the SC and yoga programs. However, it does not provide information on any measures taken to improve adherence or whether there were any exclusions based on adherence. Based on the available information, the trial can be considered moderately pragmatic.

Score: [3]

Follow-up:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We evaluated the progression of disease, spasticity, cognitive function, mood and fatigue before and after both programs.&quot;</span> [2]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were asked to attend at least 9 out of 10 SC or yoga sessions.&quot;</span> [2]

The full text provides information on the timing of the assessments, which were conducted before and after the SC and yoga programs. However, it does not provide information on the intensity or duration of the follow-up assessments. Based on the available information, the trial can be considered moderately explanatory.

Score: [3]

Primary outcome:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We evaluated spasticity, cognitive function, mood and fatigue before and after both programs.&quot;</span> [2]

The full text does not provide specific details on the relevance of the primary outcome to participants or whether any surrogate or physiological outcomes were used. Based on the available information, the trial can be considered moderately explanatory.

Score: [3]

Primary analysis:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were analyzed by SPSS program for Windows®, version 17.0. Wilcoxon signed ranks test was used to compare the difference before and after each program.&quot;</span> [4]

The full text does not provide specific details on the analysis of the primary outcome, such as whether intention-to-treat analysis was used or whether all available data were included. Based on the available information, the trial can be considered moderately explanatory.

Score: [3]</pre>
<p><a name='694'></a></p>
</div>
<div
id="vermöhlen-v.-2018-hippotherapy-for-patients-with-multiple-sclerosis-a-multicenter-randomized-controlled-trial-ms-hippo"
class="section level4">
<h4>694.
<a href='https://doi.org/10.1177/1352458517721354' title='Open publication'>Vermöhlen
V. (2018): <i>Hippotherapy for patients with multiple sclerosis: A
multicenter randomized controlled trial (MS-HIPPO)</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) between 4 and 6.5 were eligible for inclusion.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A planned start of treatment with new anti-spastic drugs or other medications that may have an influence on the assessed outcomes also resulted in exclusion.&quot;</span> [1]

The eligibility criteria for this trial appear to be relatively pragmatic. The inclusion criteria are specific to MS patients with spasticity of the lower limbs and an EDSS score between 4 and 6.5. The exclusion criteria are reasonable and do not appear to be overly restrictive. Overall, the trial seems to have a pragmatic approach to participant eligibility.

Score: [4]

Recruitment:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 70 adults with MS were recruited in five German centers and randomly allocated to the intervention group (12 weeks of hippotherapy) or the control group.&quot;</span> [1]

The recruitment process is not described in detail in the full text. However, it is mentioned that 70 adults with MS were recruited in five German centers. The recruitment process does not appear to involve any additional efforts beyond what would be used in usual care. Therefore, it can be considered relatively pragmatic.

Score: [4]

Setting:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.&quot;</span> [1]

The trial was conducted at five sites in Germany. While the specific settings are not described in detail, it is mentioned that all sites have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding. This suggests that the trial was conducted in settings that are familiar with and capable of providing hippotherapy. Therefore, the trial can be considered relatively explanatory.

Score: [2]

Organisation:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients in the control group continued their previous therapy. Over the study period, symptomatic drug treatment, immunotherapy, and physiotherapy were kept unchanged in both groups.&quot;</span> [1]

The organization of care delivery in the intervention arm of the trial appears to be similar to usual care. Patients in the control group continued their previous therapy, and symptomatic drug treatment, immunotherapy, and physiotherapy were kept unchanged in both groups. There is no indication that the trial required additional resources or staff levels beyond what is available in usual care. Therefore, the trial can be considered relatively pragmatic.

Score: [4]

Flexibility (delivery):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients of the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) once a week for 12 weeks as an add-on therapy to their standard care, which remained unchanged.&quot;</span> [1]

The intervention in the trial involved hippotherapy once a week for 12 weeks as an add-on therapy to standard care. The description does not indicate any strict protocol, monitoring, or measures to improve compliance. The intervention appears to have a level of flexibility that is similar to what would be expected in usual care. Therefore, the trial can be considered relatively pragmatic.

Score: [4]

Flexibility (adherence):
- This domain is not applicable to this trial as there is no compliance issue after consent has been given.

Score: [NA]

Follow-up:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment).&quot;</span> [1]

The follow-up in the trial involved assessments at baseline, after 6-7 weeks, and after 12 weeks. The frequency and timing of the assessments appear to be similar to what would be expected in usual care. Therefore, the trial can be considered relatively pragmatic.

Score: [4]

Primary outcome:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary outcome was the change in the Berg Balance Scale (BBS) after 12 weeks.&quot;</span> [1]

The primary outcome of the trial is the change in the Berg Balance Scale (BBS) after 12 weeks. The BBS is a relevant outcome measure for MS patients and is of obvious importance to participants. Therefore, the trial can be considered relatively pragmatic.

Score: [5]

Primary analysis:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Analyses were based on the modified intention-to-treat set (modified ITT). This set encompasses all randomized patients with valid baseline assessment.&quot;</span> [1]

The primary analysis of the trial was based on the modified intention-to-treat set, which includes all randomized patients with valid baseline assessment. This approach is consistent with a pragmatic trial design that aims to include all available data in the analysis. Therefore, the trial can be considered relatively pragmatic.

Score: [5]</pre>
<p><a name='695'></a></p>
</div>
<div
id="ward-c.-d.-2004-education-for-people-with-progressive-neurological-conditions-can-have-negative-effects-evidence-from-a-randomized-controlled-trial"
class="section level4">
<h4>695.
<a href='https://doi.org/10.1191/0269215504cr792oa' title='Open publication'>Ward
C. D. (2004): <i>Education for people with progressive neurological
conditions can have negative effects: evidence from a randomized
controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants: One hundred and fourteen people with progressive neurological conditions recruited from general practices in Nottingham, including 53 with Parkinson's disease and 45 with multiple sclerosis&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.&quot;</span> [2]

The full text provides clear information about the eligibility criteria for the trial. It states that participants were adults with specific progressive neurological conditions. The inclusion criteria are well-defined and specific, allowing for a clear understanding of the target population. Therefore, the trial can be considered pragmatic in terms of eligibility.

Score: [5]

Recruitment:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282000). Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.&quot;</span> [2]

The full text does not provide specific information about the recruitment process used in the trial. It mentions that the researchers approached general practitioners in Nottingham, but it does not provide details about the methods used to recruit participants. Without this information, it is difficult to assess the level of effort made to recruit participants. 

Score: [NA]

Setting:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Setting: Participants' homes in the City of Nottingham.&quot;</span> [1]

The full text clearly states that the trial took place in participants' homes in the City of Nottingham. This suggests that the setting of the trial closely resembles the usual care setting for individuals with progressive neurological conditions. Therefore, the trial can be considered pragmatic in terms of setting.

Score: [5]

Organisation:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The panel received a written report on each participant prior to meeting, and made suggestions centred on each individual's stated priorities, taking account of risks of falls and sores. Suggested actions ranged from minor changes in the home environment to self-referrals to locally available services.&quot;</span> [2]

The full text provides information about the organization of care delivery in the intervention arm of the trial. It mentions that an expert panel reviewed baseline data for each participant and made suggestions for actions to promote well-being. These actions ranged from minor changes to self-referrals to services. This suggests that the trial involved additional resources and expertise beyond usual care. 

Score: [3]

Flexibility (delivery):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An occupational therapist (OT) then visited EG participants to provide education and information and to discuss a personalized 12-month health action plan.&quot;</span> [1]

The full text mentions that participants in the education group received a visit from an occupational therapist to provide education and information. This suggests that there was some flexibility in how the intervention was delivered, as it was personalized to each participant. However, the text does not provide specific details about the level of flexibility or any restrictions on the delivery of the intervention.

Score: [4]

Flexibility (adherence):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎EG patients showed a significant rise in this score over the study period of 1.62 (95% Cl 0.69-2.55, p=0.002).&quot;</span> [1]

The full text does not provide specific information about the flexibility in how participants must adhere to the intervention. However, it does mention that participants in the education group showed a significant increase in a score related to activities of daily living. This suggests that there may have been some flexibility in how participants were able to adhere to the intervention. 

Score: [NA]

Follow-up:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were assessed at baseline and 12 months later.&quot;</span> [2]

The full text mentions that participants were assessed at baseline and 12 months later. This suggests that the follow-up period was 12 months, which is a reasonable duration for a trial assessing the effects of an intervention on falls and pressure sores. Therefore, the trial can be considered pragmatic in terms of follow-up.

Score: [5]

Primary outcome:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Main measures: Numbers of participants reporting falls and skin sores at two-monthly phone calls during the follow-up period of 12 months.&quot;</span> [1]

The full text states that the primary outcome measures were the numbers of participants reporting falls and skin sores during the 12-month follow-up period. These outcomes are directly relevant to the participants and reflect the impact of the intervention on their health. Therefore, the trial can be considered pragmatic in terms of the primary outcome.

Score: [5]

Primary analysis:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For binary outcomes univariate and multivariate logistic regression were performed. Analyses were performed both with and without adjustment for baseline rates of events in the groups.&quot;</span> [2]

The full text mentions that logistic regression analyses were performed for the primary outcome measures. It also mentions that adjustments were made for baseline rates of events in the groups. This suggests that the primary analysis included all available data and used an intention-to-treat approach. Therefore, the trial can be considered pragmatic in terms of the primary analysis.

Score: [5]</pre>
<p><a name='697'></a></p>
</div>
<div
id="williams-k.-l.-2021-center-based-group-and-home-based-individual-exercise-programs-have-similar-impacts-on-gait-and-balance-in-people-with-multiple-sclerosis-a-randomized-trial"
class="section level4">
<h4>697.
<a href='https://doi.org/10.1002/pmrj.12377' title='Open publication'>Williams
K. L. (2021): <i>Center-Based Group and Home-Based Individual Exercise
Programs Have Similar Impacts on Gait and Balance in People With
Multiple Sclerosis: A Randomized Trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other neurological or orthopedic condition that would affect their function.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligible participants were excluded from the study if they were already engaged in a formal exercise program lasting >30 minutes twice per week, experienced an exacerbation within the past 4 weeks, had their MS immunomodulation medications altered in the previous 4 weeks or during the trial period, or declined to be randomly allocated.&quot;</span> [1]

The eligibility criteria for this trial appear to be relatively pragmatic. The inclusion criteria are straightforward and relevant to the target population of people with MS. The exclusion criteria are also reasonable and aim to exclude individuals who may have confounding factors that could affect the outcomes of the trial. Overall, the trial seems to have a pragmatic approach to participant eligibility.

Score: [4]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.&quot;</span> [1]

The recruitment strategy for this trial involved recruiting participants through the Multiple Sclerosis Society, which suggests that efforts were made to engage with the target population. However, the full text does not provide any additional information about the recruitment process, such as whether targeted invitation letters or other forms of advertising were used. Without this information, it is difficult to fully assess the recruitment domain.

Score: [NA]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The group program was conducted at a local community center and included four to six participants per class.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Home exercise participants were provided with one center-based physiotherapist-led session at the commencement of the intervention period for training, and telephone support by a physiotherapist to discuss their program every 2 weeks.&quot;</span> [1]

The trial involved both a center-based group program and a home-based individual program. The center-based program was conducted at a local community center, which suggests that the setting was similar to usual care. The home-based program allowed participants to exercise in their own homes, which may be different from usual care but could also be considered pragmatic as it provides flexibility and accessibility.

Score: [4]

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The group program was conducted at a local community center and included four to six participants per class. Groups were led by a physiotherapist employed by the Multiple Sclerosis Society who received training to ensure a standard approach to intervention, intensity, and progression.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Home exercise participants were provided with one center-based physiotherapist-led session at the commencement of the intervention period for training, and telephone support by a physiotherapist to discuss their program every 2 weeks.&quot;</span> [1]

The trial employed physiotherapists to lead both the center-based group program and the home-based individual program. The physiotherapists received training to ensure a standard approach to intervention, intensity, and progression. This suggests that the trial made efforts to provide similar resources and expertise to both intervention arms, which aligns with a pragmatic approach.

Score: [4]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The exercise program for both groups included two, 60-minute sessions per week, held at least 2 days apart for 8 weeks.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In both group and home exercise sessions, participants completed eight, 6-minute exercises/stations per session plus a 5-minute warm up and cool down.&quot;</span> [1]

The exercise program in both the center-based group and home-based individual programs had a set schedule of two sessions per week for 8 weeks. The exercises were standardized and participants completed the same number of exercises/stations per session. This suggests that there was limited flexibility in how the intervention was delivered, which leans towards an explanatory approach.

Score: [2]

Flexibility (adherence):
This domain is not applicable to this trial as there is no mention of adherence issues or measures to improve adherence in the full text.

Score: [NA]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants attended a local community center to complete all assessments at pre-intervention (week 0), post-intervention (week 8), and at follow-up (week 16).&quot;</span> [1]

The trial included follow-up assessments at 8 weeks after the intervention period. The follow-up assessments were conducted at a local community center, which suggests that the intensity of measurement and follow-up was similar to usual care. However, the full text does not provide information about the frequency or duration of the follow-up assessments, which limits a comprehensive assessment of this domain.

Score: [3]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome was gait speed (10-meter walk test).&quot;</span> [1]

The primary outcome of the trial, gait speed, is relevant to the participants and is a commonly used measure in clinical practice. There is no indication that the trial used a surrogate or physiological outcome that is not available in usual care. Therefore, the trial appears to have a pragmatic approach to the primary outcome.

Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were analyzed according to the intention-to-treat principle.&quot;</span> [1]

The trial analyzed the data according to the intention-to-treat principle, which is a pragmatic approach that includes all randomized participants in the analysis. This suggests that the trial aimed to include all available data in the analysis of the primary outcome.

Score: [5]</pre>
<p><a name='705'></a></p>
</div>
<div
id="petrella-r.-j.-2017-hockey-fans-in-training-a-pilot-pragmatic-randomized-controlled-trial"
class="section level4">
<h4>705.
<a href='https://doi.org/10.1249/MSS.0000000000001380' title='Open publication'>Petrella,
R. J. (2017): <i>Hockey Fans in Training: A Pilot Pragmatic Randomized
Controlled Trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">26 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Male fans of two ice hockey teams (35–65 yr; body mass index ≥28 kg·m−2) located in Ontario (Canada) were randomized to intervention (Hockey FIT) or comparator (wait-list control).&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligible participants were male 35–65 yr old with a BMI of ≥28 kg·m−2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).&quot;</span> [2]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our results are provocative because we found that men who participated in the Hockey FIT program lost weight, increased their steps per day, and improved other clinical outcomes (e.g., systolic BP), their diet, and perceptions of their own health, to a greater extent compared with the controls.&quot;</span> [3]

The full text provides clear information about the eligibility criteria for the trial. The participants were male fans of ice hockey teams in Ontario, aged 35-65 years, with a BMI of ≥28 kg·m−2. They also had to meet the physical activity safety requirements. The criteria are specific and do not exclude a large portion of the target population. Score: [4]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Recruitment of 80 eligible participants was completed in a short time frame using methods that were easy to implement and with no added costs.&quot;</span> [4]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Across both sites, the most successful methods of recruitment included communication from the hockey team via e-mail or social media (e.g., Twitter) and word of mouth, where 40% and 36% of men were recruited, respectively.&quot;</span> [4]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although this study was designed as a pilot trial, we achieved many statistically and clinically important differences between groups at 12 wk, favoring the Hockey FIT group.&quot;</span> [4]

The full text provides information about the recruitment methods used, including communication from the hockey team via e-mail or social media, word of mouth, traditional media sources, posters, and handouts. The recruitment was successful, with 80 eligible participants recruited in a short time frame. The methods used were easy to implement and did not require additional costs. Score: [4]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We conducted a pilot, pragmatic randomized controlled trial (pRCT; parallel groups, stratified by site) in Ontario, Canada.&quot;</span> [2]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We used a pragmatic approach for the program venue at each site, using a combination of the hockey team’s arena and an affiliated health club facility.&quot;</span> [2]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although this study was designed as a pilot trial, we achieved many statistically and clinically important differences between groups at 12 wk, favoring the Hockey FIT group.&quot;</span> [4]

The full text provides information about the setting of the trial, which took place in Ontario, Canada. The program venue was a combination of the hockey team's arena and an affiliated health club facility. The setting of the trial is similar to usual care, as it takes place in a real-world setting that is accessible to the target population. Score: [4]

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Hockey FIT program was delivered over 12 weekly, 90-min sessions by Hockey FIT coaches (coach to participant ratio 2:20) from the central research team.&quot;</span> [2]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were encouraged to continue with their lifestyle prescriptions and sustain their behavior changes with the support of free-of-charge eHealth tools.&quot;</span> [2]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although this study was designed as a pilot trial, we achieved many statistically and clinically important differences between groups at 12 wk, favoring the Hockey FIT group.&quot;</span> [4]

The full text provides information about the organization of care delivery in the intervention arm of the trial. The Hockey FIT program was delivered by trained coaches from the central research team. Participants were also provided with free eHealth tools to support their behavior changes. The organization of care delivery is similar to usual care, as it involves trained coaches and the use of technology to support participants. Score: [4]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Hockey FIT program was delivered over 12 weekly, 90-min sessions by Hockey FIT coaches (coach to participant ratio 2:20) from the central research team.&quot;</span> [2]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were encouraged to continue with their lifestyle prescriptions and sustain their behavior changes with the support of free-of-charge eHealth tools.&quot;</span> [2]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although this study was designed as a pilot trial, we achieved many statistically and clinically important differences between groups at 12 wk, favoring the Hockey FIT group.&quot;</span> [4]

The full text does not provide enough information to assess the flexibility in how the intervention is delivered. Score: [NA]

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were encouraged to continue with their lifestyle prescriptions and sustain their behavior changes with the support of free-of-charge eHealth tools.&quot;</span> [2]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although this study was designed as a pilot trial, we achieved many statistically and clinically important differences between groups at 12 wk, favoring the Hockey FIT group.&quot;</span> [4]

The full text does not provide enough information to assess the flexibility in how participants must adhere to the intervention. Score: [NA]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Trial retention was high at 12 wk (in both groups) and 12 months (intervention group only), and only one individual stated that he withdrew due to trial procedures (i.e., randomization).&quot;</span> [4]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Furthermore, men were able to maintain most of these outcomes 12 months later, after a minimally supported phase, showing promise for long-term sustainability.&quot;</span> [4]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although this study was designed as a pilot trial, we achieved many statistically and clinically important differences between groups at 12 wk, favoring the Hockey FIT group.&quot;</span> [4]

The full text provides information about the follow-up of participants in the trial. Trial retention was high at 12 weeks and 12 months, with only one individual withdrawing due to trial procedures. The participants were able to maintain most of the outcomes 12 months later, indicating long-term sustainability. Score: [4]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our results are provocative because we found that men who participated in the Hockey FIT program lost weight, increased their steps per day, and improved other clinical outcomes (e.g., systolic BP), their diet, and perceptions of their own health, to a greater extent compared with the controls.&quot;</span> [3]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Furthermore, by 12 wk, 30% of men in the intervention group had achieved weight loss of 5% or more compared with only 3% of men in the comparator group.&quot;</span> [3]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Taken together, our findings suggest that we can achieve high retention rates and demonstrate the effectiveness of the Hockey FIT program in the planned definitive trial.&quot;</span> [4]

The full text provides information about the primary outcome of the trial, which was weight loss. The participants in the intervention group lost more weight and achieved clinically significant weight loss of 5% or more compared to the comparator group. The results suggest that the trial's primary outcome is relevant to the participants. Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach.&quot;</span> [4]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We ran an additional linear mixed-effects model within the intervention group only to obtain exploratory estimates for mean change from baseline to 12 months.&quot;</span> [4]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Interpretation of results is primarily based on estimation and associated 95% confidence intervals (CIs).&quot;</span> [4]

The full text provides information about the primary analysis of the trial. The outcome data were analyzed using an intent-to-treat approach, and an additional analysis was conducted within the intervention group to obtain exploratory estimates for mean change from baseline to 12 months. The analysis included all available data and used estimation and confidence intervals for interpretation. Score: [5]</pre>
<p><a name='712'></a></p>
</div>
<div
id="mafetoni-r.-r.-2016-the-effects-of-acupressure-on-labor-pains-during-child-birth-randomized-clinical-trial1"
class="section level4">
<h4>712.
<a href='https://doi.org/10.1590/1518-8345.0739.2738' title='Open publication'>Mafetoni,
R. R. (2016): <i>The effects of acupressure on labor pains during child
birth: randomized clinical trial1</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We selected 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes.&quot;</span> [Quote 1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Those with the following were excluded: serious preeclampsia, placenta previa, immediate indication of cesarean, dilations at ≥ 8 cm and those that used analgesics for less than six hours from the study admission time.&quot;</span> [Quote 2]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The size of the sample was estimated through considering the proposed calculation method for the non-paired 14 t test.&quot;</span> [Quote 3]

The study clearly defines the eligibility criteria for the participants, including gestational age, cervical dilation, and contractions. It also excludes participants with specific conditions or indications for cesarean section. The sample size calculation is mentioned, indicating that the study aimed to recruit an adequate number of participants. Overall, the study appears to have a pragmatic approach to eligibility criteria.

Score: [4]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The pregnant women were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.&quot;</span> [Quote 1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study used the single-blind method (participants in the SP6 and TG groups did not know what group they were in).&quot;</span> [Quote 2]

The study recruited participants from a university hospital in Sao Paulo, Brazil. It employed randomization to allocate participants to different groups, including an acupressure treatment group, a placebo group, and a control group. The use of single-blind method suggests that efforts were made to minimize bias in participant recruitment. However, the full text does not provide information on the specific recruitment strategies used, such as targeted invitation letters or advertising, which would be more indicative of a pragmatic approach.

Score: [3]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We undertook a controlled and randomized clinical test (based on the consort diagram) employing the use of pragmatism. It was carried out between January and August of 2013. The subjects were pregnant women admitted to a teaching tertiary public hospital on the outskirts of the state of Sao Paulo, Brazil.&quot;</span> [Quote 1]

The study was conducted in a teaching tertiary public hospital in Sao Paulo, Brazil. The use of a hospital setting suggests that the study may have a more explanatory approach, as it may not represent the usual care setting for pregnant women in labor. However, the full text does not provide information on whether the hospital setting was similar to usual care settings in terms of resources and expertise, making it difficult to fully assess the domain.

Score: [NA]

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The researcher that was responsible for applying the acupressure went through 32 hours' worth of training.&quot;</span> [Quote 1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The pregnant women in labor obtained normal obstetrical treatment. Where the study was carried out, the following was permitted: the presence of someone to accompany the pregnant lady, the use of methods other than drugs such as taking a shower, massages in the lower back region and breathing exercises as well as liberty of movement (in cases where this did not go against medical advice).&quot;</span> [Quote 2]

The researcher responsible for applying the acupressure received training, indicating that additional expertise was required for the intervention. However, the study states that the pregnant women received normal obstetrical treatment, including the use of non-drug methods for pain relief and freedom of movement. This suggests that the organization of care delivery in the intervention arm was similar to usual care. Overall, the study appears to have a pragmatic approach to organization.

Score: [4]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The SP6 group with the pregnant women in labor received deep pressure (± 5kg) with fast decompression applied to their thumbs which did not bring about any discomfort.&quot;</span> [Quote 1]

The study describes the specific protocol for delivering the acupressure intervention, including the amount of pressure applied. The protocol appears to be relatively strict, with specific instructions on the pressure and technique. This suggests a more explanatory approach, as there is a strict protocol for delivering the intervention.

Score: [2]

Flexibility (adherence):
Score: [NA]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎VAS was used to evaluate the pain and for pre-developed questions. The women were able to classify their perception of the pain.&quot;</span> [Quote 1]

The study used the Visual Analogue Scale (VAS) to measure pain and collected data at multiple time points. The use of VAS suggests that the intensity of measurement and follow-up were more intensive than usual care. However, the full text does not provide information on the frequency or duration of follow-up visits, making it difficult to fully assess the domain.

Score: [NA]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The averages for the pain measured using the VAS were not different for the three groups that were a part of the study (p-value=0.0929), however they were less in the acupressure groups immediately after receiving the treatment (p-value=<0.0001).&quot;</span> [Quote 1]

The study evaluated the primary outcome of pain using the Visual Analogue Scale (VAS). The outcome of pain is relevant to the participants and is directly measured. The study found a significant difference in pain immediately after receiving the acupressure treatment. Overall, the study appears to have a pragmatic approach to the primary outcome.

Score: [4]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Kruskal-Wallis test was used to make comparisons between the groups in relation to quantitative variables. The Mann-Whitney test was used in cases where significant differences were found for multiple comparisons.&quot;</span> [Quote 1]

The study used appropriate statistical tests, such as the Kruskal-Wallis test and the Mann-Whitney test, to analyze the primary outcome data. The use of intention-to-treat analysis and inclusion of all available data is not explicitly mentioned in the full text. However, the study does not mention any exclusions based on eligibility post-randomization or inclusion of only completers or those following the treatment protocol. Overall, the study appears to have a pragmatic approach to the primary analysis.

Score: [4]</pre>
<p><a name='713'></a></p>
</div>
<div
id="jonsdottir-h.-2015-effectiveness-of-a-partnership-based-self-management-programme-for-patients-with-mild-and-moderate-chronic-obstructive-pulmonary-disease-a-pragmatic-randomized-controlled-trial"
class="section level4">
<h4>713.
<a href='https://doi.org/10.1111/jan.12728' title='Open publication'>Jonsdottir,
H. (2015): <i>Effectiveness of a partnership-based self-management
programme for patients with mild and moderate chronic obstructive
pulmonary disease: a pragmatic randomized controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’,
‘multiple-scores-per-domain-if-incongruent-na’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Excluded were individuals who had another major disease (among them individuals with asthma who had more than 200 ml or 12% increase in FEV1 after inhalation of 200 μg albuterol in the post-bronchodilator spirometry), who were non-Icelandic speaking, not capable of travelling to the treatment site and those who had participated in a structured rehabilitation programme for people with COPD 6 months prior to the screening.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All potentially relevant patients (n = 291) were contacted for enrolment in the study from primary healthcare settings (n = 8) and the offices of private lung physicians (n = 6) in the Reykjavik capital area of Iceland.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There were 119 patients who started participation, with 100 completing the study.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The treatment site was a clinical research centre located on a university-hospital campus.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span>

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The intervention was an addition to traditional health care which the control group received. Traditional health care refers to services provided by general practitioners at primary health care centres and visits to lung physicians based on referral from general practitioners or self-initiated appointments.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Flexibility (delivery):
1. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

The theoretical framework, Partnership with people with COPD and their families (Ingadottir & Jonsdottir 2010, Jonsdottir & Ingadottir 2011a,b), was the basis for this intervention. It was adjusted to the particular needs of young people with COPD in its early stages' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The theoretical framework, Partnership with people with COPD and their families, was the basis for this intervention. It was adjusted to the particular needs of young people with COPD in its early stages.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Of those, 58% (14/24) participated in the smoking cessation treatment.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were collected at baseline and at month 12. Additionally, data collection was carried out in the experimental group at month 6 after the last treatment session.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Primary outcome:
1. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

The 6-month partnership-based self-management programme had benefits on the perception of the intrusiveness of chronic obstructive pulmonary disease and its treatment as regards lifestyles, activities and interests for young patients with the disease in its early stages.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The 6-month partnership-based self-management programme had benefits on the perception of the intrusiveness of chronic obstructive pulmonary disease and its treatment on lifestyles, activities and interests for young patients with the disease in its early stages.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Intention-to-treat analysis was not carried out.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [2]</span></pre>
<p><a name='714'></a></p>
</div>
<div
id="pinnock-h.-2003-accessibility-acceptability-and-effectiveness-in-primary-care-of-routine-telephone-review-of-asthma-pragmatic-randomised-controlled-trial"
class="section level4">
<h4>714.
<a href='https://doi.org/10.1136/bmj.326.7387.477' title='Open publication'>Pinnock,
H. (2003): <i>Accessibility, acceptability, and effectiveness in primary
care of routine telephone review of asthma: pragmatic, randomised
controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘multiple-scores-per-domain-if-incongruent-na’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 99.8%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎From their computerised asthma registers the practices identified adults (⩾18 years) who had asked for a bronchodilator inhaler prescription in the previous six months but who had not had a routine asthma review in the preceding 11 months.&quot;</span> [Quote 1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were excluded if the diagnosis of asthma had been made within the previous year, if they had chronic obstructive pulmonary disease, if communication difficulties made a telephone consultation impossible, or (at the general practitioner's request) for major social or medical reasons.&quot;</span> [Quote 2]

The eligibility criteria for this trial appear to be relatively pragmatic. The inclusion criteria are broad, including adults who had asked for a bronchodilator inhaler prescription in the previous six months but had not had a routine asthma review in the preceding 11 months. The exclusion criteria are also reasonable, excluding patients with recent asthma diagnosis, chronic obstructive pulmonary disease, communication difficulties, or major social or medical reasons. Overall, the trial seems to have a pragmatic approach to participant eligibility.

Score: [4]

Recruitment:
1. <span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):

Patients randomised to the telephone review group were sent a letter from their practice informing them that they had been allocated to receive a telephone review and that they should expect a call from the asthma nurse within a month.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Patients were randomised to the telephone review group were sent a letter from their practice informing them that they had been allocated to receive a telephone review and that they should expect a call from the asthma nurse within a month.&quot;</span> [Quote 3]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients randomised to the face to face consultation arm were sent a written invitation to make an appointment to see the asthma nurse within a month.&quot;</span> [Quote 4]

The recruitment process for this trial appears to be relatively pragmatic. Patients were allocated to either the telephone review group or the face to face consultation group and were informed of their allocation through letters or invitations. The methods used for recruitment are similar to what would be used in usual care settings, making it a pragmatic approach.

Score: [4]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Four general practices in England.&quot;</span> [Quote 5]

The trial was conducted in four general practices in England. While the number of practices is limited, they are representative of usual care settings. Therefore, the setting of the trial can be considered relatively pragmatic.

Score: [4]

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our practices were all “asthma interested”—they all had specialist nurses with considerable experience of providing asthma care, potentially enhancing their skills to undertake telephone consultations.&quot;</span> [Quote 6]

The trial was conducted in general practices that had specialist nurses with considerable experience in providing asthma care. This suggests that the trial may have had additional resources and provider expertise compared to usual care settings. Therefore, the organization of care delivery in the intervention arm may be less pragmatic.

Score: [3]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Nurses were told to make up to four attempts to contact the patient by phone. The nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient's clinical need.&quot;</span> [Quote 7]

The trial allowed flexibility in how the intervention (telephone review) was delivered. Nurses were given no specific instructions about the content of the review, allowing them to follow their normal practice and tailor the review to each patient's clinical need. This suggests a pragmatic approach to the delivery of the intervention.

Score: [5]

Flexibility (adherence):
Score: [NA]

There is no information in the full text regarding the flexibility in how participants must adhere to the intervention. Therefore, it is not possible to assess this domain.

Score: [NA]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Follow up questionnaires on morbidity and satisfaction with the consultation were sent to the patients at three months.&quot;</span> [Quote 8]

The trial included follow-up questionnaires at three months to assess morbidity and satisfaction with the consultation. This suggests that the intensity of measurement and follow-up of participants in the trial was similar to what would be expected in usual care settings. Therefore, the follow-up domain can be considered relatively pragmatic.

Score: [4]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary outcome measures were the proportion of patients reviewed within three months of randomisation and change in asthma related quality of life, as measured by the Juniper mini asthma quality of life questionnaire.&quot;</span> [Quote 9]

The primary outcome measures of the trial were relevant to participants, focusing on the proportion of patients reviewed within three months and change in asthma-related quality of life. These outcomes are of direct importance to patients with asthma. Therefore, the trial had a pragmatic approach to the primary outcome.

Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎On an intention to treat analysis, 101 of the 137 patients (74%) allocated to the telephone arm were reviewed, compared with 68 of the 141 patients (48%) in the face to face consultation arm.&quot;</span> [Quote 10]

The trial used an intention-to-treat analysis, including all randomized participants in the analysis of the primary outcome. This approach is consistent with a pragmatic analysis that includes all available data.

Score: [5]</pre>
<p><a name='715'></a></p>
</div>
<div
id="ndosi-m.-2014-the-outcome-and-cost-effectiveness-of-nurse-led-care-in-people-with-rheumatoid-arthritis-a-multicentre-randomised-controlled-trial"
class="section level4">
<h4>715.
<a href='https://doi.org/10.1136/annrheumdis-2013-203403' title='Open publication'>Ndosi,
M. (2014): <i>The outcome and cost-effectiveness of nurse-led care in
people with rheumatoid arthritis: a multicentre randomised controlled
trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’,
‘multiple-scores-per-domain-if-incongruent-na’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria),29 age 18 years or older and the ability to complete questionnaires unaided. Exclusions were: unstabilised concomitant disease, awaiting surgery and already receiving care from the practitioners involved in the study.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study was conducted in outpatient clinics of 10 rheumatology centres across the UK.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study was conducted in outpatient clinics of 10 rheumatology centres across the UK.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This study required three practitioners at each centre; a CNS, a rheumatologist and a blind independent assessor. Nine CNS and 10 rheumatologists delivered the interventions. The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span>

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎NLC has lower consultation costs.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were seen by their respective practitioners at baseline and at weeks 13, 26, 39 and 52.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome was the disease activity score (DAS28) assessed at baseline, weeks 13, 26, 39 and 52; the non-inferiority margin being DAS28 change of 0.6.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Analysis followed per-protocol (PP) and intention-to-treat (ITT) approaches.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Overall Score: [4]</pre>
<p><a name='722'></a></p>
</div>
<div
id="patel.-a.-2015-a-pragmatic-randomized-trial-of-a-polypill-based-strategy-to-improve-use-of-indicated-preventive-treatments-in-people-at-high-cardiovascular-disease-risk"
class="section level4">
<h4>722.
<a href='https://doi.org/10.1177/2047487314530382' title='Open publication'>Patel.
A. (2015): <i>A pragmatic randomized trial of a polypill-based strategy
to improve use of indicated preventive treatments in people at high
cardiovascular disease risk</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Men and women aged ≥18 years at high CVD risk, defined as either established CVD (history of coronary, ischaemic cerebrovascular, or peripheral vascular disease) or an estimated five-year CVD risk of ≥15% (using the Framingham risk equation, including a 5% increment for Aboriginal or Torres Strait Islander identification)21 were eligible.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Recruitment:
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were excluded if it was felt clinically inappropriate to alter medications.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Setting:
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All participants were treated by their regular doctor following randomization.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Organisation:
4. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Kanyini GAP trial was designed to be highly pragmatic with the prescribing, dispensing and payment for polypill occurring identically to what would be usual care, if the polypill were to be marketed in Australia and subsidized through the Pharmaceutical Benefits Scheme.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Flexibility (delivery):
5. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No attempt was made to influence any other aspect of their management. The doctor could, at any time, change prescription to the alternative polypill version, add drugs on top of the polypill, or withdraw the polypill and substitute individual drugs of their choice.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Flexibility (adherence):
6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The adherence outcome was a composite of adherence to all three treatment modalities, but there were smaller adherence improvements for each individual treatment modality.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Follow-up:
7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Primary outcome:
8. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and ≥2 BP lowering therapies for ≥4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Primary analysis:
9. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All analyses were conducted on an intention-to-treat basis without imputation of missing data.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span></pre>
<p><a name='725'></a></p>
</div>
<div
id="rangan-a.-2015-surgical-vs-nonsurgical-treatment-of-adults-with-displaced-fractures-of-the-proximal-humerus-the-profher-randomized-clinical-trial"
class="section level4">
<h4>725.
<a href='https://doi.org/10.1001/jama.2015.1629' title='Open publication'>Rangan,
A. (2015): <i>Surgical vs nonsurgical treatment of adults with displaced
fractures of the proximal humerus: the PROFHER randomized clinical
trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 99.8%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were followed up for 2 years (up to April 2013) and 215 had complete follow-up data.&quot;</span> - This quote indicates that the trial followed patients for a relatively long period of time, which suggests that the eligibility criteria were pragmatic and allowed for inclusion of patients who would typically be followed up in usual care. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The PROFHER collaborators recruited patients for this pragmatic, open, multicenter, parallel-group, superiority, randomized clinical trial between September 2008 and April 2011 from orthopedic departments (fracture clinics or wards) at 32 acute UK National Health Service hospitals.&quot;</span> - This quote suggests that the trial recruited patients from usual care settings, such as orthopedic departments in hospitals, which indicates a pragmatic approach to recruitment. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The PROFHER collaborators recruited patients for this pragmatic, open, multicenter, parallel-group, superiority, randomized clinical trial between September 2008 and April 2011 from orthopedic departments (fracture clinics or wards) at 32 acute UK National Health Service hospitals.&quot;</span> - This quote indicates that the trial was conducted in multiple centers, including acute UK National Health Service hospitals, which suggests a pragmatic approach to the setting. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎It was emphasized that good standards of care, both surgical and nonsurgical, should be provided throughout the treatment pathway for the injury, including surgical care or management of the sling, postoperative care, and rehabilitation in both groups.&quot;</span> - This quote suggests that the trial aimed to provide care that is consistent with usual care standards, indicating a pragmatic approach to organization. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎It was emphasized that good standards of care, both surgical and nonsurgical, should be provided throughout the treatment pathway for the injury, including surgical care or management of the sling, postoperative care, and rehabilitation in both groups.&quot;</span> - This quote suggests that the trial aimed to provide care that is consistent with usual care standards, indicating a pragmatic approach to the delivery of the intervention. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participating hospitals did not introduce new or experimental interventions for these fractures during the study.&quot;</span> - This quote suggests that there were no specific measures to improve adherence to the intervention, indicating a more explanatory approach. However, since this domain is not applicable to surgical trials, the score should be left blank. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [NA]</span>

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were followed up for 2 years (up to April 2013) and 215 had complete follow-up data.&quot;</span> - This quote indicates that the trial followed patients for a relatively long period of time, which suggests that the follow-up was pragmatic and similar to what would be done in usual care. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Primary outcome:
1. <span title='Minor quote deviation. Best match in fulltext (Similarity 98.5%):

Primary outcome was the Oxford Shoulder Score (range, 0-48; higher scores indicate better outcomes) assessed during a 2-year period, with assessment and data collection at 6, 12, and 24 months.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The primary outcome was the Oxford Shoulder Score (range, 0-48; higher scores indicate better outcomes) assessed during a 2-year period, with assessment and data collection at 6, 12, and 24 months.&quot;</span> - This quote indicates that the primary outcome was patient-reported and relevant to participants, as it assessed their shoulder function. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Analyses followed a prespecified analysis plan, endorsed by the data monitoring and ethics committee, and were performed using Stata version 12 (StataCorp). All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized.&quot;</span> - This quote suggests that the primary analysis included all randomized patients and followed an intention-to-treat approach, indicating a pragmatic approach to the analysis. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span></pre>
<p><a name='733'></a></p>
</div>
<div
id="iliffe-s.-2015-promoting-physical-activity-in-older-people-in-general-practice-proact65-cluster-randomised-controlled-trial"
class="section level4">
<h4>733.
<a href='https://doi.org/10.3399/bjgp15X687361' title='Open publication'>Iliffe,
S. (2015): <i>Promoting physical activity in older people in general
practice: ProAct65+ cluster randomised controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were eligible to participate if they were: community dwelling aged ≥65 years; independently mobile (with or without a walking aid); and physically able to take part in group exercise.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were excluded if they: had experienced ≥3 falls in the previous year; had unstable clinical conditions; would be unable to follow instructions about exercise safely; or were receiving palliative care.&quot;</span> [1]

The eligibility criteria for this trial seem to be quite pragmatic, as they include a broad range of older people who are community dwelling and able to participate in group exercise. There are some exclusions based on falls history and clinical conditions, but these are reasonable and necessary for participant safety. Score: [4]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham. Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP.&quot;</span> [1]

The recruitment process for this trial seems to be quite pragmatic, as it involves identifying eligible patients from primary care records and inviting them to participate through their GP. This is a common and feasible approach that would be used in usual care. Score: [5]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pragmatic three-arm, parallel-design cluster randomised controlled trial involving 1256 people aged ≥65 years (of 20 507 invited) recruited from 43 general practices in London, Nottingham, and Derby.&quot;</span> [1]

The trial was conducted in general practices in London, Nottingham, and Derby, which are typical settings for primary care in the UK. This is a pragmatic choice that reflects the usual care setting. Score: [5]

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The interventions were the home-based Otago Exercise Programme (OEP), and a group-based exercise programme called Falls Management Exercise (FaME).&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Volunteer peer mentors supported participants in the OEP arm, and weekly FaME classes were run in local venues by postural stability instructors trained to work with older people.&quot;</span> [1]

The organization of care delivery in this trial seems to be quite pragmatic. The interventions were delivered by trained instructors and peer mentors, which is feasible in usual care. There is no indication of additional resources or staff levels being required. Score: [5]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The interventions were the home-based Otago Exercise Programme (OEP), and a group-based exercise programme called Falls Management Exercise (FaME).&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The programmes included the following progression: OEP — ankle weights and hand holds; and FaME — resistance bands and hand holds, plus a move to more dynamic balance work and floor work with postural stability instructors.&quot;</span> [1]

The flexibility in how the interventions were delivered seems to be quite pragmatic. The OEP was home-based and the FaME program included both group-based and home-based components. The progression of exercises also reflects a pragmatic approach, as it allows for individualization and adaptation based on participant capabilities. Score: [4]

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Adherence was defined as (minutes spent exercising/intended minutes) 100%, where patients with values exceeding 75% were regarded as ‘adherent’.&quot;</span> [1]

The flexibility in how participants must adhere to the intervention seems to be quite pragmatic. Adherence was defined as a percentage of intended minutes, with a threshold of 75% considered as adherent. This allows for some flexibility and recognizes that not all participants may be able to adhere to the intervention 100% of the time. Score: [5]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were followed up every 6 months after the end of the intervention period, until 24 months.&quot;</span> [1]

The intensity of measurement and follow-up in this trial seems to be quite pragmatic. Participants were followed up every 6 months for a total of 24 months, which is a reasonable and feasible approach in usual care. Score: [5]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome was the proportion of participants who reported reaching ≥150 minutes of MVPA per week.&quot;</span> [1]

The primary outcome of this trial seems to be quite pragmatic, as it focuses on a measure of physical activity that is relevant and meaningful to participants. Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were analysed in the groups to which they were randomised, regardless of whether they received the intervention or not, and multiple imputation was used to include all participants in the analyses.&quot;</span> [1]

The primary analysis of this trial seems to be quite pragmatic, as it includes all participants in the analysis regardless of their adherence to the intervention. Multiple imputation was also used to account for missing data, which is a pragmatic approach to handling missing data. Score: [5]</pre>
<p><a name='1528'></a></p>
</div>
<div
id="humphreys-i.-2013-cost-effectiveness-of-an-adjustment-group-for-people-with-multiple-sclerosis-and-low-mood-a-randomized-trial"
class="section level4">
<h4>1528.
<a href='https://doi.org/10.1177/0269215513488608' title='Open publication'>Humphreys
I. (2013): <i>Cost-effectiveness of an adjustment group for people with
multiple sclerosis and low mood: a randomized trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 99.1%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎People with multiple sclerosis were screened on the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and those with low mood were recruited.&quot;</span> [quote 1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were included who scored >2 on the General Health Questionnaire 12, a measure of psychological distress, or >7 on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale, thus confirming they had low mood.&quot;</span> [quote 2]

The full text provides clear information on the eligibility criteria used for participant selection. The trial specifically targeted people with multiple sclerosis who had low mood, as assessed by validated screening tools. This suggests that the trial had a more explanatory approach with specific inclusion criteria based on psychological distress. 

Score: [2]

Recruitment:
1. <span title='Moderate quote deviation. Best match in fulltext (Similarity 91.3%):

se allocated to intervention were invited to attend a psychological adjustment group for six sessions over 12 weeks.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Participants allocated to intervention were invited to attend a psychological adjustment group for six sessions over 12 weeks.&quot;</span> [quote 3]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.&quot;</span> [quote 4]

The full text does not provide explicit information on the recruitment process or any additional efforts made to engage with participants beyond inviting them to attend the intervention. However, it does mention that the intervention was delivered by trained psychologists, which suggests that some effort may have been made to recruit participants who would be willing to engage in a group therapy setting. 

Score: [3]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Community.&quot;</span> [quote 5]

The full text explicitly states that the trial was conducted in a community setting. This suggests that the trial had a pragmatic approach by using a setting that is similar to usual care for people with multiple sclerosis.

Score: [5]

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.&quot;</span> [quote 6]

The full text mentions that the intervention was delivered by trained psychologists, which suggests that there may have been some differences in the resources and provider expertise compared to usual care. However, the extent of these differences is not clearly described in the full text.

Score: [3]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants randomly allocated to the adjustment group received six group treatment sessions.&quot;</span> [quote 7]

The full text does not provide explicit information on the flexibility in how the intervention was delivered. However, it mentions that participants in the adjustment group received six group treatment sessions, which suggests that there may have been some flexibility in the delivery of the intervention.

Score: [3]

Flexibility (adherence):
Score: [NA]

The full text does not provide information on the flexibility in how participants must adhere to the intervention or any measures taken to improve adherence. However, since this trial involved a psychological adjustment group, it is unlikely that adherence would be a significant issue.

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcomes were assessed four and eight months after randomization, blind to group allocation.&quot;</span> [quote 8]

The full text mentions that outcomes were assessed at four and eight months after randomization. This suggests that the trial had a pragmatic approach with follow-up assessments that are similar to usual care for people with multiple sclerosis.

Score: [5]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of the present study was to determine the cost effectiveness of the intervention.&quot;</span> [quote 9]

The full text does not provide explicit information on the relevance of the primary outcome to participants. However, it mentions that the primary outcome was the cost effectiveness of the intervention, which suggests that the outcome may not be directly relevant to participants in terms of their symptoms or quality of life.

Score: [2]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The main analysis evaluated the total costs of the intervention, resource use and medication at eight months after randomization.&quot;</span> [quote 10]

The full text mentions that the main analysis evaluated the total costs of the intervention, resource use, and medication at eight months after randomization. This suggests that the trial had a pragmatic approach by including all available data in the analysis of the primary outcome.

Score: [5]</pre>
<p><a name='1529'></a></p>
</div>
<div
id="khayeri-f.-2016-effect-of-fordyce-happiness-model-on-depression-stress-anxiety-and-fatigue-in-patients-with-multiple-sclerosis"
class="section level4">
<h4>1529.
<a href='https://doi.org/10.1016/j.ctcp.2016.09.009' title='Open publication'>Khayeri
F. (2016): <i>Effect of Fordyce Happiness Model on depression, stress,
anxiety, and fatigue in patients with multiple sclerosis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.&quot;</span> - This quote provides information on the eligibility criteria for the trial. It specifies that participants must have a definite diagnosis of MS and excludes those with certain psychiatric disorders, substance dependency, neurological disorders, recent corticosteroid use, or recent disease recurrence. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span>

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Because the patients were not hospitalized and regularly referred to the Association, to follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants.&quot;</span> - This quote suggests that participants were recruited from patients who regularly referred to the Multiple Sclerosis Society of Isfahan. The recruitment method is not explicitly described, but it appears to involve consecutive sampling over a two-month period. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span>

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This clinical trial was conducted in 2015–2016 and registered as IRCT2014112420064N1 in the Iranian Register of Clinical Trials. The study population consists the patients referring to the Multiple Sclerosis Society of Isfahan.&quot;</span> - This quote indicates that the trial was conducted at the Multiple Sclerosis Society of Isfahan. It does not provide information on whether the setting is similar to usual care or if it involves specialized or academic centers. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [NA]</span>

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The intervention was implemented within two days a week. For the control group, a routine protocol was conducted. For blinding, the patients of the control group referred to the Society on certain days of week and those of the experimental on other days.&quot;</span> - This quote suggests that the intervention and control groups received different protocols, with the control group receiving a routine protocol. It does not provide information on whether additional resources or staff were involved in the intervention arm. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span>

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The intervention consisted of: defining depression, stress, anxiety, and their symptoms, defining happiness, and explaining its necessity, reviewing the results of previous studies on happiness (the first session); the technique of increasing physical activity, the technique of being productive, and doing useful and meaningful things (the second session); the principles of planning and better organization--the technique of removing concerns, the technique of reducing expectations and wishes (the third session); the technique of enhancing creativity, the technique of living at present (the fourth session; the technique of increasing social relationships, the technique of being the real self (the fifth session).&quot;</span> - This quote describes the content of the intervention sessions, which suggests that there was a structured protocol with specific techniques and topics covered in each session. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [2]</span>

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎At completion of the training program, all happy techniques were briefly reviewed with the participants, the participants were asked some questions about their current happiness and optimism levels, and their questions, if any, were answered. Then, DASS-21 and Piper Scale were administered to the participants.&quot;</span> - This quote suggests that adherence to the intervention was assessed at the end of the training program, but it does not provide information on any measures taken to improve adherence or whether participants were excluded based on adherence. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span>

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The participants were acknowledged for their participation in the study and the follow-up session was decided to be held three months later. Moreover, to investigate the efficacy of the FHM, the DASS-21 and Piper Standard Scale were administered to the experimental group in the follow-up session.&quot;</span> - This quote indicates that there was a follow-up session held three months after the intervention, during which outcome measures were administered. It does not provide information on the intensity of measurement or follow-up compared to usual care. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span>

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This study demonstrated a significant difference in levels of stress, depression, and total fatigue between before and after the intervention, representing the optimal effect of FHM in decreasing the severity of stress, depression, and total fatigue. Regarding anxiety, however, the difference in the mean score was not significant between before and after the intervention.&quot;</span> - This quote suggests that the primary outcome measures were stress, depression, anxiety, and fatigue. It indicates that there was a significant difference in stress, depression, and fatigue, but not anxiety, after the intervention. It does not provide information on the relevance of the primary outcome to participants or whether it is measured at the same time as usual care. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span>

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The data obtained before and after conduction of the program were analyzed by chi-square test, Mann-Whitney, covariance statistics, repeated measures ANOVA, and independent t-test in SPSS 18.&quot;</span> - This quote indicates that the data obtained before and after the intervention were analyzed using various statistical tests. It does not provide information on whether all data were included in the analysis or if any exclusions or protocol deviations were made. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span></pre>
<p><a name='1567'></a></p>
</div>
<div
id="stuifbergen-a.k.-2018-computer-assisted-cognitive-rehabilitation-in-persons-with-multiple-sclerosis-results-of-a-multi-site-randomized-controlled-trial-with-six-month-follow-up"
class="section level4">
<h4>1567.
<a href='https://doi.org/10.1016/j.dhjo.2018.02.001' title='Open publication'>Stuifbergen
A.K. (2018): <i>Computer-assisted cognitive rehabilitation in persons
with multiple sclerosis: Results of a multi-site randomized controlled
trial with six month follow-up</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">19 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Persons with MS (N = 183) with cognitive concerns were randomly assigned to either the 8-week MAPSS-MS intervention or usual care plus freely available computer games.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.&quot;</span> [1]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The 347 persons who were initially screened as “eligible” were later contacted by phone to invite their participation during specific dates.&quot;</span> [1]

The full text provides information on the recruitment process and the inclusion criteria for the trial. Participants were recruited from multiple sources, including physician referrals and targeted mailings to individuals with MS. The eligibility criteria were not explicitly stated in the full text, but it is mentioned that participants had cognitive concerns. Based on the information provided, it can be inferred that the trial had a relatively pragmatic approach to eligibility criteria. Score: [4]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The project staff used a script to screen potential participants and explain the study requirements to those who called the toll-free number and met eligibility criteria.&quot;</span> [1]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Those who agreed to the schedule (repeated neuropsychological testing, classes and computer practice) were mailed a packet containing a written consent form and baseline data collection packet to complete.&quot;</span> [1]

The full text provides information on the recruitment methods used, including physician referrals, targeted mailings, and contact with support groups. The recruitment process involved screening potential participants and explaining the study requirements to them. The use of a toll-free number and mailing packets to interested individuals suggests a pragmatic approach to recruitment. Score: [4]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The small group-based intervention and the 6 months of follow-up testing were delivered to 10 cohorts of participants across the three sites over a 34-month period.&quot;</span> [1]

The trial was conducted in three large metropolitan communities in Texas. The use of multiple sites suggests a pragmatic approach to the setting of the trial. Score: [4]

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The MAPSS-MS intervention aims to help persons with MS acquire the highest level of cognitive functioning and functional independence.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The intervention includes group sessions (2 h per week for 8 weeks) focused on building efficacy for use of cognitive strategies and a home-based computer training program (45 min three times per week).&quot;</span> [1]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The facilitators audio-recorded their group sessions, and the second author listened to a sample of these tapes to determine that the intervention was being delivered as intended.&quot;</span> [1]

The full text describes the organization of the intervention, which includes group sessions and home-based computer training. The use of audio recordings to monitor the delivery of the intervention suggests a pragmatic approach to organization. Score: [4]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The intervention included eight weekly 2-h group sessions focused on building efficacy for use of cognitive compensatory strategies and lifestyle activities that support cognitive functioning (e.g., sleep and rest, exercise) paired with a home-based computer-assisted cognitive training program.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The facilitators audio-recorded their group sessions, and the second author listened to a sample of these tapes to determine that the intervention was being delivered as intended.&quot;</span> [1]

The full text provides information on the delivery of the intervention, which includes group sessions and home-based computer training. The use of audio recordings to monitor the delivery of the intervention suggests a pragmatic approach to flexibility in delivery. Score: [4]

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The researchers monitored exercise practice and completion.&quot;</span> [1]

The full text mentions that the researchers monitored exercise practice and completion. This suggests that there may have been some flexibility in adherence to the intervention. However, the full text does not provide enough information to fully assess this domain. Score: [NA]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The effects of the intervention on outcomes were assessed over an 8-month period, with measurements at baseline, immediately after the 8-week MAPPS intervention, and at 3 and 6 months post-intervention.&quot;</span> [1]

The full text provides information on the follow-up period, which includes measurements at multiple time points up to 6 months post-intervention. This suggests a pragmatic approach to follow-up. Score: [4]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The purpose of this study was to test the refined MAPSS-MS intervention in a larger multi-site trial with a six-month follow-up.&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary purpose of this study was to determine the effectiveness of a novel computer-assisted cognitive rehabilitation intervention MAPSS-MS (Memory, Attention, Problem Solving Skills in MS) in a multi-site trial with persons with MS.&quot;</span> [1]

The full text clearly states that the primary purpose of the study was to determine the effectiveness of the MAPSS-MS intervention. This suggests a pragmatic approach to the selection of the primary outcome. Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data analyses were conducted using SPSS, version 24.0 for Windows (SPSS Inc., Chicago, IL, USA).&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were entered and checked for accuracy.&quot;</span> [1]

The full text mentions the use of data analysis software and the checking of data accuracy. However, it does not provide enough information to fully assess the primary analysis domain. Score: [NA]</pre>
<p><a name='1568'></a></p>
</div>
<div
id="riemenschneider-m.-2022-investigating-the-potential-disease-modifying-and-neuroprotective-efficacy-of-exercise-therapy-early-in-the-disease-course-of-multiple-sclerosis-the-early-multiple-sclerosis-exercise-study-emses"
class="section level4">
<h4>1568.
<a href='https://doi.org/10.1177/13524585221079200' title='Open publication'>Riemenschneider
M. (2022): <i>Investigating the potential disease-modifying and
neuroprotective efficacy of exercise therapy early in the disease course
of multiple sclerosis: The Early Multiple Sclerosis Exercise Study
(EMSES)</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society. Inclusion criteria were (1) 18–60  years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.&quot;</span> [1]
Score: [4]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.&quot;</span> [1]
Score: [4]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The present study is a national multicentre single-blinded parallel group randomized controlled trial (RCT) comparing two groups receiving either supervised exercise therapy (intervention group) or health education (active control group).&quot;</span> [1]
Score: [3]

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles (adapted from Stathopoulos and Felson Duchan)13: (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.&quot;</span> [1]
Score: [4]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles (adapted from Stathopoulos and Felson Duchan)13: (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.&quot;</span> [1]
Score: [4]

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients in the supervised exercise group completed 90.0 (8.6)% of the planned sessions at an average intensity of 84.4 (3.0)% HRmax (for comparison, the planned average intensity was 76.2% HRmax).&quot;</span> [1]
Score: [5]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study period covers 48 weeks with outcome assessment at baseline (T0), after 24 weeks (T24), and after 48 weeks (T48).&quot;</span> [1]
Score: [5]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The relapse rate and the global brain atrophy rate were the primary outcomes of this study.&quot;</span> [1]
Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A Poisson regression controlling for a priori defined potential confounding variables (age, gender and time since diagnosis) and expressed as an incidence-rate-ratio was applied to compare the annual relapse rate between the RCT groups.&quot;</span> [1]
Score: [5]</pre>
<p><a name='1569'></a></p>
</div>
<div
id="straudi-s.-2022-combining-a-supervised-and-home-based-task-oriented-circuit-training-improves-walking-endurance-in-patients-with-multiple-sclerosis.-the-ms_toct-randomized-controlled-trial"
class="section level4">
<h4>1569.
<a href='https://doi.org/10.1016/j.msard.2022.103721' title='Open publication'>Straudi
S. (2022): <i>Combining a supervised and home-based task-oriented
circuit training improves walking endurance in patients with multiple
sclerosis. The MS_TOCT randomized-controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 99.6%)</i></p>
<pre>
Eligibility:
1. <span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):

36 PwMS with EDSS 4–5.5 and unassisted walking have been randomly assigned' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎36 PwMS with EDSS 4–5.5 and unassisted walking have been randomly assigned...&quot;</span> [1]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The inclusion criteria were: males and females; age 18 to 70; diagnosis of MS (primary or secondary progressive, relapsing-remitting), without relapses in the preceding three months and an Expanded Disability Status Scale (EDSS) score between 4 and 5.5.&quot;</span> [2]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The exclusion criteria were: other conditions that may affect motor function, impaired cognitive functioning that interferes with the acquisition of the consent to the study.&quot;</span> [2]

The full text provides clear information on the eligibility criteria for the trial. The participants were carefully selected based on specific criteria related to their MS diagnosis, disability level, and absence of other conditions that may affect motor function. The criteria are relevant to the target population and are not overly restrictive. Score: [4]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.&quot;</span> [2]

The full text mentions that patients were recruited from a specific outpatient clinic at a university hospital. However, it does not provide details on the recruitment process or any additional efforts made to engage with patients beyond their usual care setting. More information is needed to assess the recruitment domain. Score: [NA]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.&quot;</span> [2]

The trial was conducted at Ferrara University Hospital, specifically in the Rehabilitation Outpatient Clinic. This suggests that the setting of the trial is a specialized trial or academic center rather than a usual care setting. Score: [2]

Organization:
1. <span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):

The blind evaluator, who did not supervise the training program, performed functional tests, questionnaires and instrumental measurements' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The blind evaluator, who did not supervise the training program, performed functional tests, questionnaires and instrumental measurements...&quot;</span> [2]

The full text mentions that a blind evaluator performed assessments and measurements. However, it does not provide information on any additional resources, provider expertise, or organization of care delivery in the intervention arm compared to usual care. More information is needed to assess the organization domain. Score: [NA]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎TOCT includes six workstations with five levels of complexity (step, slalom, tandem exercise, goals, obstacles, long step).&quot;</span> [2]
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients recorded the frequency and duration of the training in a precompiled logbook.&quot;</span> [2]

The full text describes the task-oriented circuit training (TOCT) program, which includes different workstations with varying levels of complexity. It also mentions that patients recorded their training frequency and duration in a logbook. These details suggest that there is flexibility in how the intervention is delivered, allowing for individualization and adaptation based on the patients' abilities and progress. Score: [4]

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A mean adherence of 6.2 out of 10 was reported for the home-based TOCT program.&quot;</span> [2]

The full text reports the mean adherence to the home-based TOCT program, which suggests that there is some flexibility in how participants must adhere to the intervention. However, more information is needed to fully assess this domain, such as details on any exclusion based on adherence or measures to improve adherence. Score: [3]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The 12-weeks follow-up after TOCT was collected in the entire population (n = 36), confirming how the positive effects on the primary outcome measure, the 6MWT, were maintained after the end of treatment.&quot;</span> [2]

The full text mentions that a 12-week follow-up was conducted to assess the maintenance of the positive effects on the primary outcome measure. This suggests that the intensity of measurement and follow-up of participants in the trial is similar to what would be expected in usual care. Score: [5]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A superiority of task-oriented program was verified for 6MWT (F, 2,88 = 7.80; p<0.001) on usual care after the 12-weeks home-based program.&quot;</span> [2]

The full text provides evidence that the trial's primary outcome, the 6-minute walking test (6MWT), is relevant to the participants and shows a superiority of the task-oriented program compared to usual care. Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An intention-to-treat analysis was carried out on all outcome measures, handling missing data (n = 2 at T1, n = 7 at T2) with the last observation carried forward approach.&quot;</span> [2]

The full text mentions that an intention-to-treat analysis was conducted on all outcome measures, including handling missing data with the last observation carried forward approach. This suggests that all data, including data from ineligible post-randomization participants, were included in the analysis of the primary outcome. Score: [5]</pre>
<p><a name='1570'></a></p>
</div>
<div
id="mazdeh-m.-2010-the-therapeutic-effect-of-avonex-rebif-and-betaferon-on-edss-and-relapse-in-multiple-sclerosis-a-comparative-study"
class="section level4">
<h4>1570. <a href='https://doi.org/' title='Open publication'>Mazdeh M.
(2010): <i>The therapeutic effect of Avonex, Rebif and Betaferon on EDSS
and relapse in multiple sclerosis: a comparative study</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Exclusion criteria were as follows: 1) history of malignancy within the past five years 2) history of HIV infection, positive serology for hepatitis B and C 3) history of infectious disease within six weeks prior to the study and need for hospitalization from an infectious cause within two months prior to the study 4) any kind of hematological abnormality such as lymphocyte count ≤ 1 x 109/ L , platelet count ≤ 100 x 109/ L , neutrophil count ≤ 1.5 x 109/ L ,and hemoglobin level ≤ 8.5 g/dl 5)any kind of definite functional abnormality in body organs that disables the patient for treatment with β- interferons(criteria for functional abnormality in such cases included:creatinin ≥ 1.6 mg/dl , AST or ALT ≥ 2.5 x maximum normal values , alkaline phosphatase ≥2.5 x maximum normal values ,and history of heart failure, myocardial infarction or arrhythmia within six months prior to the study) 6)vaccination using live virus vaccines within four weeks prior to the study 7) use of antimetabolites or cytotoxic drugs within six months prior to the study 8) patients with PPMS 9)any kind of elective surgery during the study 10)rise in hepatic enzymes or severe drug reactions during the follow up period.&quot;</span> [Explanatory] The exclusion criteria are quite extensive and exclude patients with various medical conditions and recent medical events. This suggests a more explanatory approach with lots of exclusions. Score: [2]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 2005- 2006, who had the following criteria: Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI according to McDonald’s criteria, acceptance of the 24 month protocol by the patients, not being pregnant or lactating, history of having received a kind of β- interferon under the supervision of a neurologist in a period of no more than 30 days prior to the study.&quot;</span> [Explanatory] The study included all patients with MS who met the specified criteria and were referred to the hospital during a specific time period. This suggests a more explanatory approach with targeted recruitment from a specific population. Score: [2]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Ninety patients referring to Farshchian Hospital were entered in this study.&quot;</span> [Pragmatic] The trial was conducted at Farshchian Hospital, which suggests that the setting of the trial was similar to the usual care setting where patients would receive treatment. Score: [5]

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Treatment with all forms of β- interferons is accompanied with mild, moderate and severe side effects.&quot;</span> [Explanatory] The mention of side effects suggests that the trial may have required additional resources and monitoring to manage these side effects, indicating a more explanatory approach. Score: [2]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Each of these drugs have a significant effect in reducing the relapse rate, progression of disease and MRI findings though none of them has a positive effect on PPMS.&quot;</span> [Explanatory] The mention of a strict protocol and the lack of positive effect on a specific type of MS suggests a more explanatory approach with a strict protocol and limited flexibility in how the intervention is delivered. Score: [2]

Flexibility (adherence):
Score: [NA] This domain is not applicable as there is no mention of adherence issues in the full text.

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The patients in all three groups were evaluated at the end of months 6, 12, 18, 24 and in case of development of reactions were excluded from the study.&quot;</span> [Pragmatic] The mention of regular evaluations at specific time points suggests a pragmatic approach to follow-up. Score: [4]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We aimed to compare the therapeutic effect of Avonex (Av), Betaferon (Be) & Rebif (Re) on the Expanded Disability Status Scale (EDSS) in Multiple Sclerosis (MS).&quot;</span> [Pragmatic] The primary outcome of the trial is directly relevant to the participants as it measures the therapeutic effect on a scale specific to MS. Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Comparative study of the average First and Final EDSS, using the paired sample t.test, showed a significant statistical difference in all three groups.&quot;</span> [Pragmatic] The use of intention-to-treat analysis with all available data suggests a pragmatic approach to the primary analysis. Score: [5]</pre>
<p><a name='1769'></a></p>
</div>
<div
id="millar-j.h.-1967-long-term-treatment-of-multiple-sclerosis-with-corticotrophin"
class="section level4">
<h4>1769.
<a href='https://doi.org/10.1016/s0140-6736(67)90850-1' title='Open publication'>Millar
J.H. (1967): <i>Long-term treatment of multiple sclerosis with
corticotrophin</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<pre>
Eligibility:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎only patients who could walk with or without walking aids were admitted to the trial&quot;</span>
- Reasoning: The trial excluded patients who were unable to walk, which is not representative of the broader population of patients with multiple sclerosis. 
- Score: [2]

Recruitment:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients with multiple sclerosis were randomly selected into treated and control groups&quot;</span>
- Reasoning: The trial used random selection to assign patients to the treated and control groups, which is a pragmatic approach to recruitment.
- Score: [4]

Setting:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This controlled study was started in 1963 in three cities- Belfast, Leeds, and Manchester.&quot;</span>
- Reasoning: The trial was conducted in multiple cities, which increases the generalizability of the findings to different settings.
- Score: [4]

Organisation:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Both treated and control groups were given aneurin 100 mg. by injection monthly.&quot;</span>
- Reasoning: The trial did not mention any additional resources or changes in care delivery for the treated group, suggesting that the organization of care was similar to usual care.
- Score: [5]

Flexibility (delivery):
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The dose of corticotrophin was adjusted to produce just enough 'mooning' of the face to be appreciated by the physician in charge of the trial and the dose was not increased during a relapse.&quot;</span>
- Reasoning: The trial allowed for flexibility in adjusting the dose of corticotrophin based on individual patient response, which is similar to usual care.
- Score: [5]

Flexibility (adherence):
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients with diabetes mellitus or hypertension or who gave a history of psychiatric illness or peptic ulcer were not admitted to the treated group.&quot;</span>
- Reasoning: The trial excluded patients with certain comorbidities, which may not reflect the flexibility in adherence seen in usual care.
- Score: [2]

Follow-up:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All cases were seen at three-monthly intervals and scored on the Kurtzke (1961) scale; relapses lasting longer than twenty-four hours were also scored by a system in the three centres.&quot;</span>
- Reasoning: The trial had regular follow-up visits and assessments, which may be more intensive than usual care.
- Score: [3]

Primary outcome:
- Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

there was no evidence to show that corticotrophin prevented deterioration or reduced the number or severity of the relapses;' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎There is no evidence to show that corticotrophin prevented deterioration or reduced the number or severity of the relapses.&quot;</span>
- Reasoning: The trial's primary outcome was relevant to the participants as it assessed the impact of corticotrophin on disease progression and relapses.
- Score: [5]

Primary analysis:
- Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The total results were obtained by adding the results from the three cities; this was considered justifiable since the methods of selection, treatment, and scoring were essentially the same.&quot;</span>
- Reasoning: The trial used intention-to-treat analysis by including all available data from the three cities, which is a pragmatic approach.
- Score: [5]</pre>
<p><a name='1770'></a></p>
</div>
<div
id="hoogstraten-m.c.-1990-long-term-effect-of-acth-treatment-of-relapse-in-multiple-sclerosis"
class="section level4">
<h4>1770.
<a href='https://doi.org/10.1111/j.1600-0404.1990.tb01590.x' title='Open publication'>Hoogstraten
M.C. (1990): <i>Long-term effect of ACTH treatment of relapse in
multiple sclerosis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘not-applicable-without-score’, ‘score-prefix-missing-before-colon’,
‘multiple-scores-per-domain-if-incongruent-na’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 99.7%)</i></p>
<pre>
Eligibility:
- <span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):

Only patients with a clinical or laboraton- supported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse, were included.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Only patients with a clinical or laboratory-supported definite diagnosis of MS according to the Poser criteria, suffering from a relapse, were included.&quot;</span> [1]
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients with contraindications to bed rest or ACTH-treatment, such as hypersensitivity to ACTH, acute infections, cardial insufficiency, psychosis, pregnancy, Cushing syndrome or peptic ulcer, were excluded.&quot;</span> [1]

The eligibility criteria for this trial seem to be quite pragmatic, as they include patients with a definite diagnosis of MS and a relapse, while excluding those with contraindications to the treatment. However, it is unclear if there were any additional exclusions or selection tests not mentioned in the text. Therefore, the score for eligibility is: <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [4]</span>

Recruitment:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Only 29 patients entered the trial. The number of patients was much smaller than was hoped for when the study was envisaged. This was due to a changing attitude towards bed rest and the introduction of short term high dose methylprednisolone treatment, which rapidly has gained a wide acceptance among neurologists.&quot;</span> [2]

The text does not provide specific information about the recruitment methods used in this trial. However, it does mention that the number of patients enrolled was smaller than expected due to changes in treatment practices. This suggests that the recruitment may not have involved extra efforts beyond usual care. Therefore, the score for recruitment is: <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [4]</span>

Setting:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Three neurological departments in the Netherlands participated in this study.&quot;</span> [3]

The trial was conducted in three neurological departments in the Netherlands. While this suggests that the trial may have been conducted in specialized or academic centers, it is unclear if these settings are different from usual care settings for MS patients. Therefore, the score for setting is: <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [3]</span>

Organisation:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There were no statistically significant differences between both patient groups at the start of treatment.&quot;</span> [4]
- <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

Side effects, like a mild raise of bloodpressure. mild diabetes mellitus, Cushing face, mood alterations, urinary tract infection, were significantly more often seen in the ACTH group.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Side effects, like a mild raise of blood pressure, mild diabetes mellitus, Cushing face, mood alterations, urinary tract infection, were significantly more often seen in the ACTH group.&quot;</span> [5]

The text does not provide explicit information about the resources, provider expertise, or organization of care delivery in the intervention arm of the trial. However, it does mention that there were no significant differences between the patient groups at the start of treatment, suggesting that the organization of care may have been similar to usual care. Additionally, the mention of side effects in the ACTH group suggests that there may have been additional resources or expertise required for managing these side effects. Therefore, the score for organization is: <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [3]</span>

Flexibility (delivery):
- Not applicable. <span style='background-color: #ff9e81' title='Added response during extraction'>Score: [NA]</span> The text does not provide information about the flexibility in how the intervention was delivered.

Score: [NA]

Flexibility (adherence):
- Not applicable. <span style='background-color: #ff9e81' title='Added response during extraction'>Score: [NA]</span> The text does not provide information about the flexibility in how participants were required to adhere to the intervention.

Score: [NA]

Follow-up:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Follow-up was performed in the 6th and 12th week of treatment and 6, 9, and 12 months after the start of treatment.&quot;</span> [6]

The trial included follow-up assessments at multiple time points up to 12 months after the start of treatment. This suggests that the intensity of measurement and follow-up of participants in the trial may have been more extensive than usual care. Therefore, the score for follow-up is: <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [2]</span>

Primary outcome:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our results showed a greater improvement in some symptoms of relapse in MS patients after 6 or more weeks in the ACTH-treated patients. This difference did not outlast 6 months in any respect.&quot;</span> [7]

The primary outcome of the trial was the improvement in symptoms of relapse in MS patients. While the text does not explicitly mention the relevance of the primary outcome to participants, it suggests that the improvement in symptoms was not sustained beyond 6 months. This may indicate that the primary outcome was relevant to participants. Therefore, the score for primary outcome is: <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [4]</span>

Primary analysis:
- <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

MannWhitney U tests revealed a statistically significant greater improvementin the ACTH group in the brain stem and sensory FS, the ISS and in the Ambulation Index, but at 6 months none of these significant differences were still present.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Mann-Whitney U tests revealed a statistically significant greater improvement in the ACTH group in the brain stem and sensory FS, the ISS and in the Ambulation Index, but at 6 months none of these significant differences were still present.&quot;</span> [7]

The text does not provide explicit information about the analysis of the primary outcome. However, it mentions the use of Mann-Whitney U tests to compare the treatment groups. This suggests that the analysis may have included all available data. Therefore, the score for primary analysis is: <span style='background-color: #ff9e81' title='Added score prefix during extraction'>Score: [4]</span></pre>
<p><a name='1771'></a></p>
</div>
<div
id="langeskov-christensen-m.-2021-efficacy-of-high-intensity-aerobic-exercise-on-cognitive-performance-in-people-with-multiple-sclerosis-a-randomized-controlled-trial"
class="section level4">
<h4>1771.
<a href='https://doi.org/10.1177/1352458520973619' title='Open publication'>Langeskov-Christensen
M. (2021): <i>Efficacy of high-intensity aerobic exercise on cognitive
performance in people with multiple sclerosis: A randomized controlled
trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’,
‘multiple-scores-per-domain-if-incongruent-na’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">27 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited from Danish MS clinics&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For inclusion and exclusion criteria, see Langeskov-Christensen et al.24&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [NA]</span>
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on the Z-scores, 37 pwMS (43%) were classified as cognitively impaired&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eighty-six participants were recruited from Danish MS clinics&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants gave written informed consent&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study was approved by the ethical committee of the Central Denmark Region, Denmark&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited from Danish MS clinics&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The PAE group underwent supervised high-intensity PAE for 24 weeks&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The waitlist group continued their habitual lifestyle without commencing PAE&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Organization:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The PAE group underwent supervised high-intensity PAE for 24 weeks&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Exercise adherence was high with 44.8 ± 2.6 completed sessions&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The PAE intervention was well tolerated, with no serious adverse events&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Supervised PAE sessions were conducted twice weekly during the 24 weeks&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The session volume increased from 30 to 60 minutes during the intervention&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The intensity increased from 65% to 95% of individual maximum heart rate&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Flexibility (adherence):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Exercise adherence was high with 44.8 ± 2.6 completed sessions&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Twelve pwMS were unable to adhere with the prescribed intensity of 90%–95% of HRmax&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span>
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There were 13 dropouts after 24 weeks (RCT dropout = 15.1%)&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Results at T48 showed that after 24 weeks of self-guided physical exercise, the improvements in cardiorespiratory fitness following PAE disappeared&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>
2. <span title='Minor quote deviation. Best match in fulltext (Similarity 98.6%):

. Long-term retrieval (+5.3 (2.0–8.6); p < 0.01), consistent long-term retrieval (+5.6 (1.1–10.1); p = 0.01), and delayed recall (+0.6 (0.1–1.1); p = 0.02) in the SRT improved along with the verbal domain (+0.4 (0.1–0.6); p < 0.01) and total BRB-N (0.2 (0.0–0.4); p = 0.02) Z-scor' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Long-term retrieval, consistent long-term retrieval, and delayed recall in the SRT improved along with the verbal domain and total BRB-N Z-scores&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There were 9 additional dropouts from 24 to 48 weeks (total dropout = 25.6%)&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No between-group changes in the total group were observed in BRB-N scores following PAE&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span>
2. <span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

In the cognitively impaired subgroup (43% of the total group) the between-group point estimate suggested a potential clinical relevant improvement in the Symbol Digit Modalities Test' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎In the cognitively impaired subgroup, the between-group point estimate suggested a potential clinically relevant improvement in the Symbol Digit Modalities Test&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Cardiorespiratory fitness increased in the total group and the cognitively impaired subgroup&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All longitudinal data for the total group and the cognitively impaired subgroup were analyzed using an intention-to-treat linear mixed effects model&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Age, sex, education level, MDI score, and MS type were included in the model when analyzing cognitive performance outcomes&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Likelihood-ratio tests were used to test for equal/unequal standard deviations and correlations in the two groups for each outcome&quot;</span> - <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span></pre>
<p><a name='1772'></a></p>
</div>
<div
id="calkwood-j.-2014-impact-of-a-switch-to-fingolimod-versus-staying-on-glatiramer-acetate-or-beta-interferons-on-patient--and-physician-reported-outcomes-in-relapsing-multiple-sclerosis-post-hoc-analyses-of-the-epoc-trial"
class="section level4">
<h4>1772.
<a href='https://doi.org/10.1186/s12883-014-0220-1' title='Open publication'>Calkwood
J. (2014): <i>Impact of a switch to fingolimod versus staying on
glatiramer acetate or beta interferons on patient- and
physician-reported outcomes in relapsing multiple sclerosis: post hoc
analyses of the EPOC trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i>Minor score formatting issues fixed during extraction:
‘squared-brackets-around-score’</i></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Men and women aged 18–65 years with relapsing forms of MS, as defined by the 2005 revised McDonald criteria [14], and an Expanded Disability Status Scale (EDSS) score of 0–5.5 were eligible to participate in the study.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were required to have received a single iDMT (except natalizumab) continuously for at least 6 months prior to study initiation and to be candidates for therapy change.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎EPOC was a 6-month, randomized, open-label, multicenter, phase 4 study conducted in the USA and Canada.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [3]</span>

Organization:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients randomized to the iDMT group either remained on the same therapy or, following consultation with a physician, were switched immediately to another approved iDMT.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were required to have received a single iDMT (except natalizumab) continuously for at least 6 months prior to study initiation and to be candidates for therapy change.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Flexibility (adherence):
1. Not applicable as there is no compliance issue after consent has been given. <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [NA]</span>

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎EPOC was a 6-month, randomized, open-label, multicenter, phase 4 study conducted in the USA and Canada.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span>

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary endpoint was the change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score.&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [5]</span>

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Post hoc analyses were conducted using SAS software v9.2 (SAS, Cary, NC, USA).&quot;</span> <span style='background-color: #ffe9e2' title='Moved squared brackets during extraction'>Score: [4]</span></pre>
<p><a name='1773'></a></p>
</div>
<div
id="medina-perez-c.-2014-effects-of-a-resistance-training-program-and-subsequent-detraining-on-muscle-strength-and-muscle-power-in-multiple-sclerosis-patients"
class="section level4">
<h4>1773.
<a href='https://doi.org/10.3233/NRE-141062' title='Open publication'>Medina-Perez
C. (2014): <i>Effects of a resistance training program and subsequent
detraining on muscle strength and muscle power in multiple sclerosis
patients</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">15 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The patient inclusion criteria included a confirmed disease diagnosis by a neurologist, according to Mc-Donald criteria (McDonald, 2001); ability to walk (with or without aid) at least 20 m without rest; absence of other diseases that might have affected muscle function.&quot;</span> 
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were randomly assigned to two different groups, the exercise group (EG) or the control group (CG).&quot;</span>

The eligibility criteria for this trial are clearly described in the full text. Participants were required to have a confirmed diagnosis of multiple sclerosis, be able to walk at least 20 meters without rest, and not have any other diseases that might affect muscle function. The random assignment of participants to the exercise group and control group also suggests that the trial aimed to include a representative sample of MS patients. Score: [4]

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All participants were recruited among six MS rehabilitation centers within the region of Castilla y León (Spain).&quot;</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.&quot;</span>

The recruitment process for this trial involved recruiting participants from multiple MS rehabilitation centers. The full text does not provide information on any additional efforts made to recruit participants beyond the usual care setting. However, it does mention that a group meeting was held to provide information about the study and invite patients to participate. Based on this information, it can be inferred that some effort was made to engage with patients and recruit them for the trial. Score: [3]

Setting:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.&quot;</span>

The setting of the trial was in MS rehabilitation centers, which suggests that it closely resembled the usual care setting for MS patients. The fact that the training sessions took place in these centers and that patients were supervised by physical therapists further supports the pragmatic nature of the trial setting. Score: [5]

Organisation:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The EG, which included 16 women and 14 men (49.6 ± 11.0 yr), performed 12 weeks of resistance training followed by a detraining period where resistance exercise or other structured physical activity was avoided.&quot;</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A 12-week resistance training program similar to the one described in this study was offered to CG after completion of the intervention.&quot;</span>

The organization of care delivery in the intervention arm of the trial involved a 12-week resistance training program followed by a detraining period. The control group also received a similar resistance training program after the intervention period. This suggests that the trial closely mirrored the usual care in terms of the organization of care delivery. Score: [5]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Subjects performed coupled concentric-eccentric bilateral seated knee extension training using a weight stack machine (BH® Fitness Nevada Pro-T, Spain) twice per week during 12 weeks, with at least 48 h of rest between sessions.&quot;</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎After a standardized cycling warm-up, and one set of 5 repetitions (reps) with a light load, participants performed 3 sets of 8–12 reps with a load that was progressively increased from 35 to 70% of MVIC through the training period.&quot;</span>

The delivery of the intervention involved a specific protocol for resistance training using a weight stack machine. The protocol included a standardized warm-up and a progressive increase in the load used for the exercises. The full text does not provide information on the flexibility allowed in the delivery of the intervention, such as the use of different exercise modalities or modifications based on individual patient needs. Score: [3]

Flexibility (adherence):
Not applicable. The full text does not mention any issues related to adherence to the intervention. Score: [NA]

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Testing was performed on three different occasions: before (week 0) and after (week 12) the training program, and after the detraining period (week 24).&quot;</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All subjects taking part in the study (n = 42) completed all the scheduled testing protocols.&quot;</span>

The follow-up in this trial involved assessments at three different time points: before the training program, after the training program, and after the detraining period. The full text does not provide information on the intensity or frequency of the measurements and follow-up beyond these time points. However, it does mention that all participants completed all the scheduled testing protocols, indicating a high level of follow-up. Score: [4]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The resistance training protocol improved maximal strength and muscle power, but not muscle endurance.&quot;</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The EG improved MVIC (P = 0.004), torque (P = 0.004) and average power (P < 0.001) after the resistance training period.&quot;</span>

The primary outcome of this trial was the effect of the resistance training program on maximal strength, muscle power, and muscle endurance. The full text provides clear information on the primary outcome and the results of the intervention on these outcomes. Score: [5]

Primary analysis:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were analyzed using SPSS® 17.0 (SPSS Inc., USA). Results are presented as mean ± standard deviation (SD). Shapiro-Wilk normality test was used to assess normal data distribution.&quot;</span>
2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To assess any training or detraining effect, as well as any difference between groups, MVIC, torque, average power and muscle endurance raw values were examined using two-way ANOVA with repeated measurements for group and time.&quot;</span>

The primary analysis of the trial involved the use of statistical tests to examine the effects of the training and detraining periods on the outcome measures. The full text provides information on the statistical methods used and the presentation of results. Score: [5]</pre>
</div>
</div>
<div id="quote-accuracy" class="section level3">
<h3>Quote accuracy</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<ul>
<li>637 quotes for 53 / 53 (100%) publications, median 10 (IQR 9-14,
range 8-27)</li>
<li>606 / 637 (95.1%) perfect <span
style="border-bottom: 1px dashed black;">quotes from the publication
full text</span></li>
<li>0 / 637 (0%) perfect <span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">quotes from
the LLM prompt briefing</span> - were instructions quoted (ok) or
examples (unwanted beahviour)?</li>
<li>31 / 637 (4.9%) quotes with deviations from source, where the
accuracy was measured by a <a
href="https://maxbachmann.github.io/RapidFuzz/Usage/distance/Levenshtein.html#normalized-similarity">“normalized
Levenshtein similarity”</a> <span
style="border-bottom: 1px dashed black;"
title="Weights for insertion: 1, deletion: 0.5, substitution: 1.5. Penalizes &quot;positive hallucinations&quot; (insertions) more than omissions of e.g. brackets and references (deletions).">with
custom weights</span>, ranging from 0-100%
<ul>
<li><span style="background-color: #ffe9e2">21 minor</span> deviations
(95% ≤ similarity &lt; 100%); mean: 98.5%</li>
<li><span style="background-color: #ff9e81">8 moderate</span> deviations
(75% ≤ similarity &lt; 95%); mean: 90.7%</li>
<li><span style="background-color: red">2 major</span> deviations
(similarity &lt; 75%); mean: 67.3%</li>
</ul></li>
</ul>
<div class="datatables html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-696a2e57c8036e56fb47" style="width:100%;height:auto;"></div>
<script type="application/json" data-for="htmlwidget-696a2e57c8036e56fb47">{"x":{"filter":"none","vertical":false,"fillContainer":false,"data":[["Humphreys I. (2013)","Straudi S. (2022)","Straudi S. (2022)","Millar J.H. (1967)","Hoogstraten M.C. (1990)","Hoogstraten M.C. (1990)","Hoogstraten M.C. (1990)","Langeskov-Christensen M. (2021)","Langeskov-Christensen M. (2021)","Carter A. (2014)","Cutter G. (2019)","Dodd K. J. (2011)","Feys P. (2019)","Feys P. (2019)","Feys P. (2019)","Feys P. (2019)","Feys P. (2019)","Feys P. (2019)","Finch P. (2014)","Freeman J. (2019)","Hermens H. (2008)","Jongen P. J. (2019)","Jongen P. J. (2019)","Pozzilli C. (2002)","Torkhani E. (2021)","Torkhani E. (2021)","Velikonja O. (2010)","Jonsdottir, H. (2015)","Jonsdottir, H. (2015)","Pinnock, H. (2003)","Rangan, A. (2015)"],["fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext"],["<span title='Moderate quote deviation. Best match in fulltext (Similarity 91.3%):\n\nse allocated to intervention were invited to attend a psychological adjustment group for six sessions over 12 weeks.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Participants allocated to intervention were invited to attend a psychological adjustment group for six sessions over 12 weeks.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):\n\n36 PwMS with EDSS 4–5.5 and unassisted walking have been randomly assigned' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎36 PwMS with EDSS 4–5.5 and unassisted walking have been randomly assigned...&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):\n\nThe blind evaluator, who did not supervise the training program, performed functional tests, questionnaires and instrumental measurements' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The blind evaluator, who did not supervise the training program, performed functional tests, questionnaires and instrumental measurements...&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nthere was no evidence to show that corticotrophin prevented deterioration or reduced the number or severity of the relapses;' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎There is no evidence to show that corticotrophin prevented deterioration or reduced the number or severity of the relapses.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):\n\nOnly patients with a clinical or laboraton- supported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse, were included.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Only patients with a clinical or laboratory-supported definite diagnosis of MS according to the Poser criteria, suffering from a relapse, were included.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nSide effects, like a mild raise of bloodpressure. mild diabetes mellitus, Cushing face, mood alterations, urinary tract infection, were significantly more often seen in the ACTH group.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Side effects, like a mild raise of blood pressure, mild diabetes mellitus, Cushing face, mood alterations, urinary tract infection, were significantly more often seen in the ACTH group.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nMannWhitney U tests revealed a statistically significant greater improvementin the ACTH group in the brain stem and sensory FS, the ISS and in the Ambulation Index, but at 6 months none of these significant differences were still present.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Mann-Whitney U tests revealed a statistically significant greater improvement in the ACTH group in the brain stem and sensory FS, the ISS and in the Ambulation Index, but at 6 months none of these significant differences were still present.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.6%):\n\n. Long-term retrieval (+5.3 (2.0–8.6); p < 0.01), consistent long-term retrieval (+5.6 (1.1–10.1); p = 0.01), and delayed recall (+0.6 (0.1–1.1); p = 0.02) in the SRT improved along with the verbal domain (+0.4 (0.1–0.6); p < 0.01) and total BRB-N (0.2 (0.0–0.4); p = 0.02) Z-scor' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Long-term retrieval, consistent long-term retrieval, and delayed recall in the SRT improved along with the verbal domain and total BRB-N Z-scores&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nIn the cognitively impaired subgroup (43% of the total group) the between-group point estimate suggested a potential clinical relevant improvement in the Symbol Digit Modalities Test' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎In the cognitively impaired subgroup, the between-group point estimate suggested a potential clinically relevant improvement in the Symbol Digit Modalities Test&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):\n\nant. The exercise group experienced improvements in multidimensional fatigue and in most HRQoL dimensions at three months. These improvements are consistent with previous systematic reviews,24,25 although some conflicting evidence also ex' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The exercise group experienced improvements in multidimensional fatigue and in most HRQoL dimensions at three months. These improvements are consistent with previous systematic reviews, although some conflicting evidence also exists.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.6%):\n\nCONFIDENCE was a Phase 4, interventional, open-label, randomized, 2-arm, parallel-group, global study with a duration of 6 months.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The CONFIDENCE study was a Phase 4, interventional, open-label, randomized, 2-arm, parallel-group, global study with a duration of 6 months.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 60.3%):\n\nTo determine whether the PRT group improved more than the control group immediately after the 10-week program,' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Analysis of covariance using the baseline measures as covariates was used to determine whether the PRT group improved more than the control group immediately after the 10-week program.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.6%):\n\nthe sessions included elements of education, individual knowledge acquisition also related to observing others, and communication within the context of shared experiences and social interactions.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The training sessions included elements of education, individual knowledge acquisition also related to observing others, and communication within the context of shared experiences and social interactions.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.1%):\n\npervision. pwMS received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Participants received training instructions by email and were asked to train three times weekly according to a personalized training intensity schedule.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nparticipants were able to run 5 km without interruption at 12 weeks. pwMS wore an activity tracker (Withings Pulse Ox) at the waist that registered the intensity of steps per minute. Participants were asked to weekly upload data to allow remote supervision of the training adherence' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Participants wore an activity tracker that registered the intensity of steps per minute and were asked to weekly upload data to allow remote supervision of the training adherence.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.3%):\n\ntwo group training sessions were organized (weeks 4 and 8) at a 400-m outdoor running track at KULeuven. Participants performed their individual training session simultaneously, while being observed by the project dedicated researcher (MSc exercise physiology and PhD) and master students (rehabilitation sciences and physiotherapy). This allowed to monitor individual progress and discuss potential risk for injuries.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Two group training sessions were organized at an outdoor running track, allowing for monitoring of individual progress and discussion of potential risk for injuries.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 88.9%):\n\nwere asked to train three times weekly according to a personalized training intensity schedule' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Participants were asked to train three times weekly according to a personalized training intensity schedule.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 91.8%):\n\nPatients were tested at two time points (0 and 12 weeks).' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Participants were tested at two time points (0 and 12 weeks).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.6%):\n\ntreatment plans were approved by the clinical teacher in charge.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The treatment plans were approved by the clinical teacher in charge.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 81.2%):\n\nundertaken in eight centres from two regions in the UK.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The study was undertaken in eight centres from two regions in the UK.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):\n\nThe outcome measures used in the present study are in line with the international classification of functioning, disability, and health (ICF) model. The outcome measures on functioning level were: the Action Research Arm Test (ARA), Wolf Motor Function Test (WMFT), the Barthel Index (BI) and the Abilhand questionnaire. The disability outcome measure was: the Nine Hole Peg Test (NHPT) and the health outcome measure was the MOS 36-item short-form health survey (SF-36).' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The main outcome measures used in the present study are in line with the international classification of functioning, disability, and health (ICF) model. The outcome measures on functioning level were: the Action Research Arm Test (ARA), Wolf Motor Function Test (WMFT), the Barthel Index (BI) and the Abilhand questionnaire. The disability outcome measure was: the Nine Hole Peg Test (NHPT) and the health outcome measure was the MOS 36-item short-form health survey (SF-36).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nin a 6-month, single-centre, randomized (1:1), unmasked, controlled trial in RRMS patients with Expanded Disability Status Scale (EDSS) score ≤4.0,' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎In a 6-month, single-centre, randomized (1:1), unmasked, controlled trial in RRMS patients with Expanded Disability Status Scale (EDSS) score ≤4.0...&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 74.3%):\n\npatients who chose to receive CDT after study completion. The enrolment started February 2013 and ended April 2016.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎A total of 158 patients were screened for eligibility...The enrolment started February 2013 and ended April 2016.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 91.6%):\n\nwere randomised in a ratio 2:1 to an intervention group (133) or a control group (68).' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Patients were randomised in a ratio 2:1 to an intervention group (133) or a control group (68).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nThe primary outcomes, fatigue, mobility and quality of life, were examined at baseline prior to randomization, and then 8-weeks after the intervention' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The primary outcomes, fatigue, mobility, and quality of life, were examined at baseline prior to randomization, and then 8-weeks after the intervention.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nThe primary outcomes, fatigue, mobility and quality of life, were examined at baseline prior to randomization, and then 8-weeks after the intervention' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The primary outcomes, fatigue, mobility, and quality of life, were examined at baseline prior to randomization, and then 8-weeks after the intervention.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\npatients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective study.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎20 patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective study.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nThe theoretical framework, Partnership with people with COPD and their families (Ingadottir & Jonsdottir 2010, Jonsdottir & Ingadottir 2011a,b), was the basis for this intervention. It was adjusted to the particular needs of young people with COPD in its early stages' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The theoretical framework, Partnership with people with COPD and their families, was the basis for this intervention. It was adjusted to the particular needs of young people with COPD in its early stages.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nThe 6-month partnership-based self-management programme had benefits on the perception of the intrusiveness of chronic obstructive pulmonary disease and its treatment as regards lifestyles, activities and interests for young patients with the disease in its early stages.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The 6-month partnership-based self-management programme had benefits on the perception of the intrusiveness of chronic obstructive pulmonary disease and its treatment on lifestyles, activities and interests for young patients with the disease in its early stages.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):\n\nPatients randomised to the telephone review group were sent a letter from their practice informing them that they had been allocated to receive a telephone review and that they should expect a call from the asthma nurse within a month.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Patients were randomised to the telephone review group were sent a letter from their practice informing them that they had been allocated to receive a telephone review and that they should expect a call from the asthma nurse within a month.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.5%):\n\nPrimary outcome was the Oxford Shoulder Score (range, 0-48; higher scores indicate better outcomes) assessed during a 2-year period, with assessment and data collection at 6, 12, and 24 months.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The primary outcome was the Oxford Shoulder Score (range, 0-48; higher scores indicate better outcomes) assessed during a 2-year period, with assessment and data collection at 6, 12, and 24 months.&quot;<\/span>"],[91.2698412698413,97.4025974025974,97.8571428571428,99.1869918699187,98.6842105263158,99.4594594594595,99.1666666666667,98.6206896551724,98.75,97.8540772532189,93.5714285714286,60.3260869565217,95.5882352941177,94.0789473684211,99.4413407821229,93.3333333333333,88.8888888888889,91.8032786885246,95.5882352941177,81.1594202898551,98.9495798319328,99.3288590604027,74.3362831858407,91.5789473684211,99.3421052631579,99.3421052631579,99.1525423728814,99.5098039215686,99.2395437262358,97.9166666666667,98.4771573604061]],"container":"<table class=\"display\">\n  <thead>\n    <tr>\n      <th>Author & Year<\/th>\n      <th>Source<\/th>\n      <th>Quote with deviation<\/th>\n      <th>Similarity<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"bPaginate":false,"dom":"ft","order":[[3,"desc"]],"columnDefs":[{"targets":3,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 1, 3, \",\", \".\", null);\n  }"},{"visible":false,"targets":1},{"className":"dt-right","targets":3}],"autoWidth":false,"orderClasses":false}},"evals":["options.columnDefs.0.render"],"jsHooks":[]}</script>
</div>
<div id="formatting-accuracy" class="section level3">
<h3>Formatting accuracy</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<ul>
<li>31 / 53 (58.5%) usable responses with correctly formatted
scores</li>
<li>22 / 53 (41.5%) usable responses with minor fixable score formatting
issues
<ul>
<li>18 with ‘squared-brackets-around-score’</li>
<li>11 with ‘multiple-scores-per-domain-if-incongruent-na’</li>
<li>2 with ‘missing-score-na-with-slash’</li>
<li>2 with ‘score-prefix-missing-before-na’</li>
<li>1 with ‘not-applicable-without-score’</li>
<li>1 with ‘score-prefix-missing-before-colon’</li>
<li>1 with ‘score-prefix-missing-before-number’ <br><br></li>
</ul></li>
<li>49 / 56 (87.5%) publications yielded usable responses in the first
try</li>
<li>4 / 56 (7.1%) publications yielded usable responses after a median
of 1.5 retries (IQR 1-2, range 1-2), thus being ultimately successful
<ul>
<li>5 responses with failure reason ‘early-stop’</li>
<li>1 responses with failure reason ‘exceeded-max-tokens-2000’</li>
</ul></li>
<li>3 / 56 (5.4%) publications yielded no usable responses and were thus
ultimately unsuccessful. <a
href="https://doi.org/10.1177/1352458515576261">Bogosian A. (2015)</a>,
<a href="https://doi.org/10.1177/0269215520923089">Mayo N. E.
(2020)</a>, <a
href="https://doi.org/10.1136/jnnp-2015-312221">Weinstock-Guttman B.
(2016)</a>
<ul>
<li>14 responses with failure reason ‘early-stop’</li>
</ul></li>
</ul>
<div class="datatables html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-51fa8d625b1f63d18c0b" style="width:100%;height:auto;"></div>
<script type="application/json" data-for="htmlwidget-51fa8d625b1f63d18c0b">{"x":{"filter":"none","vertical":false,"fillContainer":false,"data":[["1","2","3","4","5","6","7","8","9","10","11","12","13","14","15","16","17","18","19","20"],["Bogosian A. (2015)","Bogosian A. (2015)","Bogosian A. (2015)","Feys P. (2019)","Giovannoni G. (2016)","Grossman P. (2010)","Grossman P. (2010)","Mayo N. E. (2020)","Mayo N. E. (2020)","Mayo N. E. (2020)","Weinstock-Guttman B. (2016)","Weinstock-Guttman B. (2016)","Weinstock-Guttman B. (2016)","Weinstock-Guttman B. (2016)","Weinstock-Guttman B. (2016)","Weinstock-Guttman B. (2016)","Weinstock-Guttman B. (2016)","Weinstock-Guttman B. (2016)","Petrella, R. J.  (2017)","Petrella, R. J.  (2017)"],["early-stop","early-stop","early-stop","early-stop","exceeded-max-tokens-2000","early-stop","early-stop","early-stop","early-stop","early-stop","early-stop","early-stop","early-stop","early-stop","early-stop","early-stop","early-stop","early-stop","early-stop","early-stop"],[false,false,false,true,true,true,true,false,false,false,false,false,false,false,false,false,false,false,true,true],["Eligibility:\n- 'Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).' [1]\n- 'Exclusion criteria were severe cognitive impairment, as determined by a score of 20 or smaller on the Telephone Interview for Cognitive Status-Modified (TICS-M) and high suicide risk, as assessed by a score of 20 or greater on the Clinical Outcome of Routine Evaluation (CORE-10).' [1]\n- 'Finally, people were excluded if they reported any serious psychological disorders (e.g. psychosis, substance abuse), severe hearing impairment, attending other psychological therapies or prior formal training in mindfulness.' [1]\n\nThe full text provides clear information on the eligibility criteria for the trial. Participants were required to have a diagnosis of PPMS or SPMS, Internet access, and some level of distress. Exclusion criteria were also clearly defined, including severe cognitive impairment, high suicide risk, serious psychological disorders, severe hearing impairment, attending other psychological therapies, or prior formal training in mindfulness. Based on this information, the trial appears to have a more explanatory approach with some exclusions based on specific criteria. \n\nScore: [3]","Eligibility:\n1. 'Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).' [Quote 1]\n2. 'Exclusion criteria were severe cognitive impairment, as determined by a score of 20 or smaller on the Telephone Interview for Cognitive Status-Modified (TICS-M) and high suicide risk, as assessed by a score of 20 or greater on the Clinical Outcome of Routine Evaluation (CORE-10).' [Quote 2]\n3. 'Finally, people were excluded if they reported any serious psychological disorders (e.g. psychosis, substance abuse), severe hearing impairment, attending other psychological therapies or prior formal training in mindfulness.' [Quote 2]\n\nThe eligibility criteria for this trial appear to be relatively pragmatic. Participants were required to have a diagnosis of PPMS or SPMS, which is relevant to the target population. The inclusion of Internet access as a criterion may limit the generalizability of the trial to individuals who do not have access to the internet. The exclusion criteria are also pragmatic, focusing on factors that may impact the ability to participate in the intervention. Overall, the trial seems to have a balance between explanatory and pragmatic elements.\n\nScore: [4]","Eligibility:\n1. 'Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).' [Quote 1]\n2. 'Exclusion criteria were severe cognitive impairment, as determined by a score of 20 or smaller on the Telephone Interview for Cognitive Status-Modified (TICS-M) and high suicide risk, as assessed by a score of 20 or greater on the Clinical Outcome of Routine Evaluation (CORE-10).' [Quote 2]\n3. 'Finally, people were excluded if they reported any serious psychological disorders (e.g. psychosis, substance abuse), severe hearing impairment, attending other psychological therapies or prior formal training in mindfulness.' [Quote 2]\n\nThe full text provides clear information on the eligibility criteria for the trial. Participants were required to have a diagnosis of PPMS or SPMS, Internet access, and some level of distress. Exclusion criteria were also clearly defined, including severe cognitive impairment, high suicide risk, serious psychological disorders, severe hearing impairment, attending other psychological therapies, or prior formal training in mindfulness. Based on this information, the trial appears to have a pragmatic approach to eligibility criteria. \n\nScore: [4]","Eligibility:\n1. 'Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.' [1]\n2. 'Exclusion criteria were reports to have run 5 km in the preceding 6 months or a relapse occurring in the preceding 3 months.' [1]\n3. 'Recruited participants showed only mild walking impairment and likely had high exercise self-efficacy levels as they were willing to engage in an individual community-located running training.' [1]\n\nThe eligibility criteria for this trial were quite pragmatic, as they included adults with MS who were able to walk 5 km without rest or use of an assistive device. However, the exclusion criteria were more explanatory, as they excluded individuals who had recently run 5 km or experienced a relapse. Additionally, the participants recruited for the trial had mild walking impairment and high exercise self-efficacy levels, which may limit the generalizability of the results to a broader population of individuals with MS. \n\nScore: [3]","Eligibility:\n1. 'Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis (CARE-MS) II, a 2-year randomized, rater-blinded, active-controlled, head-to-head, phase 3 trial, compared efficacy and safety of alemtuzumab 12 mg with subcutaneous interferon-β-1a (SC IFN-β-1a) 44 μg in patients with RRMS.' [1]\n2. 'Methods have been published elsewhere.12 CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).' [2]\n3. 'In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.' [3]\n\nThe full text provides information on the eligibility criteria of the trial, including the specific patient population (patients with RRMS with inadequate response to prior DMTs) and the randomization of patients to the intervention and control groups. The eligibility criteria are not overly restrictive, as the trial includes a relatively large number of patients. Score: [4]\n\nRecruitment:\n1. 'Methods have been published elsewhere.12 CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).' [2]\n2. 'In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.' [3]\n\nThe full text does not provide specific information on the recruitment methods used in the trial. However, it is mentioned that the trial was randomized and included a relatively large number of patients, suggesting that recruitment efforts were likely made to engage with patients. Score: [3]\n\nSetting:\n1. 'Methods have been published elsewhere.12 CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).' [2]\n2. 'In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.' [3]\n\nThe full text does not provide specific information on the setting of the trial. However, it is mentioned that the trial was a head-to-head comparison of two different treatments, suggesting that the trial may have been conducted in multiple settings. Score: [3]\n\nOrganisation:\n1. 'Methods have been published elsewhere.12 CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).' [2]\n2. 'In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.' [3]\n\nThe full text does not provide specific information on the resources, provider expertise, and organization of care delivery in the intervention arm of the trial. However, it is mentioned that the trial compared two different treatments, suggesting that there may have been differences in the resources and organization of care delivery between the two arms. Score: [3]\n\nFlexibility (delivery):\n1. 'Methods have been published elsewhere.12 CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).' [2]\n2. 'In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.' [3]\n\nThe full text does not provide specific information on the flexibility in how the intervention is delivered. However, it is mentioned that the trial compared two different treatments, suggesting that there may have been differences in the flexibility of delivery between the two arms. Score: [3]\n\nFlexibility (adherence):\n1. 'Methods have been published elsewhere.12 CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).' [2]\n2. 'In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.' [3]\n\nThe full text does not provide specific information on the flexibility in how participants must adhere to the intervention. However, it is mentioned that the trial compared two different treatments, suggesting that there may have been differences in the flexibility of adherence between the two arms. Score: [3]\n\nFollow-up:\n1. 'Methods have been published elsewhere.12 CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).' [2]\n2. 'In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.' [3]\n\nThe full text does not provide specific information on the intensity of measurement and follow-up of participants in the trial. However, it is mentioned that the trial was a 2-year trial, suggesting that there may have been regular follow-up visits and measurements. Score: [3]\n\nPrimary outcome:\n1. 'Alemtuzumab-treated patients were more likely than SC IFN-β-1a","Eligibility:\n- 'A total of 164 patients with MS referred themselves after having received information via the outpatient neurology clinic of the University Hospital Basel, other physicians, or advertisements posted in the Swiss Multiple Sclerosis Society Bulletin.' [1]\n- 'Neurologists verified all patients for the following inclusion criteria: 1) diagnosis of relapsing-remitting (but no more than 2 exacerbations within the last year) or secondary progressive MS21 and 2) an Expanded Disability Status Scale (EDSS)22 score of ≤6 (no to moderately severe disability), with ≤1 step increase within the last year.' [1]\n- 'Excluded were patients with reported or medically recorded diagnoses of current serious psychological disorders other than depression and anxiety syndromes, evidence of dementia as indicated by testing below the fifth percentile in at least 3 of 6 dimensions of neuropsychological functioning (i.e., attention and concentration, processing speed, executive function, verbal memory, and verbal processing), other currently life-threatening or severely disabling physical disorders, current MS exacerbation, symptomatic MS medication altered in the last 3 months, other disorders of the CNS, pregnancy, or inability to speak or read German.' [1]\n\nThe eligibility criteria for this trial appear to be relatively pragmatic. Patients were recruited from multiple sources, including outpatient clinics, physicians, and advertisements, which suggests a broad range of participants were included. The inclusion criteria focused on specific MS diagnoses and disability levels, but did not exclude patients based on comorbidities or other factors that may limit generalizability. The exclusion criteria were also relatively straightforward and did not include excessive exclusions that would limit the applicability of the trial results. Overall, the trial seems to have a pragmatic approach to eligibility.\n\nScore: [4]","Eligibility:\n- 'A total of 164 patients with MS referred themselves after having received information via the outpatient neurology clinic of the University Hospital Basel, other physicians, or advertisements posted in the Swiss Multiple Sclerosis Society Bulletin.' [1]\n- 'Neurologists verified all patients for the following inclusion criteria: 1) diagnosis of relapsing-remitting (but no more than 2 exacerbations within the last year) or secondary progressive MS21 and 2) an Expanded Disability Status Scale (EDSS)22 score of ≤6 (no to moderately severe disability), with ≤1 step increase within the last year.' [1]\n- 'Excluded were patients with reported or medically recorded diagnoses of current serious psychological disorders other than depression and anxiety syndromes, evidence of dementia as indicated by testing below the fifth percentile in at least 3 of 6 dimensions of neuropsychological functioning (i.e., attention and concentration, processing speed, executive function, verbal memory, and verbal processing), other currently life-threatening or severely disabling physical disorders, current MS exacerbation, symptomatic MS medication altered in the last 3 months, other disorders of the CNS, pregnancy, or inability to speak or read German.' [1]\n\nThe eligibility criteria for this trial appear to be relatively pragmatic. Patients were recruited from multiple sources, including outpatient clinics, physicians, and advertisements, which suggests a broad range of participants were included. The inclusion criteria focused on specific MS diagnoses and disability levels, but did not exclude patients based on comorbidities or other factors that may limit generalizability. The exclusion criteria were also relatively straightforward and did not include excessive exclusions. Overall, the trial seems to have a pragmatic approach to participant eligibility.\n\nScore: [4]","Eligibility:\n- 'The target population was community dwelling individuals aged 19 to 65 who have been diagnosed after 1994 with multiple sclerosis.' [1]\n- 'Specific inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ⩽5.5 on the Expanded Disability Status Scale (EDSS),10 even if they do use an aid for daily activities; and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity).' [1]\n\nThe eligibility criteria for this trial appear to be relatively pragmatic. The trial includes individuals with multiple sclerosis who are representative of the target population in terms of age and diagnosis. The inclusion criteria also consider the ambulatory status and activity level of the participants, which are relevant factors for determining eligibility in usual care. The criteria do not seem to have excessive exclusions or selection tests that are not used in usual care. \n\nScore: [4]","Eligibility:\n1. 'Specific inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ⩽5.5 on the Expanded Disability Status Scale (EDSS),10 even if they do use an aid for daily activities; and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity).' [1]\n2. 'Excluded were people who were (1) unable to speak and read English or French; (2) unable to respond to simple questions on orientation and memory; (3) have an additional illness that restricts their function; and/or (4) experienced a relapse during the past 30 days as this may affect physical activity/exercise participation.' [1]\n\nThe eligibility criteria for this trial appear to be relatively pragmatic. Participants were required to be ambulatory and self-reported as sedentary or irregularly active, which is likely representative of the population that would receive this intervention in usual care. There were some exclusions based on language ability, cognitive function, additional illnesses, and recent relapse, but these exclusions seem reasonable and not overly restrictive. Overall, the trial seems to have a pragmatic approach to eligibility.\n\nScore: [4]","Eligibility:\n- 'The target population was community dwelling individuals aged 19 to 65 who have been diagnosed after 1994 with multiple sclerosis.' [1]\n- 'Specific inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ⩽5.5 on the Expanded Disability Status Scale (EDSS),10 even if they do use an aid for daily activities; and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity).' [1]\n- 'Excluded were people who were (1) unable to speak and read English or French; (2) unable to respond to simple questions on orientation and memory; (3) have an additional illness that restricts their function; and/or (4) experienced a relapse during the past 30 days as this may affect physical activity/exercise participation.' [1]\n\nThe eligibility criteria for this trial appear to be quite pragmatic. The trial includes individuals who are representative of the target population of people with multiple sclerosis, with specific criteria related to ambulatory status and level of physical activity. The exclusion criteria are reasonable and do not overly restrict the population. Overall, the trial seems to have a pragmatic approach to participant eligibility.\n\nScore: [4]","Eligibility:\n1. 'Fifty relapsing patients with multiple sclerosis (MS) who had been on natalizumab therapy ≥24 months and were contemplating natalizumab discontinuation were enrolled.' [1]\n2. 'Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria,19 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.' [1]\n3. 'Candidates were excluded from the study if active disease was identified at baseline per clinical (presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).' [1]\n\nThe eligibility criteria for this trial appear to be relatively pragmatic. The inclusion criteria are broad, including patients with relapsing MS who have been on natalizumab therapy for at least 24 months and have an EDSS score of ≤7.0. The exclusion criteria are also straightforward, excluding patients with active disease at baseline. Overall, the trial seems to enroll participants who are similar to those who would receive this intervention in usual care. Score: [4]","Eligibility:\n1. 'Fifty relapsing patients with multiple sclerosis (MS) who had been on natalizumab therapy ≥24 months and were contemplating natalizumab discontinuation were enrolled.' [1]\n2. 'Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria,19 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.' [1]\n3. 'Candidates were excluded from the study if active disease was identified at baseline per clinical (presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).' [1]\n\nThe eligibility criteria for this trial appear to be relatively pragmatic. The inclusion criteria are broad, including patients with relapsing MS who have been on natalizumab therapy for at least 24 months and have an EDSS score of ≤7.0. The exclusion criteria are also straightforward, excluding patients with active disease at baseline. Overall, the trial seems to enroll participants who are similar to those who would receive this intervention in usual care. Score: [4]","Eligibility:\n1. 'Fifty relapsing patients with multiple sclerosis (MS) who had been on natalizumab therapy ≥24 months and were contemplating natalizumab discontinuation were enrolled.' [1]\n2. 'Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria,19 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.' [1]\n3. 'Candidates were excluded from the study if active disease was identified at baseline per clinical (presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).' [1]\n\nThe eligibility criteria for this trial appear to be relatively pragmatic. The inclusion criteria are broad, including patients with relapsing MS who have been on natalizumab therapy for at least 24 months. The exclusion criteria are also straightforward, excluding patients with active disease at baseline. Overall, the trial seems to enroll participants who are similar to those who would receive this intervention in usual care. Score: [4]","Eligibility:\n1. 'Fifty relapsing patients with multiple sclerosis (MS) who had been on natalizumab therapy ≥24 months and were contemplating natalizumab discontinuation were enrolled.' [1]\n2. 'Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria,19 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.' [1]\n3. 'Candidates were excluded from the study if active disease was identified at baseline per clinical (presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).' [1]\n\nThe eligibility criteria for this trial appear to be relatively pragmatic. The inclusion criteria are broad, including patients with relapsing MS who have been on natalizumab therapy for at least 24 months and have an EDSS score of ≤7.0. The exclusion criteria are also straightforward, excluding patients with active disease at baseline. Overall, the trial seems to enroll participants who are similar to those who would receive this intervention in usual care. Score: [4]","Eligibility:\n1. 'Fifty relapsing patients with multiple sclerosis (MS) who had been on natalizumab therapy ≥24 months and were contemplating natalizumab discontinuation were enrolled.' [1]\n2. 'Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria,19 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.' [1]\n3. 'Candidates were excluded from the study if active disease was identified at baseline per clinical (presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).' [1]\n\nThe eligibility criteria for this trial appear to be relatively pragmatic. The inclusion criteria are broad, including patients with relapsing MS who have been on natalizumab therapy for at least 24 months and have an EDSS score of ≤7.0. The exclusion criteria are also straightforward, excluding patients with active disease at baseline. Overall, the trial seems to enroll participants who are similar to those who would receive this intervention in usual care. Score: [4]","Eligibility:\n1. 'Fifty relapsing patients with multiple sclerosis (MS) who had been on natalizumab therapy ≥24 months and were contemplating natalizumab discontinuation were enrolled.' [1]\n2. 'Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria,19 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.' [1]\n3. 'Candidates were excluded from the study if active disease was identified at baseline per clinical (presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).' [1]\n\nThe eligibility criteria for this trial appear to be relatively pragmatic. The inclusion criteria are broad, including patients with relapsing MS who have been on natalizumab therapy for at least 24 months. The exclusion criteria are also straightforward, excluding patients with active disease at baseline. Overall, the trial seems to enroll participants who are similar to those who would receive this intervention in usual care. Score: [4]","Eligibility:\n1. 'Fifty relapsing patients with multiple sclerosis (MS) who had been on natalizumab therapy ≥24 months and were contemplating natalizumab discontinuation were enrolled.' [1]\n2. 'Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria,19 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.' [1]\n3. 'Candidates were excluded from the study if active disease was identified at baseline per clinical (presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).' [1]\n\nThe study enrolled patients who had been on natalizumab therapy for at least 24 months and were contemplating discontinuation. The inclusion criteria were clearly defined and the exclusion criteria were based on clinical and MRI evaluations. The study population appears to be representative of patients who would receive this intervention in usual care. Score: [5]","Eligibility:\n1. 'Fifty relapsing patients with multiple sclerosis (MS) who had been on natalizumab therapy ≥24 months and were contemplating natalizumab discontinuation were enrolled.' [1]\n2. 'Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria,19 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.' [1]\n3. 'Candidates were excluded from the study if active disease was identified at baseline per clinical (presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).' [1]\n\nThe eligibility criteria for this trial appear to be relatively pragmatic. The inclusion criteria are broad, including patients with relapsing MS who have been on natalizumab therapy for at least 24 months and have an EDSS score of ≤7.0. The exclusion criteria are also straightforward, excluding patients with active disease at baseline. Overall, the trial seems to enroll participants who are similar to those who would receive this intervention in usual care. Score: [4]","Eligibility:\n1. 'Male fans of two ice hockey teams (35–65 yr; body mass index ≥28 kg·m−2) located in Ontario (Canada) were randomized to intervention (Hockey FIT) or comparator (wait-list control).' [1]\n2. 'Eligible participants were male 35–65 yr old with a BMI of ≥28 kg·m−2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).' [2]\n3. 'Our results are provocative because we found that men who participated in the Hockey FIT program lost weight, increased their steps per day, and improved other clinical outcomes (e.g., systolic BP), their diet, and perceptions of their own health, to a greater extent compared with the controls.' [3]\n\nThe full text provides clear information about the eligibility criteria for the trial. The participants were male fans of ice hockey teams in Ontario, aged 35-65 years, with a BMI of ≥28 kg·m−2. They were required to meet PA safety requirements. The eligibility criteria are pragmatic and similar to those in usual care. Score: [5]","Eligibility:\n1. 'Male fans of two ice hockey teams (35–65 yr; body mass index ≥28 kg·m−2) located in Ontario (Canada) were randomized to intervention (Hockey FIT) or comparator (wait-list control).' [1]\n2. 'Eligible participants were male 35–65 yr old with a BMI of ≥28 kg·m−2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).' [2]\n3. 'Our study had several strengths. In this study, we sought to reflect real-world conditions, in preparation for the definitive trial, where our goal will be to determine the effect of this program under conditions we expect it to be applied after research (23).' [3]\n\nThe full text provides clear information about the eligibility criteria for the trial. The participants were male fans of ice hockey teams, aged 35-65 years, with a BMI of ≥28 kg·m−2. They were required to meet the physical activity safety requirements. The eligibility criteria are pragmatic and similar to those that would be used in usual care. Score: [5]"]],"container":"<table class=\"display\">\n  <thead>\n    <tr>\n      <th> <\/th>\n      <th>Author &amp; Year<\/th>\n      <th>Reason for failed response (click to show LLM response)<\/th>\n      <th>Ultimately successful<\/th>\n      <th>LLM response<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"bPaginate":false,"dom":"ft","columnDefs":[{"targets":2,"render":"function(data, type, row, meta) { return '<a onclick=\"javascript:alert(`'+row[4]+'`)\" style=\"cursor: pointer\">' + data + '<\/a>' }"},{"targets":[0,4],"visible":false},{"orderable":false,"targets":0}],"order":[],"autoWidth":false,"orderClasses":false}},"evals":["options.columnDefs.0.render"],"jsHooks":[]}</script>
</div>
<div id="llm-prompt" class="section level3">
<h3>LLM prompt</h3>
<ul>
<li>Model: <code>gpt-3.5-turbo-16k-0613</code></li>
<li>Temperature: <code>0</code></li>
<li>Briefing derived from: <a
href="http://precis-2.org/Help/Documentation/ToolkitDownload">PRECIS-2
Toolkit page 4</a></li>
</ul>
<div id="system-prompt" class="section level4">
<h4>System prompt</h4>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<pre>
You are an expert in clinical trial design and are tasked to assess the PRECIS-2 scores of a trial based on the full text of its publication. You have the following briefing:
---
# PRECIS-2 Domains
* Eligibility: To what extent are the participants in the trial similar to those who would receive this intervention if it was part of usual care? For example, score 5 for very pragmatic criteria essentially identical to those in usual care; score 1 for a very explanatory approach with lots of exclusions (e.g. those who don’t comply, respond to treatment, or are not at high risk for primary outcome, are children or elderly), or uses many selection tests not used in usual care.
* Recruitment: How much extra effort is made to recruit participants over and above what that would be used in the usual care setting to engage with patients? For example, score 5 for very pragmatic recruitment through usual appointments or clinic; score 1 for a very explanatory approach with targeted invitation letters, advertising in newspapers, radio plus incentives and other routes that would not be used in usual care.
* Setting: How different is the setting of the trial and the usual care setting? For example, score 5 for a very pragmatic choice using identical settings to usual care; score 1, for a very explanatory approach with only a single centre, or only specialised trial or academic centres.
* Organisation: How different are the resources, provider expertise and the organisation of care delivery in the intervention arm of the trial and those available in usual care? For example, score 5 for a very pragmatic choice that uses identical organisation to usual care; score 1 for a very explanatory approach if the trial increases staff levels, gives additional training, require more than usual experience or certification and increase resources.
* Flexibility (delivery): How different is the flexibility in how the intervention is delivered and the flexibility likely in usual care? For example, score 5 for a very pragmatic choice with identical flexibility to usual care; score 1 for a very explanatory approach if there is a strict protocol, monitoring and measures to improve compliance, with specific advice on allowed co-interventions and complications.
* Flexibility (adherence): How different is the flexibility in how participants must adhere to the intervention and the flexibility likely in usual care? For example, score 5 for a very pragmatic choice involving no more than usual encouragement to adhere to the intervention; score 1 for a very explanatory approach that involves exclusion based on adherence, and measures to improve adherence if found wanting. In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.
* Follow-up: How different is the intensity of measurement and follow-up of participants in the trial and the likely follow-up in usual care? For example, score 5 for a very pragmatic approach with no more than usual follow up; score 1 for a very explanatory approach with more frequent, longer visits, unscheduled visits triggered by primary outcome event or intervening event, and more extensive data collection.
* Primary outcome: To what extent is the trial's primary outcome relevant to participants? For example, score 5 for a very pragmatic choice where the outcome is of obvious importance to participants; score 1 for a very explanatory approach using a surrogate, physiological outcome, central adjudication or use assessment expertise that is not available in usual care, or the outcome is measured at an earlier time than in usual care.
* Primary analysis: To what extent are all data included in the analysis of the primary outcome? For example, score 5 for a very pragmatic approach using intention to treat with all available data; score 1 for a very explanatory analysis that excludes ineligible post-randomisation participants, includes only completers or those following the treatment protocol.
---
 
</pre>
</div>
<div id="user-prompt" class="section level4">
<h4>User prompt</h4>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<pre>
This is the full text to be assessed:
---
%FULLTEXT%
---

For each of the 9 domains of PRECIS-2, perform the following steps:
1. Extract 1-3 relevant quotes from the full text.
2. Explain your reasoning in 1 paragraph.
3. Give a score X from 1 (very explanatory) to 5 (very pragmatic) in square brackets like this: "Score: [X]". If the full text does not contain enough information to assess a specific domain, report "Score: [NA]".

Do not provide a final summary paragraph in the end.
 
</pre>
</div>
</div>
</div>

</div>

<script>
$(document).ready(function() {
  // add bootstrap table styles to pandoc tables
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed table-sm');

  // initialize mathjax

});
</script>

<script type="text/javascript">
$(document).ready(function () {
  FlexDashboard.init({
    fillPage: true,
    orientation: "columns",
    storyboard: false,
    defaultFigWidth: 576,
    defaultFigHeight: 460,
    defaultFigWidthMobile: 360,
    defaultFigHeightMobile: 460,
    resize_reload: true
  });
  var navbar = $(".navbar").first();
  var body = $("body").first();
  var sidebar = $(".section.sidebar").first();
  function addNavbarPadding() {
    var navHeight = navbar.outerHeight();
    body.css("padding-top", (navHeight + 8) + "px");
    sidebar.css("top", navHeight + "px");
    var resizeEvent = window.document.createEvent("UIEvents");
    resizeEvent.initUIEvent("resize", true, false, window, 0);
    window.dispatchEvent(resizeEvent);
  }
  if (!window.Shiny) setTimeout(addNavbarPadding, 100);
  $(document).on("shiny:idle", function() {
    setTimeout(addNavbarPadding, 50);
  });
});
</script>

</body>
</html>
